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Abstract 
 
The current landscape of nanotechnology has focussed attention on materials that self-
assemble. The search for such materials has unsurprisingly led to the biological world, where 
functional nanoscale biomolecular assemblies are in abundance. Amyloid fibrils are one such 
self-assembling biological structure, formed when native proteins misfold into insoluble fibrous 
quaternary structures. This research has explored the use of amyloid fibrils formed from waste 
proteins, namely crude crystallin proteins from fish eye lenses, as biological nanowires. 
The use of amyloid fibrils as nanowires was investigated by examining the ability to control 
their dimensions and arrangement, along with analysis of their properties, such as stability and 
conductivity. TEM and AFM studies on the model amyloid forming protein, bovine insulin, 
showed that a number of fibril length distributions can be achieved, by systematically altering 
fibril growth and storage conditions. Although the same set of conditions cannot be directly 
applied to crystallin fibrils, these fibrils can also be produced on a range of length scales. 
Amyloid fibrils can be manipulated and aligned in a controlled manner by dielectrophoresis; 
this tool could later be used to incorporate amyloid fibrils into a biosensing or bioelectronics 
device. 
Dielectrophoresis was also used to immobilise crystallin fibrils between electrode pairs, in 
order to investigate the conductivity of small numbers of fibrils. These experiments 
complemented work carried out on the conductivity of amyloid fibril networks, using fabricated 
interdigitated electrodes.  In the unmodified state, amyloid fibrils formed from bovine insulin, 
fungal hydrophobins, and crude crystallins were all shown to have low conductivity, with 
current values in the range of 10-8–10-10 A recorded at bias voltages of 0–2 V. Amyloid fibrils 
were used as a template for the synthesis of conductive nanowires, by modification with the 
conducting polymers polyaniline and polypyrrole, increasing conductivity by one and four 
orders of magnitude respectively.  
The functionalisation of fibrils with glucose oxidase enabled the creation of a very simple 
glucose sensing device. This device, consisting of a gold electrode modified with the glucose 
oxidase functionalised fibrils, showed an electrochemical response in the presence of glucose 
and the mediator FcOH. Future work is necessary to optimise the use of amyloid fibrils in this 
way; however, this study confirms a role for amyloid fibrils from a low cost source in 
bionanotechnology. 
Chapter 1 – Introduction  1 
 
 
 
1. Chapter One  
Introduction 
 
1.1. Context 
A role has been recognised for a number of biomolecules and biomolecular assemblies 
in the fast emerging field of bionanotechnology, where they may be used in a number 
of ways; for example, as nanowires. Amyloid fibrils, a highly ordered misfolded protein 
state, are one such biomolecular assembly that has been identified with potential in this 
area. However, the majority of work in the literature has focused on the use of amyloid-
like fibrils formed from engineered peptides. This thesis aims to investigate the use of 
amyloid fibrils, formed from native proteins, as biological nanowires – with a focus on 
those formed from cheap, readily available proteins.  
This chapter provides a background on amyloid fibril structure and their formation, 
along with how these unique structures may fit into the field of bionanotechnology. 
 
1.2. Bionanotechnology 
The term bionanotechnology refers to the interaction between the fields of biology and 
nanotechnology, with nanotechnology being defined as the creation, design, and 
manipulation of structures or particles with dimensions smaller than 100 nm (Chan, 
2006). Once a field solely utilised by engineers and physical scientists, nanotechnology 
is now being used by the biological and medical research communities, and is drawing 
inspiration, and in some cases raw materials, from the biological world.  
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In the search for new nanomaterials and components, a focus has been placed on those 
that self-assemble, with this “bottom-up” approach to manufacturing being recognised 
as one of the ways of manufacturing in the future (Gras, 2007a). Traditional “top-
down” fabrication of nanomaterials and components involves processes like 
lithography to produce such structures by patterning; by contrast, “bottom-up” 
assembly refers to the creation of nanostructures via self-assembly from relatively 
simple building blocks, and biology can aid in the provision of these building blocks 
(Figure 1.1). 
 
 
Figure 1.1. A comparison of the “top-down” and “bottom-up” approaches to 
manufacturing of nanomaterials. The top-down fabrication process is based on the 
patterning of assemblies using lithography. The bottom-up approach is based on the 
interaction of simple building blocks to form a well-ordered assembly by molecular 
recognition and self-assembly. Schematic taken from Gazit (2007). 
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Nanostructures include nanotubes (NT), nanofibres (NF), nanobelts (NB), nanodisks 
(ND), and nanoparticles (NP), as shown in Figure 1.2. The smallest dimensions of 
these structures are usually less than 100 nm, for example, platinum nanoparticles are 
usually in the 6-10 nm diameter size range (El-Sayed, 2001), and carbon nanotubes 
(CNTs) can vary from 0.4-100 nm diameter, with variable lengths (Ding et al., 2001; 
Tang et al., 2001).  
 
Figure 1.2. A schematic representation of common nanostructures. Adapted from 
Chopra et al. (2007). 
 
The shift to a “bottom-up” approach has unsurprisingly led to the wide use of biological 
molecules and macromolecular assemblies, as these biological species are similar in 
size to nanostructures. Some typical sizes of proteins and biological species are given in 
Table 1.1 (Vo-Dinh, 2005). Potential has been seen for a number of these assemblies to 
be translated into functional nanomaterials.  
 
Table 1.1. Typical sizes of biological species. Adapted from Vo-Dinh (2005). 
Biological species Example Typical size 
Small proteins Chymotrypsin 4 nm sphere 
Large proteins Aspartate transcarbamoylases 7 nm sphere 
Small assemblies Ribosome 20 nm sphere 
Large assemblies Viruses 100 nm sphere 
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1.3. Amyloid fibrils 
Amyloid fibril is the name given to the insoluble fibrous quaternary structure formed by 
the assembly of normally soluble protein or peptide monomers into intermolecularly 
hydrogen bonded β-sheets (Chiti and Dobson, 2006). The structure of amyloid fibrils is 
discussed in greater detail below (Section 1.3.1.). The name “amyloid” was given based 
on the first identification of these insoluble deposits (Virchow, 1854), where they were 
stained with iodine, making them amylose-like. In later years, protein components were 
identified (Friedreich and Kekulé, 1859), but the name amyloid has remained.  
Amyloid fibrils are best known for their role in a number of diseases, such as 
Alzheimer’s disease, Type II diabetes, Parkinson’s disease and Creutzfeld-Jacob 
disease (Chiti and Dobson, 2006). In these diseases, commonly occurring proteins 
misfold forming insoluble fibrillar aggregates. Functional amyloid assemblies also exist 
(Otzen and Nielsen, 2008), and these are discussed in Section 1.3.1. It is now known 
that amyloid fibrils can form from a variety of different protein and peptide solutions, 
and this, as well as a number of other desirable properties (Gras, 2007a), has shifted 
research into amyloid fibrils from being solely into their involvement in disease, to 
include their use as novel bionanomaterials. 
 
1.3.1. Amyloid fibril structure 
A number of different techniques, including electron microscopy (EM), atomic force 
microscopy (AFM), X-ray fibre diffraction, and solid-state nuclear magnetic resonance 
(ssNMR), have been employed to fully characterise both the macromolecular and 
internal structure of amyloid fibrils (Makin and Serpell, 2005). 
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There is a wide range of different morphologies of fibrils: straight and twisted fibrils, 
linear assemblies with several laterally associated fibrils (Kowalewski and Holtzman, 
1999), rings (Hatters et al., 2003), and large spherical clusters of fibrils called 
spherulites (Krebs et al., 2004). Solution conditions can favour a particular morphology 
as was observed by Petkova et al. (2005), in their work on β-amyloid fibrils, where the 
predominant structure present was controlled by subtle variations in fibril growth 
conditions. The basic unit of amyloid fibrils is known as a protofilament, and amyloid 
fibrils consist of a number of these, typically 2-6, each of which is about 2-5 nm in 
diameter (Serpell et al., 2000). This protofilament structure of amyloid fibrils is seen to 
be conserved across a range of proteins (Serpell et al., 2000), although the way the 
protofilaments associate with each other can differ. Different numbers and 
arrangements of protofilaments have even been observed under the same experimental 
conditions (Jiménez et al., 1999; Makin and Serpell, 2004). Figure 1.3 shows the 3-D 
reconstruction of insulin fibrils and depicts fibrils formed with two, four, and six 
protofilaments (Jimenez et al., 2002). In some cases, the protofilaments twist together 
to form rope-like fibrils 7-13 nm wide (Goeden-Wood et al., 2003; Serpell et al., 2000), 
while in other cases, the protofilaments associate laterally to form long ribbons that are 
2-5 nm thick and up to 30 nm wide (Saiki et al., 2005).  
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Figure 1.3. The protofilament structure of amyloid fibrils. Often a variety of different 
protofilament structures exist for amyloid fibrils from a protein. A) Surface 
representation of 3-D maps of the four insulin fibril structures. From left to right: A 
pair of protofilaments, the four protofilament compact fibril, the six protofilament 
fibril, the twisted ribbon. B) Molecular model of an amyloid fibril derived from cryo-
EM analysis of SH3 domain fibrils. This model shows the β-sheet structure of amyloid 
fibrils within the protofilaments. Figures taken from Jimenez et al. (2002). 
 
Amyloid fibrils have a cross-β structure (Figure 1.4), which was first observed by X-
ray fibre diffraction from the egg stalk of the lacewing Chrysopa (Geddes et al., 1968), 
and consists of β-strands, approximately 4.7 Å apart, arranged perpendicular to the 
fibril axis, and β-sheets, approximately 10 Å apart,  running parallel to the axis of the 
fibril (Makin and Serpell, 2005; Serpell et al., 2000). Other proposed models for the 
internal structure of amyloid fibrils include a β-helical structure, that of hollow 
nanotubes, and also a model where the native structure of the monomeric protein is 
largely retained (Makin and Serpell, 2005).  
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Figure 1.4. Schematic of the hierarchies of amyloid fibril structure, from fibril, to 
protofilament, to the internal cross-β structure. Schematic taken from Jaskolski (2001). 
 
1.3.2. Amyloid fibril formation 
When a polypeptide chain comes off the ribosome there are a number of different 
structures that can be formed: the native state of the protein, which is reached through 
the formation of intermediate structures, and degraded and aggregated structures as 
shown in Figure 1.5 (Dobson, 2003a).  
Chapter 1 – Introduction  8 
 
 
 
 
Figure 1.5. Schematic of the different states that may be adopted by a protein molecule 
following synthesis at the ribosome. U = Unfolded, I = Intermediate, N = Native. The 
arrows show the transitions from state to state, with the dotted arrows representing 
transitions which sometimes occur. Schematic taken from Dobson (2003a). 
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The state a protein adopts under specific conditions depends on the relative 
thermodynamic and kinetic stabilities of the various states (Dobson, 2003b).  Amyloid 
fibrils are just one type of aggregated state that can be adopted by a protein, but are 
unique in having such a highly ordered ‘misfolded’ structure (Dobson, 2003a). This 
highly ordered amyloid structure is also stable, as shown by the diagram in Figure 1.6 
(Jahn and Radford, 2008). The kinetics of protein folding have been explained through 
the concept of an energy landscape, with a rough energy landscape showing the various 
other states the protein may exist in and their relative stabilities (Jahn and Radford, 
2008). 
 
 
Figure 1.6.  Schematic showing a combined energy landscape for protein folding and 
aggregation, taken from Jahn and Radford (2008). A) There are a number of 
conformational states which are available to a polypeptide chain, each differing in 
energy and entropy. The surface represents the roughness of the energy landscape. 
Shown in light grey, is from polypeptide chain to the native monomeric state, and in 
dark grey, where there is an increase in roughness, intermolecular protein association. 
B) There are a number of proposed pathways between the different conformational 
states; unfolded (U), intermediate (I), native (N), ordered aggregate (OA), amorphous 
aggregate (AA), oligomer (O), and fibril (F). 
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Amyloid fibril formation is shown schematically in Figure 1.7. The native monomeric 
state of the protein is disrupted in some way, by a change in physical and/or chemical 
conditions, causing the formation of partially folded intermediate species. These 
intermediates then self-assemble into ladders of β-strands which then aggregate to form 
amyloid fibrils (Cherny and Gazit, 2008).   
 
Figure 1.7. The formation of amyloid fibrils. The folded monomer undergoes a 
conformational transformation from the native state to form a partially unfolded 
intermediate species. These intermediates then self-assemble to form a fibril “nucleus”, 
from which protofilaments are formed by elongation of the nuclear unit. These 
protofilaments then come together to form a mature fibril (Jimenez et al., 2002).  
 
Amyloid fibril formation has been shown to have many characteristics of a nucleated 
growth mechanism (Chiti and Dobson, 2006). The kinetics and formation of amyloid 
fibrils is discussed in greater detail in Chapter 3. 
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1.3.3. Sources of amyloid fibrils 
Amyloidogenic proteins are diverse in sequence and share few characteristics, which 
reinforces the idea that the amyloid structure can be generated by many polypeptide 
sequences (Fowler et al., 2007). It has been shown that many proteins can be induced to 
form fibrils under appropriate physical and chemical conditions, such as temperature 
and pH extremes, solvents and chaotropic agents (Gras, 2007a). In addition to the more 
than 25 different proteins associated with different amyloid pathologies (Krishnan and 
Lindquist, 2005), a number of different proteins/peptides form amyloid fibrils, both in 
nature and in vitro (Stefani and Dobson, 2003).  
Functional amyloid structures also exist. It has been identified that nature uses the 
cross-β mode of self-organisation in many structural contexts (Otzen and Nielsen, 
2008). Functional amyloid proteins have been found across varied domains of life 
including humans, invertebrates, fungi, and bacteria. Some examples of these 
functional amyloid proteins include those playing roles in human melanosomes (Berson 
et al., 2003; Fowler et al., 2005), spider and moth silk (Iconomidou et al., 2000; 
Kenney et al., 2002), the termination factor Sup35 in yeast (True and Lindquist, 2000), 
coatings of fungal spores (Kwan et al., 2006), and in bacteria, curli protein and 
inclusion bodies (Carrio et al., 2005; Chapman et al., 2002). 
It has been proposed that, if the correct conditions are found, amyloid fibril formation is 
a generic property of all proteins (Chiti and Dobson, 2006). So far, a number of 
proteins that are not known to form fibrils in disease or nature have been induced to 
form fibrils in vitro, these include bovine insulin (Nielsen et al., 2001b), wheat proteins 
(Mackintosh et al., 2009), hen egg lysozyme (Krebs et al., 2000), α-lactoglobulin 
(Graveland-Bikker and de Kruif, 2006), milk proteins (Thorn et al., 2005), ovalbumin, 
and bovine serum albumin (Pearce et al., 2007). 
In this thesis, three different amyloid-forming proteins are used, bovine insulin, crude 
crystallin proteins, and fungal hydrophobins, each possessing unique and interesting 
properties. Bovine insulin is used as the model amyloid-forming protein in this study, 
since it is very well characterised (Brange et al., 1997; Jimenez et al., 2002; Nielsen et 
al., 2001a; Nielsen et al., 2001b; Podesta et al., 2006; Whittingham et al., 2002), and 
forms defined fibrils very rapidly from the native structure.  
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The other amyloid-forming proteins used are fungal hydrophobins, mentioned 
previously as one of many proteins that form functional amyloids (Kwan et al., 2006), 
and fish eye crystallin proteins. Amyloid fibrils formed from crude fish eye crystallin 
proteins are the main focus of this study, since if amyloid fibrils are to be used 
successfully in bionanotechnology, there is a need for production of amyloid fibrils 
from a readily available and inexpensively sourced protein (Waterhouse and Gerrard, 
2004). Crude fish crystallins meet this requirement, as we have shown in our lab that 
they can be produced in large quantities from low value waste products (Healy et al., 
2011). 
Each of these amyloid fibril sources are discussed in more detail in Chapter 2. 
 
1.3.4. Characterisation of amyloid fibrils 
A number of techniques exist for the characterisation of amyloid fibrils, with the main 
ones being the recognition of a fibrillar structure, either by microscopy or by X-ray 
scattering, as well as the ability to bind and shift the spectral properties of certain 
hydrophobic dyes. Circular dichroism (CD) and Fourier Transform Infrared 
spectroscopy (FTIR) can also reveal the high β-sheet content of amyloid fibrils. 
Transmission electron microscopy (TEM) is commonly used to recognise fibrillar 
morphology in in vitro protein aggregation (Nilsson, 2004). As well as confirming the 
presence of amyloid fibrils, it also provides useful structural information as the latest 
TEMs can operate at close to one Å resolution (Smith, 2008). TEM generally shows 
amyloid fibrils to be straight, unbranching fibres, with 70-120 Å diameters, and of 
variable lengths (Cohen et al., 1982). 
AFM can also be used for visual characterisation of fibrils. Due to the nature and 
limitations of AFM, it is most useful and reliable for topographic measurements. AFM 
has been used previously in a number of cases to study self-assembly and the surface 
structure of amyloid fibrils (Dong et al., 2006; Morris et al., 1999; Podesta et al., 
2006). 
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As detailed in Section 1.3.2, amyloid fibrils have a “cross-β” structure, with β-sheets 
arranged parallel to the fibril axis with their constituent β-strands perpendicular to the 
axis. This cross-β structure is recognised by X-ray fibre diffraction, with the resulting 
diffraction pattern having two characteristic signals, a sharp reflection at 4.7 Å along 
the same direction as the fibril axis and a more diffuse reflection at between 10 and 11 
Å perpendicular to the fibril direction, arising from the molecular spacings between the 
β-strands and β-sheets respectively (Eanes and Glenner, 1968) (Figure 1.8). 
 
 
Figure 1.8. X-ray fibre diffraction is a common method for recognising the cross-β 
structure of amyloid fibrils (A). The resulting diffraction pattern (B) has two 
characteristic signals, a sharp reflection at 4.7 Å along the same direction as the fibril 
axis and a more diffuse reflection at between 10 and 11 Å perpendicular to the fibril 
direction, arising from the molecular spacings between the β-strands and β-sheets 
respectively. Figure adapted from (Biancalana and Koide, 2010; Makin and Serpell, 
2005). 
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Amyloid fibrils may also be characterised by specific chemical staining, such as with 
the dyes Congo red and Thioflavin T (ThT). When stained with Congo red, amyloid 
fibrils show an apple-green colour when viewed in a light microscope under cross-
polarised light. ThT is a benzothiazole dye that binds to amyloid fibrils, and while 
much research has been done, the mechanism of this binding is yet to be fully 
understood (Khurana et al., 2005; Krebs et al., 2005; Wolfe et al., 2010). It was first 
introduced in 1959 as a dye that shows enhanced fluorescence upon binding to amyloid 
fibrils in tissue sections (Vassar and Culling, 1959). It is now commonly used for 
amyloid fibril detection with the dye being added to samples and a characteristic ThT 
fluorescence emission at approximately 480 nm detected when excited at 450 nm. ThT 
binding of amyloid fibrils can be used in a number of ways such as diagnosis of 
amyloid fibrils in tissue sections using fluorescence microscopy (Vassar and Culling, 
1959), to directly observe amyloid fibril growth using total internal reflection 
fluorescence spectroscopy (Ban et al., 2006), and for monitoring of extracted amyloid 
fibrils and in vitro amyloid fibril formation using fluorescence spectroscopy (LeVine 
III, 1993; Naiki et al., 1989). The ThT assay measures the change in fluorescence 
intensity of ThT upon binding to amyloid fibrils (Nilsson, 2004). 
In this thesis TEM, AFM,  X-ray fibre diffraction, and the ThT assay have been used 
for characterisation of amyloid fibril structures.  
 
1.4. Amyloid fibrils in bionanotechnology 
Over the past decade, there has been an increasing interest in the use of amyloid fibrils 
in bionanotechnology for a range of different applications due to them possessing a 
number of desirable properties that recommends their use in this field (Cherny and 
Gazit, 2008; Gras, 2007b; Gras, 2009; Hamada et al., 2004; Mankar et al., 2011; 
Waterhouse and Gerrard, 2004). Some of these properties are generic characteristics of 
proteins, whereas others are specific to the amyloid fibril structure. 
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1.4.1. Properties of amyloid fibrils 
In addition to self-assembly, the topography of amyloid fibrils also recommends their 
use as nanomaterials. They naturally exist in the nanometre scale, with widths of 
generally 7-10 nm and lengths of up to several microns (Gras, 2007a). These lengths 
are usually highly heterogeneous, and this is addressed in Chapter 3. When using 
biological molecules in the assembly of nanostructures it is important to have a high 
level of longevity in the structure formed (Gras, 2007a). Because of their highly 
ordered β-sheet structure, amyloid fibrils are stable at pH and temperature extremes 
(Scheibel, 2005), as well as at high pressure (Dirix et al., 2005). This observed stability 
is particularly relevant, due to the similarities in these conditions to those likely to be 
encountered in an industrial setting, where these nanostructures may be manufactured 
or used (Scheibel et al., 2003). 
The mechanical properties of amyloid fibrils are also of interest. Amyloid fibrils have 
been shown to have a strength comparable to steel and are flexible, with a stiffness 
similar to that of silk (Smith et al., 2006). These mechanical properties are overall 
similar to those seen in spider silk, which could be expected as both are β-sheet rich 
protein fibrils (Smith et al., 2006). The major difference is that while spider silk 
requires complex biological machinery to reach its final form, amyloid fibrils self-
assemble in solution. 
As amyloid fibrils can be formed from a vast number of different proteins and peptides 
(Fowler et al., 2007), there is huge sequence versatility available (Gras, 2007a). It is 
also possible to target specific amino acids to be exposed on the fibril surface so that 
additional functionality can be introduced to fibrils through the attachment of bioactive 
groups, enzymes and other non-protein groups (Hartgerink, 2004). Functionality can 
also be added to fibrils through the formation of “cofibrils” as demonstrated by 
MacPhee and Dobson with the incorporation of fluorescence into fibrils by the 
formation of mixed fibrils of insulin and a fluorescent peptide (MacPhee and Dobson, 
2000). 
The favourable surface interactions of amyloid fibrils are another feature that 
recommends their use in bionanotechnology. Amyloid fibrils can interact with and bind 
to non-biological solid surfaces while remaining intact, unlike globular proteins (Gras, 
2007a).  
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1.4.2. Applications in bionanotechnology 
A number of different applications for amyloid fibrils in bionanotechnology have been 
identified, in medicine, health and nutrition, catalysis, electronics, plastics and 
structural materials (Waterhouse and Gerrard, 2004). Significant steps have already 
been taken towards the use of amyloid fibrils in various applications. Amyloid fibrils 
may be used as functional templates, where by modification via enzyme 
immobilisation, metal coating, or other chemical modifications, they may be used as 
nanowires, or as enzyme scaffolds for biosensing, bioremediation, or other applications. 
Many polymers, either synthetic or natural, may form gels and/or liquid crystal phases 
(Cherny and Gazit, 2008). Amyloid fibril hydrogels have applications in both tissue 
engineering and drug delivery.  
Amyloid fibrils have been used as nanoscaffolds for enzyme immobilisation, with the 
dimensions of amyloid fibrils offering a large surface area, which increases the active 
enzyme area, in addition to the other known benefits of enzyme immobilisation such as 
reusability and increased stability (Brady and Jordaan, 2009).  The chemistry of the 
different amino acid side chains can be exploited to add functionality to fibrils 
(Hartgerink, 2004) via the formation of cross-links between mature fibrils and enzymes 
of interest. Organophosphate hydrolase and glucose oxidase  have both been covalently 
attached to amyloid fibrils in this manner, making active fibrils that could be used in 
bioremediation, antimicrobial films and biosensing (Pilkington et al., 2010; Raynes et 
al., 2011; Yemini et al., 2005a).  
Another mode of enzyme immobilisation to fibrils is the creation of fusion proteins, 
where the protein of interest is fused to an amyloid-forming protein monomer prior to 
fibril formation, resulting in decorated fibrils. By this method green fluorescent protein, 
barnase bacterial protein, carbonic anhydrase, glutathione-S-transferase, and 
cytochromeb562 have been attached to fibrils (Baldwin et al., 2006; Baxa et al., 2002). 
Chapter 1 – Introduction  17 
 
 
 
Amyloid fibrils also show promise in tissue engineering, with functionalised amyloid 
fibril scaffolds promoting cell growth and adhesion. For example, it was seen that 
designed amyloidogenic peptide sequences that had been functionalised with an 
integrin recognition motif, produced fibrils that interacted specifically with cells 
(Bongiovanni et al., 2011; Gras et al., 2008). A number of amyloid forming proteins 
and peptides have been shown to form hydrogels (Aggeli et al., 2003; Bhak et al., 
2010; Maity et al., 2011). For example, Aggeli et al showed that a peptide derived from 
hen lysozyme forms pH dependent gels, which may be used in scenarios where a 
responsive material is desirable (Aggeli et al., 2003).  Responsive materials such as 
these have potential biomedical applications, where biocompatibility and/or 
biodegradability is sought after (Waterhouse and Gerrard, 2004). 
 
1.5. Nanowires 
Nanowires, along with nanotubes, nanobelts, and nanosprings, are a type of 1-D 
nanostructure, which have been the subject of increasing research focus due to their 
unique properties, as when materials are reduced to the nanometre scale, new electrical, 
optical, and mechanical properties are often displayed. The high aspect ratio of 1-D 
nanostructures also provides a large surface-to-volume ratio, which can be beneficial to 
a number of applications, for example, the immobilisation of enzymes for biosensing. 
There are also other properties that enhance these materials’ desirability and 
applicability, such as control over dimensions and arrangement, and stability under a 
range of conditions, particularly those conditions that may be encountered in potential 
applications. 
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In general, 1-D nanostructures are formed by promoting the crystallisation of solid-state 
structures along one dimesion, and this process can be carried out by a range of 
different mechanisms, with the main ones identified by Wanekaya et al. (2006) as: 
1) The use of 1-D template structures to direct the formation of the nanostructure. 
2) The use of the intrinsically anisotropic crystallographic structure of a solid to 
achieve 1-D growth. 
3) The use of a liquid/solid interface to reduce the symmetry of a seed. 
4) The use of appropriate capping agents to kinetically control the growth rates of 
various facets of a seed. 
Nanowires can be formed from a number of different materials, with CNTs and 
crystalline nanowires such as silicon nanowires (SiNW) gaining the most attention 
since their discovery in 1991 and 1998 respectively (Iijima, 1991; Yu et al., 1998). 
Nanowires are also often formed from other metals, semiconductors, and inorganic 
compounds. Of interest to this thesis are nanowires formed from biological materials. 
 
1.5.1. Biological nanowires 
Not only are the dimensions of many biological macromolecules comparable to 
nanoscale building blocks, the presence of high-aspect ratio elongated structures in 
biology means that a number of biological macromolecules and macromolecular 
assemblies have been investigated as nanowires. With most of the biological structures 
investigated having low conductivity in the native state, the use of biomolecules, such 
as nucleic acids, viruses, proteins, and peptides, as templates for the formation of 
metallic and semiconductor nanowires has been explored. The different biomolecules 
that have been investigated for use as nanowires, along with their dimensions, sources, 
and with what they have been modified, are summarised in Table 1.2. 
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Table 1.2. Summary of the variety of different biomolecules and biomolecular 
assemblies that have been investigated as nanowires, or as templates for nanowire 
formation. 
Biomolecule/ 
Biomolecular 
assembly 
Dimensions 
(diameter/length) 
Source Modified 
nanowires 
(biomolecule 
as a 
template) 
References 
A) Nucleic 
acids 
    
DNA 1-2 nm/tunable in 
micron range 
PCR Au, Ag, Pt, Pd, 
Cu 
(Braun et al., 1998; Ford et al., 
2001; Kim et al., 2010; Monson 
and Woolley, 2003; Patolsky et 
al., 2002; Richter et al., 2000; 
Richter et al., 2001; Seidel et al., 
2004) 
B) Viruses     
Tobacco 
mosaic virus 
(TMV) 
18 nm, 4 nm 
(central 
channel)/300 nm  
 CdS, PbS, Pd, 
FeO, Si, Ni, Co, 
Ag, Au, Pt, 
CoPt, FePt3 
(Dujardin et al., 2003; Knez et al., 
2003; Lim et al., 2010; Shenton et 
al., 1999; Tsukamoto et al., 2007) 
C) Proteins     
Collagen 1.5 nm/300 nm Self-assembly 
from proteins 
produced by 
recombinant 
expression 
Au, ZnO (Bai et al., 2007; Bai et al., 2009; 
Orza et al., 2011) 
Actin 8 nm/up to 10 μm  Au (Patolsky et al., 2004) 
Microtubules 25 nm/several 
microns 
Isolated from 
porcine brain 
tissue 
Ag, Au, Co, 
FeO, Ni, Pd,  
(Behrens et al., 2004; Zhou et al., 
2008; Zhou et al., 2010) 
Amyloid fibrils 10-20 nm/up to 
several microns 
Self-assembly 
from proteins 
produced by 
recombinant 
expression, and 
from crude 
waste materials 
Conducting 
polymers 
(PEDOT-S, 
PTAA, PPF), 
H2PtCl6, Ag, 
Fe3+ 
(Choi et al., 2011; Hamedi et al., 
2008; Herland et al., 2007; Hsieh 
and Hsieh, 2010; Leroux et al., 
2010; Malisauskas et al., 2008; 
Scheibel et al., 2003; Tanaka et 
al., 2008; Tang et al., 2010) 
D) Peptides     
Peptide 
nanotubes 
1-100 nm/ Self-assembly 
from engineered 
peptide 
solutions 
Au, Ag, Cu, Pt, 
Zns 
(Banerjee et al., 2003; Banerjee et 
al., 2005; Djalali et al., 2002; 
Djalali et al., 2003; Kasotakis et 
al., 2009; Song et al., 2004) 
Amyloid-like 
peptide 
nanotubes 
Eg. FF peptide 
1-100 nm/  Au, Ag, Co3O4 (Carny et al., 2006; Reches and 
Gazit, 2003; Ryu et al., 2009) 
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1.5.2. Nucleic acids 
DNA molecules have been identified as interesting building blocks for nanotechnology 
due to their size, chemical robustness, and the ability to synthesise large amounts for 
relatively low costs. In terms of size, the diameters of ssDNA and dsDNA are 
approximately 1 and 2 nm respectively, and the length of DNA can be easily tuned, 
from nanometres to microns, using a range of techniques such as PCR, DNA ligation 
and enzymatic digestion, with the length per nucleoside subunit 0.34 nm (Gu et al., 
2006).  
In regards to using the DNA molecule itself as a nanowire, the inherent conductivity of 
DNA is in debate, with current values in the nanoAmp range recorded under applied 
potentials up to 6 V recorded for DNA networks of 100 nm wires (Cai et al., 2000),  
and studies also reporting that DNA is insulating at lengths greater than 40 nm, where 
currents remained below the noise level of approximately 1 pA under applied potentials 
up to 10 V for bundles of approximately 10 DNA molecules (Storm et al., 2001). 
What has been of more interest, due to these poor electrical characteristics, is the use of 
DNA molecules as templates for self-assembly of metallic nanowires. This work began 
in 1998, when Braun created the first conductive nanowire using DNA as a template for 
the formation of conductive silver nanowires (Braun et al., 1998). Since this pioneering 
study, DNA nanowires have been formed via modification with silver (Braun et al., 
1998), gold (Kim et al., 2006; Patolsky et al., 2002), platinum (Ford et al., 2001; Seidel 
et al., 2004), palladium (Richter et al., 2000; Richter et al., 2001), and copper (Monson 
and Woolley, 2003). 
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1.5.3. Viruses  
Whole biological organisms have also attracted attention as nanowires, such as the 
Tobacco Mosaic Virus (TMV).  TMV is a rod shaped RNA virus, which is formed from 
the self assembly of 2130 coat protein subunits which are arranged helically with a coil 
of RNA that spans the length of the virus (Shenton et al., 1999). The TMV is uniform 
in diameter and length, existing with dimensions of 18 nm and 300 nm respectively. 
The TMV also has a 4 nm hollow core, and has chemically distinct internal and 
external surfaces, meaning that it may be modified on both its internal and external 
surfaces (Dujardin et al., 2003; Tsukamoto et al., 2007).  
Nanowires have been formed using TMV as a template with surface modification of the 
TMV by cadmium sulfide, lead sulfide, iron oxide, silica (Shenton et al., 1999), 
platinum, palladium, and gold (Dujardin et al., 2003; Lim et al., 2010). The central 
channel of TMV has also been used as a template, with 3 nm nickel and cobalt 
nanowires being produced this way (Knez et al., 2003), as well as a variety of other 
nanowires (Dujardin et al., 2003; Tsukamoto et al., 2007). 
Other viruses have also been used for this purpose, such as the M13 bacteriophage, 
which was used as a scaffold for the synthesis of ZnS, CdS, CoPt, and FePt nanowires 
(Mao et al., 2004). 
 
1.5.4. Proteins 
There are a number of naturally occurring fibrous protein structures, and globular 
proteins can also be induced to form fibrous structures, as in the case of amyloid fibrils. 
The morphology and dimensions of these protein structures make them excellent 
candidates for the formation of self assembling 1-D nanostructures. 
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Protein structures have the advantage of chemical and biological diversity, providing 
building blocks with heterogeneity. The amino acid building blocks also give the 
opportunity to exploit the chemistry of the various side chains for derivitisation and 
functionalisation, be it for metallic modification or the immobilisation of enzymes. The 
option for genetic control of the primary sequence further enhances this property, and 
via recombinant expression it is possible to easily generate large amounts of a protein 
of interest, making them a readily available source. Additionally, typically fibrous 
proteins have a higher relative stability than globular proteins, and unique mechanical 
properties (Wong Po Foo and Kaplan, 2002). 
 The use of proteins as biological nanowires has been explored in some detail, with a 
variety of different protein structures used. These protein/peptide nanotubes (PNTs), 
and nanofibres (PNFs), have been used as template molecules in a number of different 
ways.  Figure 1.9 shows a schematic representation of the three most common ways; 
by modification with metallic nanoparticles (NPs), conducting polymers (CPs), and 
metal ions.  
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Figure 1.9. Schematic showing the most common ways in which protein/peptide 
nanotubes/nanofibres (PNTs/PNFs) are used for the templating of conductive 
nanowires. 1) The PNT/PNF is modified with metallic nanoparticles (NPs). This may 
occur such that the PNT/PNF itself is decorated with metallic NPs (a), or with the 
PNT/PNF being used as a “sacrificial” template for the formation of a chain of 
metallic NPs (b). 2) The PNT/PNF is modified with conducting polymer (CP) 
monomers, with the polymerisation reaction being carried out in the presence of the 
PNT/PNF, forming a coating of conducting polymer on the surface of the PNT/PNF. 3) 
The PNT/PNF is modified with metal ions. a) A coating of metal may be formed on the 
exterior of the PNT/PNF, or b) on the interior of a PNT. In some cases, c), the PNT can 
then be removed, leaving a thin metallic nanowire. 
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1.5.5. Collagen 
As the major component of the extracellular matrix of bone, cartilage, skin, blood 
vessels and corneas, collagen is one of the most abundant proteins in higher organisms. 
The collagen triple helix is approximately 300 nm long and 1.5 nm in diameter, and 
collagens consist of one or more of these triple helices (Kadler et al., 1996). It is this 
hierarchical design, along with the relative dimensions of the building molecules, that 
give collagen its superior mechanical properties, creating a tough and robust material 
(Buehler, 2006).  
Collagen has been modified to form both gold and zinc oxide nanowires (Bai et al., 
2007; Bai et al., 2009; Orza et al., 2011). Bai et al. (2007) used a collagen-like triple 
helix, which is formed from a polypeptide that was genetically engineered and contains 
a fragment from the natural collagen sequence. With collagen being using largely in 
tissue engineering applications, the application of metallically modified collagen has 
also been investigated here. Orza et al. (2011) constructed a matrix of gold coated 
collagen nanofibres and demonstrated how these could be used for the growth and 
differentiation of human adult stem cells. 
 
1.5.6. Actin 
Filamentous actin (F-actin), formed by the polymerisation of monomers of globular 
actin (G-actin), has a diameter of 8 nm and exists in lengths up to 10 μm (Kabsch and 
Vandekerckhove, 1992). In vivo, the polymerisation and depolymerisation of actin is a 
dynamic equilibrium; however, in vitro, actin can be stabilised against 
depolymerisation (Cooper, 1987), and this is essential for the use of actin as a 
filamentous building block, or as a nanowire. Protein-metal nanowires have been 
formed based on the use of G-actin as a molecular building block, with the filaments 
being coated with gold nanoparticles (Patolsky et al., 2004), the process shown in 
Figure 1.9, 1a.  
 
 
Chapter 1 – Introduction  25 
 
 
 
1.5.7. Microtubules 
Microtubules are proteinaceous cylindrical structures which are assembled from tubulin 
protofilaments, resulting in a structure with an external diameter of 25 nm and several 
microns in length (Nogales, 2001). In vivo, they are part of the cytoskeleton, and are 
involved in processes such as motility and intracellular transport. Tubulin, from which 
microtubules are formed, can also form other structures, such as sheets, spirals, and 
rings. Nanowires of nickel, cobalt, silver, gold, and iron oxide have all been formed 
around the microtubule template (Behrens et al., 2004; Zhou et al., 2008; Zhou et al., 
2010). 
 
1.5.8. Peptides 
Peptides have been identified as excellent building blocks for nanotechnology, due to 
chemical variety, biocompatibility, and their ability to spontaneously associate into a 
range of structures such as nanofibrils, nanotapes, nanoribbons, nanospheres, and 
nanotubes (Valéry et al., 2011). The elongated structures achievable have variable 
dimensions, some with diameters as small as 1 nm, and others up to hundreds of 
nanometres (Valéry et al., 2011). Self-assembling peptides have also been investigated 
as nanowires, mainly as template molecules. Like proteins, peptides offer surfaces 
which can be functionalised, which has seen the creation of nanowires of gold (Djalali 
et al., 2002; Djalali et al., 2003; Kasotakis et al., 2009), silver (Kasotakis et al., 2009; 
Reches and Gazit, 2003), copper (Banerjee et al., 2003), cobalt oxide (Ryu et al., 
2009), platinum (Kasotakis et al., 2009; Song et al., 2004), zinc sulfide (Banerjee et al., 
2005), and even trilayered metal-insulator-metal coaxial cables (Carny et al., 2006).   
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1.5.9. Amyloid inspired peptides 
Peptide design is based on the predicted interactions between the side chains, which has 
resulted in inspiration from amyloid fibrils, with a number of self-assembling peptides 
being fragments of amyloid-forming proteins (Cherny and Gazit, 2008). The peptide 
that has attracted the most attention in this field over the last few years is the dipeptide 
diphenylalanine (FF). This short aromatic peptide is the key recognition sequence of the 
Alzheimer’s disease β-amyloid peptide and forms discrete and hollow nanotubes in 
solution (Reches and Gazit, 2003). Aside from being modified with metals, Gazit and 
co-workers have also shown the ability to control arrangement of these peptide 
nanotubes, with vertical arrays created by vapour deposition (Adler-Abramovich et al., 
2009), and alignment of nanotubes in a magnetic field (Hill et al., 2007). Some 
investigation has also been made into their conductive properties in the unmodified 
state. By immobilising FF peptide nanotubes between electrodes using 
dielectrophoresis, Castillo et al. created current-voltage (I-V) curves for small bundles 
of nanotubes (Castillo et al., 2008). The current transmitted through the immobilised 
nanotubes after an applied potential of 0-3 V was in the pA range, confirming that the 
peptide nanotubes had high resistance. 
 
1.6. Amyloid fibrils as nanowires 
Amyloid inspired peptide nanotubes have gained a large amount of attention as 
nanowires. Less research has involved amyloid fibrils formed from whole amyloid 
forming proteins, although there are some previous investigations that have looked at 
amyloid fibrils as both unmodified and modified nanowires, beginning with the work of 
Schiebel et al. in 2003, where amyloid-like fibres formed from the N-terminal and 
middle region (NM region) of Sup25p, a prion determinant from Saccharomyces 
cerevisiae, were shown to act as insulators with high resistance and, after modification 
via gold toning, to conduct with low resistance (Scheibel et al., 2003). Another study 
on unmodified fibrils formed from an elastin-related polypeptide showed these amyloid 
fibrils to be able to sustain electrical conduction, with current values in the range of 
several nanoAmps at 0-2 Volts (del Mercato et al., 2007) these, however, are still low 
current values in comparison to other nanowires such as CNTs.  
Chapter 1 – Introduction  27 
 
 
 
Amyloid fibril nanowires have also been investigated with the fibrils undergoing 
modification by conducting polymers as well as other metallic modifications. Insulin 
amyloid fibrils have been used as scaffolds for the formation of conducting polymer 
nanowires, with insulin amyloid fibrils being modified with the conducting polymers 
poly(thiophene acetic acid) (PTAA), alkoxysulfonate PEDOT (PEDOT-S), and 
poly(propylene fumarate) (PPF) (Hamedi et al., 2008; Herland et al., 2008; Tanaka et 
al., 2008).  Insulin amyloid fibrils have also been modified with the platinum complex, 
hexachloroplatanic acid (Tang et al., 2010),  and silver nanoparticles (Leroux et al., 
2010), as well as being used as a sacrificial template for the formation of gold 
nanowires (Hsieh and Hsieh, 2010). Amyloid fibrils formed from α-synuclein and 
lysozyme have also been used in this way, with fibrils modified with iron (Choi et al., 
2011) and silver (Malisauskas et al., 2008) respectively. 
 
1.7. Nanowire applications 
Nanowires, be they biological, metallic, or semiconducting, have a range of different 
applications in the fields of electronics, optics, magnetic medium, thermoelectronics, 
and sensing. In this thesis, biosensing was used as a model nanowire application. 
 
1.8. Biosensing 
Biosensing is the detection and quantification of biological and chemical species, and is 
critical to many areas of health care and life science. It involves the transduction of a 
signal that is associated with the selective recognition of a species of interest (Patolsky 
et al., 2006). As efficient biosensing requires direct interaction with biomolecules of 
dimensions in the nanoscale, it is predictable that this field requires techniques and 
probing tools that exist on a similar scale (Li et al., 2005) and so nanostructures, such 
as nanowires, offer the opportunity to develop novel sensors. 
The four most commonly used types of biosensing devices based on nanowires are 
nanowire-modified microtips, single nanowire field-effect transistors (FETs), porous 
nanowire films, and nanoelectrode arrays (Li et al., 2005). These are shown 
schematically in Figure 1.10.  
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Figure 1.10. Schematic representations of the four most common types of biosensing 
devices based on nanowires. A) Nanowire-modified microtips, B) Single nanowire 
field-effect transistors (FETs) C) Porous nanowire films, and D) Nanoelectrode arrays.  
 
Nanowire-modified microtips (Figure 1.10, A) have a single nanowire extended from a 
microtip, and this can be used to probe a single cell or single molecules (Li et al., 
2005). Depending on the detection technique, the nanowire may either be attached to an 
optical fibre for optical detection, or to an electrode for electrical or electrochemical 
detection. Single nanowire FETs (Figure 1.10, B) function by exhibiting a conductivity 
change along the nanowire in response to variations in the electric field or potential at 
the surface (Patolsky et al., 2006). The standard set-up involves a semiconductor 
nanowire connected to a metal source and drain electrodes through which current flows. 
This current flow between the source and drain electrodes, via the nanowire, is 
switched on and off by a third electrode, the gate. The surface of the nanowire is often 
modified with receptor groups that recognise specific molecules, i.e., the analyte of 
interest. The binding of the analyte of interest results in an increase/decrease in the 
conductance of the nanowire and this is the signal that is associated with the presence 
of this analyte. 
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Porous nanowire films (Figure 1.10, C) can exist as a thin film which is cast on a 
conventional electrode, or as a 3-D porous film (Li et al., 2005), most often in the 
creation of an enzyme-based electrochemical sensor (described in Section 1.8.1). CNTs 
have been used in this way, with the large surface-to-volume ratio and good electrical 
conductance of carbon nanotubes allowing them to act as both the immobilisation 
matrix for the enzyme, and also the mediator molecules, which are present to improve 
the electron transport between the active site of the enzyme and the electrode. 
Nanoelectrode arrays (Figure 1.10, D) are usually comprised of arrays of vertically 
aligned CNTs. The electrochemical signal is a characteristic of the oxidation-reduction 
reaction of the analyte, as opposed to non-specific charges sensed by FETs, which 
results in high specificity (Li et al., 2005). 
There have been some previous investigations in the use of PNTs/PNFs as 
immobilisation scaffolds for the creation of enzyme electrode sensors, specifically 
using PNTs/PNFs formed from the FF peptide, a collagen-type peptide, and the ionic 
complementary peptide EFK16-11 (Qian et al., 2009; Yemini et al., 2005a; Yemini et 
al., 2005b; Yemini et al., 2006). In this thesis, amyloid fibrils are used as an 
immobilisation matrix for glucose oxidase (GOx), creating a porous nanowire film-type 
biosensor. This is discussed in detail in Chapter 5. 
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1.8.1. Glucose sensing 
Glucose sensing has a very important role in both the diagnosis and management of 
diabetes, as well as in the food industry. In diabetes, careful monitoring of blood and 
urine glucose levels is necessary to correctly diagnose and manage the disease. Glucose 
monitoring is used in the food industry during fermentation processes, as the amount of 
glucose greatly influences the quality of food products. 
Since the creation of the first glucose monitor in 1971, this field has grown rapidly due 
to high demand, with glucose sensors dominating the biosensor market (Oliver et al., 
2009). There are a number of different types of glucose sensors, with detection methods 
based on fluorescence, electrochemistry, and spectroscopy, among many others. For the 
purpose of this thesis, the focus is on those sensors which use enzyme electrodes, a 
mode of detection which was first created in 1962 (Clark Jr and Lyons, 1962). 
Enzyme electrodes function by using enzymes that catalyse oxidation-reduction 
reactions, and so donate and accept electrons. This electron movement from the enzyme 
may then be used to produce a concentration-dependent current or voltage, which may 
be measured using electrodes. In glucose sensing, the enzyme GOx is widely used. 
GOx catalyses the conversion of glucose to gluconolactone; detail of this reaction and 
the GOx enzyme can be found in Section 5.2. GOx modified electrodes can be used in 
glucose sensing either by measuring oxidation and reduction of a mediator molecule, 
eg. ferrocene, or by measuring peroxide amperometrically using a platinum electrode. 
The schematic in Figure 1.11 shows how these two scenarios work. 
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Figure 1.11. Schematic showing the functioning of glucose oxidase (GOx) enzyme 
electrodes as glucose sensors. These can work in one of two ways; A) Through the 
amperometric detection of hydrogen peroxide using a platinum electrode, and B) By 
measuring the oxidation and reduction of a mediator molecule. 
 
1.9. Thesis objectives 
This introduction has provided background information regarding the structure, 
formation, and sources of amyloid fibrils, as well as how amyloid fibrils may be used in 
the field of bionanotechnology. 
Amyloid fibrils formed from three different protein systems were used throughout this 
thesis. Bovine insulin was used as a model amyloid forming protein due to it being very 
well characterised. Fungal hydrophobins were used due to their formation of well 
aligned rodlets, making it an interesting system. Finally, crude fish crystallin proteins 
were used as a readily available protein source, due to the proteins being able to be 
extracted from waste products. The early part of this study involved formation and 
characterisation of amyloid fibrils from these three protein sources. Due to gaps in the 
current knowledge on amyloid fibrils formed from crude fish crystallins, these were 
characterised in greater detail. 
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There are a number of favourable properties in a nanowire, and the ability of amyloid 
fibrils, particularly those formed from crude crystallin proteins, to realise these led to a 
focus on this protein. As such, the stability in solution of crystallin fibrils was 
examined. This is particularly relevant in light of what has been shown regarding the 
stability in solution of a leading amyloid-like peptide nanotube, and also potential end-
point applications, such as their use in biosensing. 
A systematic study was then conducted in order to investigate the ability to control the 
dimensions of amyloid fibrils. Given what is known about amyloid fibril formation 
(Brange et al., 1997), it was hypothesised that altering the growth and storage 
conditions used for the formation of amyloid fibrils would influence the dimensions of 
the resulting fibrils. Control over fibril dimensions enhances their desirability as 
nanomaterials, as well as being necessary for the experimental set-up in Chapter 4. 
Although there have been previous studies that have utilised modified amyloid fibrils as 
nanowires, less is known about the intrinsic conductivity of amyloid fibrils formed 
from native proteins in the unmodified state. This was investigated by examining the 
conductive properties of amyloid fibril networks formed from three different native 
protein sources, with direct comparison to literature values for amyloid-like fibrils 
formed from peptides. Conductivity measurements on individual, or small bundles of 
fibrils were also carried out; in order to do this crystallin fibrils were manipulated and 
immobilised between electrodes by dielectrophoresis. The ability to control the 
arrangement of amyloid fibrils on a microchip would open up new opportunities for 
their use in bionanotechnology. 
It was then of interest to investigate the use of amyloid fibrils in a model nanowire 
application. Other nanowires, including biological ones, have been used in the 
construction of glucose sensors, and the use of amyloid fibrils was investigated. 
Methods already existed for enzyme immobilisation onto bovine insulin fibrils, and the 
aim was to also immobilise enzymes, in this case glucose oxidase, to amyloid fibrils 
formed from crude fish crystallins. The use of these functionalised fibrils in glucose 
sensing was explored. 
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1.10. Thesis overview  
Chapter 2 details the formation and characterisation of amyloid fibrils formed from the 
three protein sources used in this thesis; bovine insulin, fungal hydrophobins, and crude 
fish crystallins. An investigation into the stability of amyloid fibrils formed from crude 
crystallin proteins is also detailed in this chapter. 
Chapter 3 focuses on the use of growth and storage conditions to control the length of 
amyloid fibrils formed from bovine insulin and crude fish crystallins. 
Chapter 4 presents the conductive properties of networks of amyloid fibrils formed 
from bovine insulin, fungal hydrophobins, and crude fish crystallins; along with the 
modification of bovine insulin with conducting polymers. Amyloid fibrils formed from 
crude crystallin proteins were also manipulated and isolated using dielectrophoresis. 
Chapter 5 details an investigation into the use of amyloid fibrils in the construction of a 
glucose sensor, chosen as a model nanowire application. This entails the creation of 
glucose oxidase functionalised fibrils, electrochemical characterisation of amyloid 
fibrils, and the glucose sensing capabilities of an electrode modified with functionalised 
fibrils. 
Chapter 6 summarises the major findings of this thesis, and future directions to be 
pursued from this work. 
Chapter 7 outlines the experimental procedures used throughout this body of work.  
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2. Chapter Two 
Formation and characterisation of amyloid 
fibrils 
 
2.1. Introduction 
In this thesis, three different amyloid-forming proteins are used: bovine insulin, fungal 
hydrophobins, and crude crystallin proteins. Fibrils formed from each of these different 
proteins differ in morphology, and each has unique and interesting properties. This 
thesis focuses mainly on those fibrils formed from crude crystallin proteins, which were 
extracted from fish eye lenses. If these fibrils, or protein nanofibres (PNFs), are able to 
be used in bionanotechnology, this will add value to a low cost waste product.  
This chapter demonstrates the formation of amyloid fibrils from these three protein 
sources. The amyloid fibrils formed were characterised by microscopy and the ThT 
assay, with crystallin fibrils also being characterised by X-ray fibre diffraction. X-ray 
fibre diffraction is one of the main techniques used to ascertain the presence of the 
characteristic “cross-β” amyloid fibril structure and diffraction patterns for amyloid 
fibrils formed from crude fish crystallins have not previously been obtained. 
 If amyloid fibrils formed from crude crystallin proteins are to be used as building 
blocks for bionanotechnology, as nanowires or as a nanoscaffold, there are a number of 
issues that need to be addressed in order to make them more attractive for commercial 
applications, one of these being stability. This chapter also investigates the stability in 
solution of crystallin amyloid fibrils. 
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2.2. Amyloid fibrils formed from bovine insulin 
As less is known about fibrils formed from crude fish crystallins, amyloid fibrils from 
bovine insulin were also used extensively in this study, as a model amyloid fibril 
system. Bovine insulin forms amyloid fibrils very rapidly, and this fibril system has 
been very well characterised. There is a large amount of literature available on insulin 
amyloid fibrils, including detail of their morphology (Jimenez et al., 2002; Nielsen et 
al., 2001a), and mechanism and kinetics of their formation (Bouchard et al., 2000; 
Brange et al., 1997; Devlin et al., 2006; Nielsen et al., 2001b). There have also been 
studies that have investigated their use in bionanotechnology, as scaffolds for enzyme 
immobilisation (Pilkington et al., 2010; Raynes et al., 2011), and as nanowire templates 
(Herland et al., 2007; Herland et al., 2008; Hsieh and Hsieh, 2010; Hsieh and Hsieh, 
2011). 
 
2.2.1. Bovine insulin 
Bovine insulin is a globular protein with a molecular weight of approximately 5.7 kDa. 
In its native state, the polypeptide hormone has a mainly helical structure with two 
polypeptide chains, linked by two inter-chain and one intra-chain disulfide bonds 
(Figure 2.1) (Blundell et al., 1971). Bovine insulin consists of 51 amino acids, 20 in 
the A chain, shown in Figure 2.1 in orange, and 31 in the B chain, shown in blue. In 
solution, insulin exists as an equilibrium mixture of monomers, dimers, tetramers, 
hexamers, and possibly higher order states (Nielsen et al., 2001b). It is accepted in the 
literature that it is the monomeric form of insulin that forms amyloid fibrils (Brange et 
al., 1997). Bovine insulin used throughout this study was obtained commercially. 
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Figure 2.1. PyMOL image of the native structure of bovine insulin. In this ribbon 
representation, the A chain is shown in orange, and the B chain is shown in blue. The 
three disulfide bonds are shown in stick representation and are coloured yellow. This 
image was constructed using PyMOL from PDB file 2A3G (Delano, 2002). 
 
 
2.2.2. Bovine insulin fibrillation 
Bovine insulin is often used in studies of amyloid formation as it forms fibrils very 
rapidly from disruption of the natively hexameric structure, into monomers that then 
progress through the fibril formation pathway (Brange et al., 1997). More detail of the 
mechanism of fibril formation from bovine insulin is given in Chapter 3.  In vitro, 
insulin can be converted from this native structure to the fibrillar form by incubation at 
high insulin concentrations, low pH and high temperature, with fibrillation occurring 
under these conditions within hours (Krebs et al., 2004; Nielsen et al., 2001b; Waugh, 
1946). Other studies have also used denaturants such as guanidine hydrochloride and 
urea to form amyloid-like aggregates from insulin (Ahmad et al., 2003; Ahmad et al., 
2004) 
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 For this study, insulin amyloid fibrils were formed by subjecting bovine insulin to low 
pH, high temperatures, and the presence of salt. The standard conditions used were 
those developed in-house to optimise fibril formation, and involved incubation of 
insulin at 5.8 mg/mL, in buffer containing 100 mM NaCl, 25 mM HCl, pH 1.6, at 60 °C 
for 24 hours (Section 7.2.1). The presence of fibrils was then confirmed using ThT 
(Section 7.2.2), a fluorescent dye that is frequently used to detect amyloid formation in 
vitro (LeVine III, 1993), and visually, by the appearance of fibrillar structures under 
TEM (Section 7.5). 
In situ ThT fluorescent measurements were carried out in a 96 well plate reader, with 
fibrillation monitored by measuring fluorescence over four hours of incubation, with 
measurements taken every five minutes (Section 7.2.1). Figure 2.2 shows the increase 
in ThT fluorescence over the period of incubation. The observed ThT fluorescence 
intensity had a classic sigmoidal pattern (Nielsen et al., 2001b), with a lag phase, here 
of approximately 40 minutes, followed by a rapid increase in fibril formation (Figure 
2.2). A plateau is then reached, indicating that most soluble protein has been converted 
into fibrils.  
Figure 2.3 shows a representative TEM image of amyloid fibrils formed from bovine 
insulin. When amyloid fibrils are viewed by TEM they generally share an elongated, 
unbranched, fibrillar appearance, as visible in the network of fibrils shown in Figure 
2.3 . 
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Figure 2.2.  Time profiles for ThT induced fluorescence of bovine insulin incubated at 
a concentration of 5.8 mg/mL in fibril buffer (closed square), and control sample 
containing no insulin (open square), at 60 °C. Each reading represents an average of 
triplicate well readings, with the error bars representing standard error. 
 
 
 
Figure 2.3. Representative TEM image with negative staining of amyloid fibrils formed 
from bovine insulin. Scale bar is 0.2 μm. 
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2.3. Amyloid fibrils formed from fungal hydrophobins 
Amyloid fibrils formed from fungal hydrophobins are unique in that the fibrils formed 
are part of a spontaneously forming monolayer of amyloid fibril “rodlets” (Sunde et al., 
2008). The formation of this rodlet monolayer with unique amphipathic properties has 
lead to investigations into the use of hydrophobins in bionanotechnology (Gras, 2007; 
Hou et al., 2009; Wang et al., 2010; Zampieri et al., 2010; Zhao et al., 2007). 
 
2.3.1. Fungal hydrophobins 
Hydrophobins are a family of low molecular weight (7-9 kDa) proteins with a 
characteristic pattern of cysteine residues that form four disulfide bonds. Other than 
these conserved cysteine residues, the family shares little amino acid sequence 
homology, but have very similar hydrophobicity plots (Sunde et al., 2008). This protein 
family is unique to fungi, where in vivo, they are secreted as soluble monomers and 
upon reaching an interface, aggregate spontaneously to form robust polymeric 
monolayers that are highly amphipathic (Linder et al., 2005). A TEM image showing a 
hydrophobin monolyer formed in vitro is shown in Figure 2.4 (Morris et al., 2011). 
These monolayers act as natural surfactants, reducing the surface tension of the medium 
and allowing fungi to breach the air/water interface and to produce hyphae (Wösten et 
al., 1999).  
 
 
Figure 2.4. Negatively stained TEM micrograph of an in vitro formed rodlet 
monolayer. From Morris et al. (2011). 
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There are two classes of hydrophobins, referred to as Class I, and Class II. Class I 
hydrophobins form insoluble polymer rodlets, Class II hydrophobins form polymers 
that are soluble in some organic solvents – with no rodlet appearance (Sunde et al., 
2008). For this study, the hydrophobin protein used was the Class I hydrophobin EAS, 
named so as it is the protein encoded by the easily-wettable gene from Neurospora 
crassa, which was obtained from Margie Sunde at the University of Sydney. A NMR 
solution structure of this protein is shown in Figure 2.5. EAS has a β-barrel fold 
comprised of four antiparallel β-sheets, with an additional two-stranded β-sheet, and 
two sizeable disordered regions (Figure 2.5) (Kwan et al., 2006). 
 
 
Figure 2.5. PyMOL image of the native solution structure of the Class I hydrophobin 
EAS.  In this ribbon representation, the β-sheets are shown in orange, and the 
disordered loops are shown in blue. This image was constructed using PyMOL from 
PDB file 2FMC (Delano, 2002; Kwan et al., 2006). 
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2.3.2. Hydrophobin fibrillation 
The rodlets formed by Class I hydrophobins have been shown to have many structural 
and morphological similarities with amyloid fibrils. EAS rodlets have been previously 
shown to bind Congo red and ThT (Mackay et al., 2001). All that is required for the 
formation of rodlets is the creation of a hydrophobic:hydrophilic interface, which 
triggers rodlet assembly (Wösten and de Vocht, 2000). A model for rodlet assembly is 
shown in Figure 2.6. 
 
Figure 2.6. Model for assembly of hydrophobin rodlet monolayer. Monomers diffuse to 
the hydrophilic-hydrophobic interface, where they assemble into the rodlet monolayer. 
This interface may be A), an air/water interface, or B), a solid/water interface. 
Schematic adapted from Wösten and de Vocht  (2000). 
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The effect of a number of different conditions, namely protein concentration, the 
presence/absence of agitation (shaking), and of 5 mm glass beads, on the formation of 
hydrophobin rodlets was investigated.  Shaking was used to provide air pockets in the 
solution, creating additional air/water interfaces. The presence of glass beads was used 
to increase the available surface area on which the rodlets could form, and therefore the 
number of solid/water interfaces. The different conditions under which rodlets were 
formed are summarised in Table 2.1. Rodlet formation was monitored for each of the 
samples using the ThT assay in a plate reader.  ThT was included in the nanopure H2O, 
and rodlet formation monitored in real time. Rodlet formation was monitored by 
measuring fluorescence at 482 nm over three hours of incubation (Section 7.3.2).  
Replicates were carried out in a single plate, the typical variation seen between plates 
was less than 10 %. 
 
Table 2.1. Details of the different conditions used to form EAS hydrophobin rodlets. 
Sample Native protein 
concentration 
(mg/mL) 
Solvent Temperature Shaking 
(Y/N) 
Glass beads 
(Y/N) 
1 0 Nanopure H2O 60 °C N N 
2 0.1     
3 0.5     
4 1.0     
5 0   Y N 
6 0.1     
7 0.5     
8 1.0     
9 0   N Y 
10 0.1     
11 0.5     
12 1.0     
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Figure 2.7 compares fibrillation patterns of EAS rodlet formation at 0, 0.1, 0.5, and 1.0 
mg/mL, with all samples incubated at 60 °C in nanopure H2O (Table 2.1, 1-4). Of the 
concentrations examined, 0.5 mg/mL was the lowest at which an increased ThT 
fluorescence was observed, with no increase in fluorescence seen for the 0.1 mg/mL 
sample. As fibril formation is known to be a nucleation dependent polymerisation 
mechanism, there exists a critical concentration, below which fibrillation does not 
occur. It is unlikely in this case that this is the true critical concentration of EAS for 
rodlet formation, as previous work has shown rodlet formation to occur at 
concentrations lower than 1 μg/mL (Wösten and de Vocht, 2000). However, large 
variations in critical concentration have been observed previously in amyloid fibril 
systems, such as in the case of β-lactoglobulin fibrillation, where critical concentrations 
ranging from 0.33 wt % to 2.5 wt % have been reported (Kroes-Nijboer et al., 2009). 
This type of discrepancy has lead to the need to clarify the definition of critical 
concentration to the concentration of native protein where the conversion from protein 
to fibrils is too low to be determined by the method in question (Arnaudov and De 
Vries, 2005). 
Of interest is also the lack of the characteristic sigmoidal shaped curve for fibrillation 
kinetics, as observed in the formation of insulin fibrils (Figure 2.2). No distinct lag 
phase was observed for EAS rodlet formation. This is likely due to the fact that the 
amyloid like structure is functional in vivo for hydrophobins, with fast kinetics being a 
functional feature of the system (Kwan et al., 2006). The rate of rodlet formation was 
seen to increase with increasing concentration (Figure 2.7). 
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Figure 2.7. Time profiles for ThT induced fluorescence of hydrophobins incubated at 
60 °C. Samples were prepared at 0 mg/mL, 0.1 mg/mL, 0.5 mg/mL, and 1.0 mg/mL in 
nanopure water (Samples 1-4, Table 2.1). Each reading represents an average of 
triplicate well readings, with the error bars representing standard error.  
 
When EAS rodlets were formed as per the conditions established above, with the 
addition of shaking (Table 2.1, 5-8), the same trend was seen as in Figure 2.7, with no 
increased fluorescence for the sample formed at 0.1 mg/mL, and above this the rate of 
rodlet formation increasing with increased concentration (Figure 2.8). When EAS 
rodlets were formed in the presence of glass beads (Table 2.1, 9-12), this trend was 
again repeated, although in this instance there was a slight increase in fluorescence 
observed for the 0.1 mg/mL sample (Figure 2.9). 
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Figure 2.8. Time profiles for ThT induced fluorescence of hydrophobins incubated at 
60 °C with shaking. Samples were prepared at 0 mg/mL, 0.1 mg/mL, 0.5 mg/mL, and 
1.0 mg/mL in nanopure water (Samples 5-8, Table 2.1). Each reading represents an 
average of triplicate well readings, with the error bars representing standard error. 
 
 
Figure 2.9. Time profiles for ThT induced fluorescence of hydrophobins incubated at 
60 °C in the presence of beads. Samples were prepared at 0 mg/mL, 0.1 mg/mL, 0.5 
mg/mL, and 1.0 mg/mL in nanopure water (Samples 9-12, Table 2.1). Each reading 
represents an average of triplicate well readings, with the error bars representing 
standard error. 
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When the time profiles for ThT induced fluorescence of hydrophobins incubated at 1 
mg/mL in each of the three conditions are plotted together (Figure 2.10), a difference 
in the rate of rodlet formation is observed. The rate of rodlet formation was calculated 
from the linear region of the curve, with the fastest rate observed for the sample that 
was incubated with glass beads (127.67 ± 5.31 RFU/min) (Table 2.2). An elevated rate 
was also seen for the shaken sample when compared to the sample with elevated 
temperature only, with calculated rates of 116.83 ± 7.31 RFU/min and 85.52 ± 1.13 
RFU/min respectively (Table 2.2). This is an expected result, as the bead provides an 
additional solid/liquid interface on which the rodlet monolayer may form, as depicted in 
Figure 2.6, B, and shaking provides a dynamic air/water interface, as depicted in 
Figure 2.6, A.  Unusually, a lower maximum fluorescence was reached with the sample 
that was shaken (Figure 2.10). 
 
 
Figure 2.10. Time profiles for ThT induced fluorescence of: hydrophobins formed at 60 
°C (black), hydrophobins formed at 60 °C with shaking (red), and hydrophobins formed 
at 60 °C in the presence of beads. All samples were prepared at 1 mg/mL in nanopure 
water. Each reading represents an average of triplicate well readings, with the error 
bars representing standard error. 
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 Table 2.2. Rate of increase in ThT fluorescence, indicative of rodlet formation, for EAS 
hydophobin rodlets formed under different conditions. All rodlets were formed at a 
concentration of 1 mg/mL in nanopure H2O. 
 
Condition Rate 
(RFU/min) 
Heating 60 °C  85.52 ± 1.13 
Heating 60 °C + shaking 116.83 ± 7.31  
Heating 60 °C + beads 127.67 ± 5.31 
 
 
The presence of rodlets was confirmed for all samples by TEM. Figure 2.11 shows a 
representative TEM image of the rodlet monolayer, with unfortunately poor resolution 
due to staining technique. AFM imaging was more effective for these structures and a 
high resolution AFM image is shown in Chapter 4. 
 
 
Figure 2.11. Representative TEM image with negative staining of amyloid fibrils 
formed from fungal hydrophobins. Scale bar is 0.2 μm. 
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2.4. Amyloid fibrils formed from crude fish crystallins 
The nanomaterials that are the main focus of this study are amyloid fibrils formed from 
mixtures of crude crystallin proteins from fish eye lenses. The PNTs/PNFs that have 
previously been investigated as having a potential role in bionanotechnology are 
typically formed from purified proteins and engineered peptides (Gazit, 2007; Hamedi 
et al., 2008; Pilkington et al., 2010), which makes their manufacture a time-consuming 
and often expensive process. If PNTs/PNFs are to be used commercially as 
nanomaterials, a large scale and low cost manufacturing process needs to be established 
(Waterhouse and Gerrard, 2004). Previous work has reported the synthesis of amyloid 
fibrils from crude crystallin protein mixtures, extracted from bovine lenses obtained 
from the abattoir (Garvey et al., 2009). Recently, fish eye lenses have been used in our 
lab for amyloid fibril manufacture (Healy et al., 2012), due to their ready availability 
from the seafood industry, and the fact that they are perceived as safer than bovine 
products in the wake of bovine spongiform encephalopathy outbreaks. Our lab has 
shown that the fibril manufacture process from fish eye crystallins can be scaled up to 
produce large quantities of fibrils (Wong, 2012); however, these fibrils are yet to be 
fully characterised, both structurally, and in terms of their applicability to 
bionanotechnological applications.  
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2.4.1. Crystallins 
In vivo, crystallin proteins are the predominant protein in the eye lense, where their role 
is to maintain lens stability and transparency (Harding, 1991). Crystallins are highly 
stable proteins, which within the lens are organised in a supramolecular β-sheet 
structure (Harding, 1991).  There are three distinct classes of crystallin proteins, 
referred to as α, β, and γ, with each of these classes having distinct subunits. α-
Crystallin is a molecular chaperone and the principal lens protein, and is a member of 
the small heat shock protein family (Harding, 1991). There are two subunits, αA and 
αB, which are closely related. The α-crystallin complex is a highly heterogenous 
aggregate of 20 kDa subunits, resulting in multimers of approximately 300 to 1000 
kDa. β-Crystallin exists as smaller complexes of approximately 50-200 kDa, formed 
from 20-30 kDa subunits, and γ-crystallins exist as monomers of approximately 20 
kDa. Further details of the different classes of crystallin proteins are shown in Table 
2.3. 
 
Table 2.3. Details of the different classes of crystallin proteins. Adapted from (Ecroyd 
and Carver, 2009; Kiss and Cheng, 2008; Posner et al., 2008). 
Class Protein sequences identified 
Mammalian Antarctic toothfish 
(Dissostichus 
mawsoni) 
Zebrafish 
(Danio rerio) 
α-crystallins αA, αB αA, αB αA, αB 
β-crystallins βA (βA1, βA2, βA3, βA4) 
βB (βB1, βB2, βB3) 
βA (βA1, βA2, βA4) 
βB (βB1, βB2, βB3) 
βA (βA1, βA2, βA4) 
βB (βB1, βB2, βB3) 
γ-crystallins γS, γA, γB, γC, γD, γE, γF γM1, γM3, γM4, 
γM5, γM7, γM8a, 
γM8b, γM8c, γ8d, 
γM8e, γM9, γN, γS1, 
γS2 
γM1, γM2a, γM2b, 
γM2c, γM2d1, 
γM2d2, γM3, γM4, 
γM5, γM6, γM7, 
γMx, γN1, γN2, γS1, 
γS2, γS3, γS4 
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The crystallin proteins used in this study were extracted from eye lenses from 
Macruronus novaezelandiae (Hoki), with fish heads obtained from local fish markets, 
and the eye lenses extracted in the lab. No sequence or structural data exists for 
crystallin proteins from M. Novaezelandiae, and so where required, sequences from 
Danio rerio (zebrafish) are used in this thesis. Figure 2.12 shows representative crystal 
structures of proteins from each of the three classes of crystallin proteins. The zebrafish 
structure was chosen where available, and if not available, the structure shown is that 
with the highest sequence similarity to the zebrafish sequence (see Appendix A). 
Within each class, the proteins are closely sequence and structurally related (Ecroyd 
and Carver, 2009), as is evident in Figure 2.12, A-E. The high β-sheet content of native 
crystallins is also apparent (Figure 2.12), with β-crystallins and γ-crystallins 
homologous β-sheet proteins (Ecroyd and Carver, 2009). 
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Figure 2.12. Representative structures of crystallin proteins generated using PyMOL 
(Delano, 2002). A) αA crystallin from D. rerio (PDB 3N3E), B) αB crystallin from H. 
sapien (PDB 3L1G), C) βA-4 crystallin from H. sapien (PDB 3LWK), D) βB-2 
crystallin from B. taurus, and E) γB crystallin from H. sapien (PDB 2JDF).  
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2.4.2. Crystallin fibrillation 
The disease cataract, defined as the opacity of the eye lens, which results in 48 % of 
global blindness (World Health Organisation (WHO), 2011) is caused by crystallin 
aggregation and precipitation. One proposed mechanism for this is the formation of 
amyloid fibrils by crystallin proteins, although to date, crystallin amyloid fibrils have 
not been found in vivo (Meehan et al., 2004). In vitro however, all three classes of 
crystallins, from bovine eye lenses, have been shown to form amyloid fibrils, when 
subjected to denaturing solvents, pH extremes, and high temperatures (Meehan et al., 
2004). 
Amyloid fibrils were formed from mixtures of crude crystallin proteins using in-house 
methods based on those of Garvey et al. (2009), developed to optimise fibril formation. 
These methods involved subjecting the protein to denaturing solvents, low pH, and 
elevated temperatures (Section 7.4.2). This process differs from some other fibril 
formation processes in that after one hour under these conditions, large amorphous 
aggregate is removed, and fibril formation then takes place. In previous studies using 
crystallins from bovine lens, where this step is not present, a large amount of 
amorphous aggregate is present in the final fibril product (Garvey et al., 2009). This is 
not desirable if these fibrils are to be used in bionanotechnology, and this additional 
step prevents the need for later purification of fibrils by proteases (Garvey et al., 2009). 
The presence of amyloid fibrils was confirmed by the ThT assay (Figure 2.13) (Section 
7.4.3). Native crystallin proteins have a high background ThT reading due to their 
predominantly β-sheet structure (Figure 2.12); however, the use of the assay is still 
valid under carefully controlled conditions.  TEM was also used, with a representative 
TEM image shown in Figure 2.14. 
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Figure 2.13. ThT induced fluorescence for control (fibril formation buffer only), native 
(unfibrilised crystallins), and fibrils (fibrilised crystallins). Each reading represents an 
average of triplicate well readings, with the error bars representing the standard 
deviation. 
 
  
 
Figure 2.14. Representative TEM image with negative staining of amyloid fibrils 
formed from crude fish crystallins. Scale bar is 0.2 μm. 
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2.5. X-ray fibre diffraction of amyloid fibrils formed from crude 
crystallins 
 
One of the key identifying features of amyloid fibrils is the characteristic cross-β 
structure (Pauling and Corey, 1951), with β-strands arranged in β-sheets and these β-
sheets then stacked perpendicular to the axis of the fibril. X-ray fibre diffraction can be 
used to examine this structure via the spacing of the isotropic reflections. Although X-
ray fibre diffraction has been used to examine the intermolecular structure of amyloid 
fibrils formed from bovine crystallins (Garvey et al., 2009), it had not previously been 
done on fibrils formed from crude fish crystallins.1  
When X-ray fibre diffraction was carried out on crude fish crystallin fibrils, isotropic 
reflections were observed at 4.6 Å and 10.3 Å (Figure 2.15) (Section 7.7). These 
reflections correspond to the spacing between hydrogen bonded β-strands within a β-
sheet and the spacing between multiple β-sheets respectively (Serpell et al. 1999). 
 
 
Figure 2.15. X-ray fibre diffraction pattern of amyloid fibrils formed from crude fish 
crystallins showing the characteristic isotropic reflections at 4.6 Å and 10.3 Å. 
                                                 
1 This work is published in (Healy et al., 2012) 
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TEM images were taken of the resuspended pellet which was used for the X-ray fibre 
diffraction. As shown in Figure 2.16, fibrils were present, with no visible unfibrilised 
protein, meaning that the observed diffraction pattern can be confidently attributed to 
the presence of amyloid fibrils. 
 
Figure 2.16. TEM images of resuspended pellet of crystallin fibrils that was used for 
the X-ray fibre diffraction experiments. Scale bar is 0.5 μm. 
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2.6. Fibril formation from semi-purified crystallin proteins 
In addition to being able to form amyloid fibrils from crude crystallin protein mixtures 
(Garvey et al., 2009), it has also been shown for bovine crystallins that each of the three 
classes of crystallin proteins (α, β, and γ) can be induced to form fibrils (Meehan et al., 
2004), indicating that the fibrils formed from the crude protein mixture are likely to 
have been contributed to by all three crystallin classes. This has not previously been 
demonstrated for fish crystallins. In order to examine whether all three classes of fish 
crystallin proteins are able to form fibrils under the same conditions that crude mixtures 
form fibrils, the crude protein extract was separated into the three classes using size 
exclusion chromatography (SEC), and each semi-purified fraction then subjected to the 
fibril formation conditions previously established (Section 7.8).  
 
2.6.1. Separation of crystallin proteins 
Aliquots of the crude crystallin protein extract, were separated into individual classes of 
crystallin proteins (αT, βT, and γT) using SEC, using methods based of those of (Garvey 
et al., 2009), with proteins eluted using 20 mM Tris, pH 8.0 (Section 7.8.1). The elution 
profile is shown in Figure 2.17.  
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Figure 2.17. Size exclusion separation of crystallin proteins extracted from fish eye 
lenses. Peak fractions corresponding to total α, β, and γ crystallins (labelled αT, βT, and 
γT) were collected to form semi-pure crystallin preparations. Protein eluting before the 
α-crystallin peak was also collected and is referred to as the high molecular weight 
(HMW) fraction. 
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By comparison with previous separations of crystallin proteins (Garvey et al., 2009; 
Pilkington, 2009), including studies which separated crystallins from barracuda 
(Sphyraena novaehollandiae) and the Antarctic toothfish (Dissostichus mawsoni) 
(Healy et al., 2012; Kiss et al., 2010), the major peaks were able to be identified. The 
first peak (unlabelled) is HMW aggregate, the second peak, labelled αT, consists of the 
two closely related subunits αA and αB (Table 2.3). The third peak, labelled βT, 
consists of high, or octomeric, and low, or dimeric and trimeric, molecular weight β-
crystallins. The fourth peak, labelled γT, consists of total γ-crystallins (Figure 2.17). 
When compared to elution profiles for bovine crystallins (Garvey et al., 2009; 
Pilkington, 2009), the elution profile for hoki crystallins shows there to be lower 
amounts of β-crystallins present. This appears to be a common feature of fish crystallin 
proteins, as is also seen for barracuda and the Antarctic toothfish (Healy et al., 2012; 
Kiss et al., 2004), and in a comparative analysis of crystallin proteins from Antarctic 
toothfish and bovine lenses (Kiss et al., 2010). The hoki elution profile also shows γ-
crystallins to be more abundant in fish than mammals, a result that is supported by the 
literature (Greiling et al., 2009; Kiss et al., 2004; Kiss et al., 2010; Kiss and Cheng, 
2008).  Estimations of relative protein abundance based on peak areas were made, and 
are compared to literature values for crystallins from other fish in Table 2.4. 
 
Table 2.4. Estimations of relative protein abundance based on peak areas. 
Fish species Crystallin class Relative protein 
abundance (%) 
Reference 
Hoki α 45 This study. Peak areas 
were calculated using 
OriginPro 8. 
β 2 
γ 53 
Toothfish α 52 (Kiss et al., 2004) 
β 5 
γ 43 
Big eye tuna α 47 (Kiss et al., 2004) 
β 12 
γ 41 
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The fractions for the first and second halves of each crystallin peak were pooled, 
resulting in six different fractions: αT1, αT2, βT1, βT2, γT1, and γT2. These fractions 
were then run on an SDS-PAGE gel to assess purity (Figure 2.18) (Section 7.1). The 
crude sample produced a number of bands (Lane 1). The αT1 and αT2 bands appear 
similar, each with a number of bands ranging from ~ 20-35 kDa (Lanes 2 and 3). 
Comparison with SDS-PAGE gels of bovine crystallin proteins reveals a higher 
heterogeneity on SDS-PAGE for α-crystallins from hoki, this was also seen for 
Antarctic toothfish and big eye tuna (Kiss et al., 2004). Those bands present at  ̴  20 
kDa correspond with α-crystallin subunits, although there are also some higher 
molecular weight bands,  ~ 30-35 kDa, which are consistent with reported values for βH 
crystallins ((Kiss et al., 2004)). This indicates that βH coeluted with α-crystallins, this 
was also seen for Antarctic toothfish and big eye tuna (Kiss et al., 2004). The βT1 and 
βT2 bands correspond with β-crystallins seen previously (Lanes 4 and 5), although the 
low molecular weight band seen in the βT2 fraction is perhaps some slight γ-crystallin 
contamination (Kiss et al., 2010).  The γT1, and γT2 bands are consistent with those 
reported in the literature for other γ-crystallins from fish (Kiss et al., 2010). The SDS-
PAGE gel confirms that the three crystallin classes were semi-purified (Kiss et al., 
2004; Kiss et al., 2010). 
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Figure 2.18. A) SDS-PAGE gel of semi-purified crystallin samples, and B), an 
enlargement of the bands of interest. L = ladder (molecular weights indicated in kDa 
on the left-hand side), 1 = crude, 2 = αT1, 3 = αT2, 4 = βT1, 5 =  βT2, 6 = γT1, and 7 = 
γT2. 
 
2.6.2. Formation of fibrils from semi-pure crystallins 
When amyloid fibrils are formed from crude crystallin mixtures, it is not known which 
classes of crystallin proteins are being converted into a fibrillar form. The ability of the 
different classes of hoki crystallin proteins to form fibrils was assessed by subjecting 
the semi-purified crystallin proteins obtained from the separation detailed in Section 
2.6.1 to the conditions established for the formation of fibrils from crude crystallin 
protein mixtures (Section 7.8.2). Details of the different crystallin protein solutions 
used for fibril formation are shown in Table 2.5. 
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Table 2.5. Crystallin protein solutions used for amyloid fibril formation 
Protein solution Components 
Crude crystallin mixture All high molecular weight crystallins, all α, β, and 
γ crystallins, 20 mM Tris, plus trace amounts  of 
protein extraction buffer 
Semi-pure crystallin 
fractions 
 αT-crystallins All α crystallins, 20 mM Tris, plus trace amounts 
of protein extraction buffer 
 βT-crystallins All β crystallins, 20 mM Tris, plus trace amounts 
of protein extraction buffer 
 γT-crystallins All γ crystallins, 20 mM Tris, plus trace amounts 
of protein extraction buffer 
 
In order to form amyloid fibrils at the same protein concentration used to form fibrils 
from crude crystallin protein mixtures, each of the samples detailed in Table 2.5 were 
freeze-dried, and then re-constituted in minimal nanopure H2O (Section 7.8.2). The 
concentration of this protein concentrate was determing by NanoDrop (A280) (Section 
7.1), and fibrils then formed as per the in-house methods (Section 7.4.2). It must be 
noted that the fractions were not dialysed following purification, and therefore 
contained a high concentration of Tris buffer (and therefore salt). This is why the crude 
crystallin mixture control (Table 2.5) was included, to ensure the freeze-drying process 
and/or the presence of Tris buffer did not affect the fibril formation process. TEM 
images were then taken to ascertain the level of amyloid fibril formation in all samples 
(Section 7.5). Figure 2.19 shows representative TEM images of amyloid fibrils formed 
from the semi-purified crystallin protein samples detailed in Table 2.5. 
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Figure 2.19. TEM images of amyloid fibrils formed from crude crystallins (A & B), αT 
fraction (C & D), βT fraction (E & F), and γT fraction (G & H). Scale bars are 1 μm (A, 
C, E, G) and 0.2 μm (B, D, F, H). 
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The crude crystallin sample formed amyloid fibrils as expected (Figure 2.19, A and B), 
with no difference in morphology to those shown in Figure 2.14, confirming that the 
freeze-drying process and the presence of Tris had not affected fibril formation. Fibrils 
also formed from all of the semi-purified crystallin fractions (Figure 2.19, C-H), with 
no noticeable differences in morphology between fractions, other than an increase in 
the density of the fibril network in those formed from the γT sample (Figure 2.19, G 
and H). This result confirms that all classes of crystallins are able to form amyloid 
fibrils (Garvey et al., 2009). It also shows that there is no loss in “quality” of fibrils 
formed from crude crystallin mixtures, and that further purification steps are 
unnecessary in the creation of quality nanofibres. 
 
2.7. Stability of crystallin fibrils 
It has previously been noted that the observed stability of other PNTs/PNFs, namely 
those formed from the FF peptide, differs significantly when the nanotubes are in 
solution (Andersen et al., 2011). An investigation into the stability in solution of FF 
peptide nanotubes tested their stability in various solutions ranging from organic 
solvents to buffer liquids, and demonstrated that the nanotubes could be dissolved in 
most solvents, including water and phosphate buffer (Andersen et al., 2011). Many of 
the applications in which these, and other PNTs/PNFs, are planned to play a central role 
involve their submersion in solvents, for example the creation of a biosensing device 
(Yemini et al., 2005a; Yemini et al., 2005b). This finding of instability in solution 
raises some doubts regarding the effectiveness of these nanotubes when used in this 
type of platform. 
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In order for crystallin fibrils to have a role in bionanotechnology, stability in a range of 
solvents is an issue that must be addressed. In the investigation into the stability of FF 
nanotubes, the size of the nanotubes, being greater than a micron in diameter and tens 
of microns in length, meant that optical microscopy could be used to observe the 
dissolution in real-time, with HPLC and mass spectrometry then used to identify the 
dissolved dipeptide in solution (Andersen et al., 2011). These same methods could not 
be used for crystallin fibrils, as the size of crystallin fibrils is outside the resolution of 
optical microscopy, and the nature of the crude protein source prevents simple 
identification by HPLC or mass spectrometry. Instead, the ThT assay was used to 
indicate the presence of fibrils in solution, and TEM was then used to visually confirm 
the presence of fibrils. 
The different solvents used, and the relevance of each solvent is detailed in Table 2.6, 
with common biological solvents and cleanroom solvents chosen due the likeliness of 
these solvents being encountered in future applications, as well as allowing for direct 
comparison with the results obtained for the FF nanotubes (Andersen et al., 2011). 
Amyloid fibrils were formed from crude crystallin proteins as per standard in-house 
techniques (Section 7.4.2), and the growth buffer then exchanged with the desired 
solvent by centrifugation (Section 7.9).   
 
Table 2.6. Details of the different solvents for which the stability of crystallin fibrils 
was investigated, and the relevance of each solvent selected. 
 
 Solvent Relevance 
A 25 % n-propanol, pH 3.8 Crystallin fibril buffer 
(control) 
B 25 % n-propanol, pH 7.0 To test the effect of 
biological pH 
C Nanopure H2O Biological relevance 
D 100 mM phosphate buffer 
(PB), pH 7.4 
Commonly used biological 
buffer solution 
E Ethanol Common cleanroom solvent 
F Isopropanol Common cleanroom solvent 
G Methanol Common cleanroom solvent 
H Acetonitrile Common cleanroom solvent 
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2.7.1. ThT assay of crystallin fibrils in different solvents 
The ThT assay was used as an indicator of the presence of amyloid fibrils in solution. 
As the ThT assay is known to be sensitive to pH and viscosity (Sabaté et al., 2008; 
Sulatskaya et al., 2010), care was taken to have appropriate ThT control measurements 
in each of the solvents of interest (Figure 2.20). Some variation was seen and so the 
appropriate control value was subtracted from each ThT assay result. 
 
 
Figure 2.20. Control measurements of ThT fluorescence in the presence of different 
solvents. From left to right: Control) ThT buffer solution, A) Crystallin fibril buffer, B) 
Crystallin fibril buffer pH 7, C) Nanopure H2O, D) 100 mM PB pH 7.4, E) Ethanol, F) 
Isopropanol, G) Methanol, and H) Acetonitrile. Error bars represent the standard 
deviation of three replicates.   
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Upon resuspension of crystallin fibrils in the solvents detailed in Table 2.6, an aliquot 
was taken at time zero, and then again after three hours. The ThT assay was then 
carried out on these samples (Figure 2.21).  At time zero, when compared to the 
control sample which was resuspended again in the fibril formation buffer, slight 
decreases were seen in the sample resuspended in nanopure H2O, isopropanol, 
methanol, and acetonitrile. However, after three hours in the solvents of interest, 
significant decreases in ThT fluorescence were only seen in the samples resuspended in 
methanol and acetonitrile, with the ThT fluorescence for fibrils in acetonitrile showing 
the largest decrease (Figure 2.21).  There was also a slight drop in fluorescence 
observed for the control sample, this is most likely due to the difficulty associated with 
resuspending the pelleted fibrils due to their tendency to clump. This is also likely to be 
responsible for the increased error bars on some samples. 
 
 
Figure 2.21. ThT fluorescence of crystallin fibrils resuspended in various solvents at T 
=0 (white fill), and at T = 3 hours (patterned fill). Samples from left to right: A) 
Crystallin fibril buffer, B) Crystallin fibril buffer pH 7, C) Nanopure H2O, D) 100 mM 
PB pH 7.4, E) Ethanol, F) Isopropanol, G)Methanol, and H) Acetonitrile. Fluorescence 
values have all had the appropriate control value subtracted (see Figure 2.20). Error 
bars represent the standard deviation of three replicates.   
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2.7.2. TEM study of crystallin fibrils in different solvents 
After several hours of incubation in the solvent of interest, TEM images were taken to 
confirm the presence or absence of fibrils in each of the samples. These images are 
shown in Figure 2.22. The sample that was resuspended in crystallin fibril buffer 
showed amyloid fibrils typical of a crystallin fibril preparation (Figure 2.22, A), 
showing that the centrifugation and resuspension procedure had not damaged the 
fibrils. For the sample that was resuspended in crystallin fibril buffer at pH 7 there are 
fibrils present; however, they seem to be of a slightly different morphology, appearing 
shorter and more discrete (Figure 2.22, B). This was not an unexpected result, as 
morphological differences have been seen previously with elevated pH in fibrils formed 
from bovine insulin (Rao, 2008), and from crude bovine crystallins (Pilkington, 2009). 
The fibrils in the sample resuspended in nanopure H2O appear unchanged (Figure 2.22, 
C).  
TEM images of the sample that was resuspended in phosphate buffer show amyloid 
fibrils, but they are very difficult to make out due to the presence of some larger, dark 
aggregate on top of the fibrils (Figure 2.22, D).  The dark aggregate observed in the 
sample resuspended in phosphate buffer was determined to be due to the presence of 
the phosphate buffer, not the fibrils dissolving. The phosphate buffer is perhaps 
interacting with the stain used for TEM, as this was present in the sample with a lower 
concentration of phosphate buffer and in a phosphate buffer only control (Figure 2.23). 
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Figure 2.22. Representative TEM images of crystallin fibrils resuspended in: A) 
Crystallin fibril buffer, B) Crystallin fibril buffer adjusted to pH 7, C) Nanopure H2O, 
D) 100 mM PB pH 7.4, E) Ethanol, F) Isopropanol, G) Methanol, and H) Acetonitrile. 
Scale bar is 0.2 μm. 
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Figure 2.23. Representative TEM images of A) Crystallin fibrils resuspended in 50 mM 
PB pH 7.4, and B) Control PB grid. Scale bar is 0.2 μm. 
 
TEM images for the samples resuspended in ethanol, isopropanol, and methanol all 
show clear fibrils (Figure 2.22, E-H). In the case of the methanol sample this result is 
somewhat contradictory to what was observed by the ThT assay (Figure 2.21), which 
suggests that although fibrils are present, they may exist in much lower quantities. TEM 
images of the sample that was resuspended in acetonitrile show no fibrils to be present 
(Figure 2.22, H), in agreement with the ThT assay. The effect of acetonitrile on 
crystallin fibrils was further investigated by resuspending fibrils in 50 % acetonitrile. 
With a lower concentration of acetonitrile fibrils remain present; however, there were a 
large number of circular fibril assemblies visible by TEM (Figure 2.24).  Organic 
solvents, including ACN, have previously been shown to dissolve amyloid fibrils 
(Hirota-Nakaoka et al., 2003). Circular fibril assemblies have also previously been 
observed, in fibrils formed from α-crystallins (Meehan et al., 2004). With further 
characterisation, this circular morphology may prove interesting for 
bionanotechnology. 
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Figure 2.24. TEM images of crystallin fibrils resuspended in 50 % acetonitrile. Scale 
bar is 1 μm (A), and 0.2 μm (B). 
 
The stability of crystallin amyloid fibrils in various solvents is summarised in Table 
2.7, and compared to results previously obtained for FF nanotubes (Andersen et al., 
2011).  It can be confirmed that crystallin amyloid fibrils are significantly more stable 
in solution than FF nanotubes, and therefore could be a more appropriate choice for a 
PNT/PNF to be used in applications where solvent contact is involved, such as 
biosensing. Their solubility in ACN was not an unexpected result, with ACN having 
been used previously in the literature to resolubilise amyloid fibrils (Kaplan and Pras, 
1987). This solubility in ACN could also give rise to further applications, such as 
sacrificial templates for metallic nanowire formation (Hsieh and Hsieh, 2010). 
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Table 2.7. Summary of stability of FF nanotubes, according to (Andersen et al., 2011), 
and crystallin amyloid fibrils in various solvents. 
 Solvent FF nanotubes 
stable? 
(Y/N) 
Crystallin amyloid fibrils stable? 
(Y/N) 
ThT assay TEM 
A 25 % n-
propanol, pH 3.8 
N/A Y Y 
B 25 % n-
propanol, pH 7.0 
N/A Y Y 
C Nanopure H2O N Y Y 
D 100 mM 
phosphate 
buffer, pH 7.4 
N Y Y 
E Ethanol N Y Y 
F Isopropanol N Y Y 
G Methanol N N Y 
H Acetonitrile N N N 
 
2.8. Summary 
This chapter has demonstrated the formation of amyloid fibrils from bovine insulin, 
fungal hydrophobins, and mixtures of crude fish crystallins. The amyloid fibrils formed 
from bovine insulin were consistent with those observed in the literature, as were those 
from fungal hydrophobins. The impact of the creation of hydrophobic:hydrophilic 
interfaces on hydrophobin rodlet formation was demonstrated via the use of real-time 
ThT assaying. The internal structure of amyloid fibrils formed from crude fish 
crystallins was investigated with X-ray fibre diffraction, and the characteristic cross-β 
diffraction pattern was observed, confirming that the amyloid-like structures seen are in 
fact true amyloid fibrils. It was also shown that amyloid fibrils are able to be formed 
from all three classes of fish crystallins, with no morphological difference observed 
between those fibrils formed from the crude and semi-purified proteins. This finding 
affirms the use of crude fish crystallins as a source of amyloid fibrils for 
bionanotechnology. 
Also in support of the use of crystallin fibrils as nanomaterials, is their stability in 
solution in a range of relevant solvents. Crystallin fibrils showed superior stability to 
another commonly used fibril source, the FF peptide, suggesting that they may be a 
more desirable source, dependent on the application, of PNTs/PNFs for 
bionanotechnology.   
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3. Chapter Three  
Controlling dimensions of amyloid fibrils 
3.1. Introduction 
Amyloid fibrils have the potential to be used in a range of applications, such as 
bioelectronics and biosensing (Waterhouse and Gerrard, 2004). In these applications, as 
well as in others, the ability to have some degree of control over the fibrils formed is 
desirable. Length control is also a way of reducing the cytotoxic potential of amyloid 
fibril based nanomaterials. Xue et al. (2009a) have shown that fibril length correlates 
with the ability of amyloid fibrils to disrupt membranes and reduce cell viability, with 
shorter fibrils showing increased cytotoxic potential. For this thesis, an additional 
motivation to control the length of amyloid fibrils was the experimental setup used in 
Chapter 4, as in order to gain information about their conductive properties, fibrils 
needed to be long enough to bridge pairs of electrodes. 
The nature of the fibrillation process is such that a large number of structural species of 
highly diverging sizes may exist simultaneously (Langkilde and Vestergaard, 2009), 
making control over this process difficult. Amyloid fibrils also exist in a range of 
morphologies, and solution conditions have previously been shown to favour a 
particular fibril morphology (Petkova et al., 2005). Amyloid fibrils described in the 
literature vary in size depending on the native protein/peptide, with diameters ranging 
from a few nanometres to greater than 30 nanometres and lengths of up to several 
microns (Gras, 2007).  
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Although the accepted mechanism for fibrillation has been applied to a range of fibril 
forming proteins/peptides, there are differences observed between the fibrils formed 
from different proteins/peptides (Gras, 2007). There have been a small number of 
studies on amyloid fibril length carried out on other protein systems (Humblet-Hua et 
al., 2008; van Raaij et al., 2008; Rogers et al., 2005a; Rogers et al., 2005b; Xue et al., 
2009b) This study focuses on the fibrils formed from bovine insulin, with the aim of 
optimising the formation process, in order to improve homogeneity in samples of these 
novel nanomaterials.1 
 
3.2. Controlling the dimensions of bovine insulin amyloid fibrils 
Bovine insulin amyloid fibrils have diameters of 7-10 nm, and are up to several microns 
long, although morphological variations are often seen in fibrils from the same 
preparation (Jimenez et al., 2002). Bovine insulin is often used in studies of amyloid 
formation as it forms fibrils very rapidly after disruption of the natively hexameric 
structure. In vitro, insulin can be converted from this native structure to the fibrillar 
form by incubation at high insulin concentrations, low pH and high temperature, with 
fibrillation occurring under these conditions within hours (Krebs et al., 2004; Nielsen et 
al., 2001a; Waugh, 1946). However, most studies have tended to focus more on the 
kinetics of insulin amyloid fibril formation rather than the dimensions of fibrils formed 
(Jansen et al., 2005; Jimenez et al., 2002; Mauro et al., 2007; Nielsen et al., 2001b). 
Mauro et al. (2007) observed some differences in the lengths of fibrils formed under 
various conditions, but were more concerned with the aggregation kinetics, and 
Jimenez et al. (2002) have observed different insulin fibril morphologies.  
                                                 
1 This work is published in (Domigan et al., 2011) 
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The mechanism of insulin amyloid fibril formation is shown schematically in Figure 
3.1. Amyloid fibril formation has been shown to have many characteristics of a 
nucleated growth mechanism (Chiti and Dobson, 2006). When the time course of the 
change of a peptide or protein from its native state into a fibrillar form is measured, a 
lag phase is generally observed, followed by a rapid exponential growth phase (Naiki et 
al., 1989). This lag phase is assumed to be the time needed for ‘nuclei’ to form (Figure 
3.1, Steps 1-3), and from here fibril growth proceeds rapidly by elongation of the fibrils 
Figure 3.1, Step 4), from association of monomers or oligomers with this nucleus 
(Chiti and Dobson, 2006). This nucleation-polymerisation mechanism of growth has 
been likened to that observed in crystallisation (Thirumalai et al., 2003).  
 
Figure 3.1. Schematic showing the nucleation-elongation mechanism for insulin fibril 
formation, adapted from Nielsen et al. (2001b). Step 1: The first thing that must occur 
is a change in quarternary structure from the oligomeric state to the monomer. Step 2: 
This involves destabilisation of the monomer to produce a partially folded intermediate 
which exists in equilibrium with unfolded structures. Step 3: This is the formation of the 
nucleus from the assembly of a few partially folded monomeric species. These first 3 
steps make up the nucleation component of insulin fibril formation. The next step (Step 
4) is elongation of the nucleus into a fibril/filament by addition of partially folded 
intermediate monomeric insulin species. 
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This chapter presents a systematic study of the use of growth and storage conditions to 
control the length of amyloid fibrils formed from bovine insulin, with length 
distributions constructed from TEM images. Growth temperature, pH, protein 
concentration, and storage conditions were examined, and were seen to offer a range of 
conditions that favour different length distributions. 
 
3.3. Effect of growth and storage conditions on bovine insulin 
amyloid fibril length distribution 
Amyloid fibrils were formed from bovine insulin under a range of growth and storage 
conditions, as detailed in Table 3.1 (Section 7.10.1). For each of these samples, unless 
stated otherwise, fibril lengths were measured from TEM images, and length 
distributions constructed (Section 7.10.2). The assumption was made that the 
appearance of fibrils on the TEM grid was representative of the bulk sample. 
Investigation into the effect of growth temperature and pH led to the establishment of 
initial growth conditions. Alterations were then made to these conditions to show the 
effect of native protein concentration and storage conditions on length distribution. 
 
3.3.1. Effect of growth temperature 
The effect of growth temperature on fibril dimensions was examined with the native 
insulin subjected to temperatures ranging from room temperature through to 60 °C.  60 
°C was chosen as the maximum temperature, as it has been shown that this yields 
insulin fibrils with a predominantly compact morphology, whereas above this a variety 
of morphologies are seen (Jimenez et al., 2002). When examining the effect of growth 
temperature, a protein concentration of 5.8 mg/mL was used, as this is the standard 
concentration used in-house for insulin fibril formation. Room temperature and 30 °C 
(Table 3.1, Conditions 1 and 2) were insufficient to cause fibril formation, with 
Thioflavin T (ThT) readings indicative of negligible amyloid fibril formation even after 
3 weeks of growth. Fibrils were seen to form more slowly at 40 °C than at the higher 
temperatures, with fibril formation confirmed after three and one days respectively.  
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A decrease in the rate of aggregation was seen with a decrease in temperature, which is 
supported by previous work that saw the same relationship between temperature and 
aggregation rate. The previous study saw that  the time to increase viscosity 4-fold of a 
bovine insulin solution, taken as being indicative of aggregation, increased from 35 °C 
to 55 °C and above this temperature little difference was observed (Brange et al., 
1997).  
For those fibril samples formed at 40 and 50 °C, although some fibrils formed, a large 
amount of unfibrilised protein remained (Figure 3.2, B-D). Thus, 60 °C (Figure 3.2, 
A), was used for the remainder of the experiments, following previous studies (Brange 
et al., 1997; Mauro et al., 2007; Nielsen et al., 2001a).   
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Table 3.1. Detail of the different growth and storage conditions used for the insulin 
amyloid fibril samples. 
Sample 
number 
Growth 
concentration 
(mg/mL) 
Growth 
temperature 
(°C) 
Buffer 
Growth 
time 
Storage 
conditions pH Salt 
1 5.8 Room temp. 1.5 100 mM NaCl 24 hrs Room temp. 
2  30     
3  40     
4  50     
5  60     
6 5.8 60 1.0 100 mM NaCl 24 hrs Room temp. 
7   2.0    
8   2.5    
9 0.5 60 1.5 100 mM NaCl 24 hrs Room temp. 
10 1.0      
11 2.0      
12 3.0      
13 4.0      
14 5.0      
15 5.8 60 1.5 100 mM NaCl 24 hrs Refrigeration 
16      Freeze/thaw x1 
17      Freeze/thaw x2 
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Figure 3.2. TEM images of fibrils formed at A) 60 °C, B) 50 °C and C) 40 °C. Scale 
bar is 0.5 μm. D) A representative image of the large amount of unfibrilised protein 
which exists at the lower temperatures. Scale bar is 0.2 μm. 
 
The lengths of fibrils formed were analysed for samples formed at 40, 50 and 60 °C, 
and it was seen that there was an increase in length with increasing growth temperature, 
with the mean fibril length 0.52, 0.59 and 0.68 μm respectively (Table 3.2). The length 
distribution (Figure 3.3), shows the average fibril length is heavily skewed by a 
population of small fibril fragments being observed no matter what the condition. This 
bias has previously been noted by Xue et al. (2009b), who commented that the 
distribution of lengths is biased towards shorter fibrils, due to longer fibrils being more 
likely to be cut off by image boundaries, by overlap with other fibrils, and by length 
dependent effects on the surface deposition efficiency of fibrils. The small range in 
length seen here between the different temperatures reflects the small temperature range 
examined, due to the lack of fibril formation at the lowest temperatures. 
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Figure 3.3. Length distribution of insulin amyloid fibrils formed at A) 40 °C, B) 50 °C, 
and C) 60 °C 
 
The differences in length that were observed at the different temperatures reiterates 
previous observations that increased temperature accelerates the elongation stage of 
fibrillation (Jansen et al., 2005), therefore, longer fibrils were observed to form at the 
higher temperature.  
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Table 3.2. Average fibril length and range for bovine insulin fibrils formed under 
different growth conditions*. 
Sample number** Average fibril length (μm) Range (μm) 
3 0.52 0.14-1.61 
4 0.59 0.13-1.94 
5 0.68 0.10-1.82 
9 1.32 0.08-6.32 
10 1.11 0.11-4.68 
11 1.33 0.19-4.22 
12 1.12 0.19-3.95 
13 0.56 0.08-2.04 
14 0.75 0.14-2.09 
15 0.57 0.10-3.31 
16 0.29 0.07-0.91 
17 0.15 0.01-0.36 
* Average lengths and ranges only calculated where possible, see detail in text. 
** See Table 3.1 for details of sample conditions 
 
3.3.2. Effect of pH 
Fibrils were formed in 100 mM NaCl adjusted to pH 1.0, 1.5, 2.0, and 2.5 with HCl in 
order to investigate the effect of pH on the length of insulin fibrils (Conditions 5-8, 
Table 3.1). No fibrils formed at pH 1.0 (Figure 3.6, A).  
Fibril formation at the different pH values was monitored by the increase in ThT 
fluorescence. As pH has been shown previously to have an effect on the ThT assay 
(Sabaté et al., 2008), ThT control measurements were taken at each of the pH values in 
the absence of insulin. As shown in Figure 3.4, no difference in fluorescence was 
observed across the pH range used, and so the control measurement at pH 1.5 was used 
when monitoring fibril formation. 
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Figure 3.4. ThT control measurements in the presence of fibril buffer at pH 1.0 (black), 
1.5 (red), 2.0 (blue), and 2.5 (green). Each reading represents an average of triplicate 
well readings, with the error bars representing standard error. 
 
The increase in ThT fluorescence at pH 1.5 and pH 2.0 followed the characteristic 
sigmoidal increase in fluorescence (Figure 3.5, red and blue traces), commonly 
observed in amyloid formation (Brange et al., 1997). At pH 2.5, the sigmoidal increase 
in fluorescence was also observed (Figure 3.5, green trace), although a much lower 
plateau was reached, demonstrating that less fibrillation was occurring at this pH. At 
pH 1.0, an increase in fluorescence was observed; however, it was not typical of fibril 
formation, and is likely due the formation of an amorphous, but β-sheet containing, 
aggregate. This reiterates the need for the formation of fibrils to be confirmed by TEM 
(Figure 3.6). 
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Figure 3.5.  Time profile of ThT fluorescence for bovine insulin incubated at 60 °C in 
fibril buffer adjusted to pH 1.0 (black), 1.5 (red), 2.0 (blue), and 2.5 (green). Control 
measurement (pH 1.5), with no insulin present, is shown in white. Each reading 
represents an average of triplicate well readings, with the error bars representing 
standard error. 
 
At the higher pH values, where fibrils did form, the change in pH changed the 
association between the fibrils. With increase in pH there was an increase in fibril-fibril 
interactions, with more clumping of fibrils observed (Figure 3.6, B-D). This is 
consistent with previous work, where fibrils formed at pH 1.6 were dialysed into 
buffers of higher pH, clumping of fibrils was also observed (Rao, 2008). Our findings 
showed that although fibrils would form at the higher pH values, pH 1.5 was optimum 
and so this was the pH used for all other experiments. Length distributions were not 
measured due to the clumping of fibrils at pH 2.0 and 2.5, making it impossible to 
clearly identify individual fibrils. 
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Figure 3.6. TEM images of fibrils formed at A) pH 1.0, B) pH 1.5, C) pH 2.0, and D) 
pH 2.5. Scale bar is 0.5 μm. 
 
With regards to the effect of pH on fibril formation, Blundell et al. observed that below 
pH 2.0, insulin is mainly in its monomeric form, with increase in pH from here 
increasing the population of dimers (Blundell et al., 1971). It was seen that this increase 
in the population of dimers was coupled to a decrease in the tendency for fibrils to 
form, supporting the idea that fibril formation requires interaction between monomers 
(Whittingham et al., 2002). This is perhaps an explanation for the observed loss of the 
defined fibrillar structure at pH values above 2.0. Nielsen et al. formed insulin fibrils at 
pH 1.6, 3.0, and 7.4, and saw shorter lag times and faster growth at the more acidic pH 
values, although did not comment on the effect on fibril structure (Nielsen et al., 
2001b).  
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3.3.3. Effect of native protein concentration 
The effect of native protein concentration on fibril dimensions was investigated using 
concentrations of bovine insulin ranging from 0.5 mg/mL (87 μM) through to 5.8 
mg/mL (1012 μM), (Conditions 5 and 9-14, Table 3.1).  Fibril formation at each 
concentration was monitored by the ThT assay (Figure 3.7). 
 
Figure 3.7. Time profile of ThT fluorescence for bovine insulin at various 
concentrations incubated at 60 °C in fibril buffer, pH 1.6. The samples were: Control 
(black), 0.5 mg/mL (red), 1.0 mg/mL (blue), 2.0 mg/mL (cyan), 3.0 mg/mL (brown), 4.0 
mg/mL (pink), 5.0 mg/mL (green), and 5.8 mg/mL (navy). Each reading represents an 
average of triplicate well readings, with the error bars representing standard error. 
 
Fibrils formed at all concentrations (Figure 3.8), with the ThT fluorescence values 
(Figure 3.7 and Figure 3.9) showing more fibrils formed at the higher concentrations, 
an expected result based on previous work (Brange et al., 1997; Khurana et al., 2003; 
Mauro et al., 2007; Nielsen et al., 2001b). 
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Figure 3.8. TEM images of fibrils formed at: A) 0.5 mg/mL, B) 1.0 mg/mL, C) and D) 
2.0 mg/mL, E) 3.0 mg/mL, F) 4.0 mg/mL, G) 5.0 mg/mL, and H) 5.8 mg/mL. Scale bars 
are 1 μm (A-E) and 0.5 μm (F-H). 
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Figure 3.9. Final ThT fluorescence (RFU) of insulin amyloid fibril samples formed at 
varying concentrations. Error bars show standard deviation of the mean from triplicate 
samples. 
 
It was observed that fibril length increased with decreasing native protein 
concentration, with fibrils formed at 0.5 mg/mL existing up to 6 μm in length (Figure 
3.10, A), as opposed to those formed at 5.8 mg/mL, where the entire population of 
fibrils formed was under 2 μm in length (Figure 3.10, G). A plot of the average fibril 
length at differing native protein concentrations also reflects this trend, with a plateau 
reached around 2 mg/mL (Figure 3.11), although with less variation observed than for 
range calculations, due to the previously mentioned existence of a large number of 
shorter species present at all growth concentrations which biases average length 
calculations. 
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Figure 3.10. Length distribution of insulin amyloid fibrils formed at A) 0.5 mg/mL, B) 
1.0 mg/mL, C) 2.0 mg/mL, D) 3.0 mg/mL, E) 4.0 mg/mL, F) 5.0 mg/mL, and G) 5.8 
mg/mL. 
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Figure 3.11. A) Average lengths of insulin amyloid fibrils formed at varying 
concentrations. Error bars show uncertainty in the mean length (σ/√(n)) calculated 
from n samples. B) Variance of fibril samples formed at varying concentrations. 
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The observation of increasing length with decreasing native protein concentration from 
the concentrations 5.8 mg/mL through to 0.5 mg/mL can be explained by the growth 
mechanism for insulin fibril formation. It has previously been observed that at low 
temperatures and concentrations, fibril nucleation (Figure 3.1, Steps 1-3) is inhibited 
while elongation (Figure 3.1, Step 4) continues on preformed fibrils (Mauro et al., 
2007; Waugh, 1946), and this observation can be applied to these results. In terms of 
the native insulin that is to be converted to amyloid fibrils, a proportion forms fibril 
nuclei, a process thought to require the nearly simultaneous interaction of 3-4 insulin 
molecules (Waugh, 1957), and a proportion is added to the nuclei to elongate the fibrils. 
What appears to be occurring at the lower concentrations is that, because nuclei 
formation is less favourable (Waugh, 1946), the ratio of “nuclei forming insulin” to 
“elongating insulin” is in favour of elongating insulin, therefore longer fibrils are 
formed. This is also supported by Figure 3.7, which shows a longer lag time, the time 
in which nuclei are forming, for the low concentrations of native insulin. This has been 
well documented in the literature; for example, Brange et al. saw an increase in the rate 
of fibrillation with increasing insulin concentration (Brange et al., 1997). Nuclei 
formation is the slowest phase of fibrillation (Waugh, 1957), and this, therefore, 
supports the theory that at high concentration more nuclei are being formed and less 
elongation is occurring. 
As previously stated, insulin fibrillation requires interaction between monomers and it 
has been shown that low protein concentration shifts the equilibrium of insulin toward 
smaller oligomers (Whittingham et al., 2002). This is another contributing factor for the 
observed length distribution. 
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Differences are observed in fibrils formed from different polypeptides (Gras, 2007), 
and other length studies of amyloid fibrils involving different native proteins 
corroborate this. Van Raaij et al., in their study of α-synuclein fibrils, saw that fibril 
length increased with increasing native protein concentration (van Raaij et al., 2008), a 
study that was in agreement with a proposed statistical model by Van Gestel and De 
Leeuw (2006). The statistical model stated that two conditions must be met in order for 
the model to be applied: that the solution is dilute enough that the effects of 
interaggregate interactions may be neglected, and that the processes described by the 
model are reversible. The α-synuclein study met both of these conditions, with much 
lower concentrations used than our study (5-250 μM as opposed to the 174-1012 μM 
used in our study), and the knowledge that the different stages in the fibrillation process 
are reversible, whereas insulin fibrillation is normally not reversible without dramatic 
changes in the solvent environment (Brange et al., 1997). 
The conflicting results observed with different native proteins demonstrate that it does 
not appear to be possible to apply results of length studies on fibrils formed from one 
protein to those formed from another. 
 
3.3.4. Effect of storage conditions 
Fibrils were formed using the standard conditions that had been adopted and then stored 
at room temperature, in refrigeration and frozen (Conditions 5, 15 and 16, Table 3.1). 
The effect of freezing on fibril dimensions was further examined by increasing the 
freeze/thaw cycles to which the fibrils were subjected (Condition 17, Table 3.1).  
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Figure 3.12. TEM images of fibrils subjected to various storage conditions. A) Room 
temperature, B) Refrigeration, C) Freeze/thaw x 1, and D) Freeze/thaw x 2. Scale bar 
is 0.2 μm. 
 
Fibrils stored at room temperature had a longer average length (0.68 μm) than both 
those that were refrigerated (0.57 μm) and frozen (0.29 μm), with freezing and then 
thawing resulting in fibrils of less than half the average length (Table 3.2). This 
decrease in length upon freezing is also evident from the histograms constructed from 
these samples (Figure 3.13). When the number of freeze thaw cycles was increased to 
two, the fibrils became even shorter (0.15 μm).  
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Figure 3.13. Length distribution of insulin amyloid fibrils stored at A) Freeze/thaw x2, 
B) Freeze/thaw x1, C) Refrigeration, and D) Room temperature. 
 
ThT readings were taken of all samples to ensure that the β-sheet structure of the fibrils 
was still intact and that the freeze thawing had not degraded the fibrils (Figure 3.14). 
The ThT values in fact increased with successive freeze thaw cycles, presumably due to 
the smaller fragments being more soluble and therefore resulting in a higher measurable 
concentration of bound dye in solution. 
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Figure 3.14. ThT fluorescence of insulin amyloid fibril sample before and after 
freeze/thaw cycles. Fluorescence is shown as a percent of the initial fluorescence of the 
sample. Error bars show standard deviation of the mean from triplicate samples. 
 
Storage condition was seen to influence the resulting length of preformed fibrils, with 
room temperature being the ideal storage temperature to maintain fibril integrity, as 
refrigeration and freezing caused a decrease in fibril length due to fracturing. This 
decrease in length seen with altered storage conditions is also interesting in light of 
recent literature where these fragmented fibrils have been identified to have different 
behaviour than the intact mature fibril.  Fibril fragments may have increased 
cytotoxicity, but have been shown to increase the efficiency of new fibril growth by 
seeding as well as having increased ability to disrupt liposome membranes – offering 
potentially new or enhanced biological properties (Xue et al., 2009a). It is also known 
that the presence of fibril fragments increases the rate of new fibrillogenesis (Xue et al., 
2009a), meaning that fibril fragments produced through freeze-thaw cycles could be 
used as fibril seeds. 
 
Chapter 3 – Controlling dimensions of amyloid fibrils 107 
 
 
 
3.4. Effect of growth and storage conditions on bovine insulin 
amyloid fibril diameter 
The effect of growth/storage conditions on the diameter of amyloid fibrils formed from 
bovine insulin was examined using AFM (Section 7.10.3). AFM measures the 
topography of a sample, and so it is height that is being measured. For this study it was 
assumed that fibril height is equivalent to diameter. Measurements were taken for 
samples formed under Conditions 5, 9, and 17 (Table 3.1), chosen as they were the 
“standard” growth condition, and conditions that gave the longest and shortest fibrils 
respectively. The change in growth and storage condition had no effect on the diameter 
of fibrils formed, with fibrils from all three conditions having an average diameter of 
7.9 ± 2.2 nm (Table 3.3). A representative AFM image is shown in Figure 3.15. 
 
 
Figure 3.15. Representative AFM image, as used for measurement of fibril diameter. 
AFM was operating in tapping mode. Scan size is 1 μm by 1 μm. 
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The fibril diameters measured by AFM were shown not to be effected by growth or 
storage condition, with diameters of all fibrils formed within the expected diameter of 
insulin amyloid fibrils of 7-10 nm (Jimenez et al., 2002). This result was also seen in 
the study by Xue et al., (2009b), where they showed there to be no significant length 
dependence of fibril diameter. 
 
Table 3.3. Average fibril diameter and range for bovine insulin fibrils formed under 
different growth conditions*. 
Sample number** 
Fibril diameter 
Mean (μm) Range (μm) 
5 (“standard”) 7.5 ± 1.4 4.3-8.9 
9 (longest) 8.4 ± 3.1 2.9-14.4 
17 (shortest) 7.8 ± 1.5 5.6-11.9 
* Average diameters and ranges only calculated for three samples, see detail in text. For each sample 
diameters of at least 50 fibrils were measured, with three diameter measurements taken along the length 
of each fibril. 
** See Table 3.1 for details of sample conditions 
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3.5. Effect of growth and storage conditions on dimensions of 
crystallin amyloid fibrils 
The conditions that gave the shortest and longest fibrils, namely, freeze-thaw cycles 
and low concentration respectively, were then applied to the crystallin fibril system, to 
investigate whether the same trend in fibril length was observed. Amyloid fibrils were 
formed from crude crystallin proteins using the “standard” conditions established in-
house to maximise fibril yield (Section 7.4.2) (Garvey et al., 2009) (Condition 18, 
Table 3.4), and also with the native protein concentration lowered by the same amount, 
relative to the “standard” protein concentration, as the concentration which resulted in 
the longest bovine insulin fibrils (Condition 9, Table 3.1). This meant that crystallin 
fibrils were then formed at 0.9 mg/mL (Condition 19, Table 3.4). Crystallin amyloid 
fibrils, formed under the “standard” conditions were also subjected to freeze/thaw 
cycles, after exchanging the solvent for water to allow freezing (Condition 20, Table 
3.4). These conditions are detailed in Table 3.4. 
 
Table 3.4. Detail of the different growth and storage conditions used for the crystallin 
amyloid fibril samples. 
Sample # Growth 
concentration 
(mg/mL) 
Growth 
temperature 
(°C) 
Buffer Growth 
time 
Storage 
conditions 
18 10 60 25 % n-propanol, 
pH 3.8 
3 days Room temp. 
19 0.9    Room temp. 
20 10    Freeze/thaw x2 
21* 10    Sonicated 
22* 10   5 months Room temp. 
* These conditions were carried out by J. Raynes and J. Healy (21 and 22 respectively with TEM images 
kindly provided (Healy et al., 2012; Raynes, 2012). 
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The fibrils formed from each of these conditions were then visualised by TEM (Section 
7.5). Representative TEM images are shown in Figure 3.16. Fibrils formed from the 
standard conditions existed in a very dense network (Figure 3.16, A and B), which 
meant that it was not possible to accurately construct full length distributions, as it was 
too difficult to discern individual fibrils. The same was true for the fibrils formed at the 
lower concentration, although a less dense network was observed (Figure 3.16, C and 
D). Subjecting crystallin fibrils to freeze/thaw cycles did seem to have some effect on 
fibril length, with a number of fragmented fibrils observed (Figure 3.16, E); however, 
this process was not nearly as efficient for crystallin fibrils as it was for insulin fibrils, 
as a proportion of the fibrils in the sample remained unchanged (Figure 3.16, F).  
Previous work carried out in our lab by Jared Raynes has shown sonication of crystallin 
fibrils to be an effective method of producing fibril fragments (Figure 3.17, A and B). 
Compared with freeze-thaw cycles, sonication appears to give the most homogenous 
distribution. These fragments can then be used as seeds to promote fibril formation or 
in other applications where short fibrils are desirable. Other work by Jackie Healy has 
shown that over time association between individual crystallin fibrils increases, 
resulting in the formation of higher order structures (Figure 3.17, C and D). Figure 
3.17, C shows a representative image of crystallin fibrils after 3 days of growth, which 
are approximately 10-20 nm wide, and then when imaged again after five months of 
growth 200 nm thick bundles were observed (Figure 3.17, D) (Healy et al., 2012). 
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Figure 3.16. Representative TEM images of crystallin fibrils formed under standard 
conditions (A & B), low concentration (C & D), and those subjected to freeze/thaw 
cycles (E & F). Scale bars are 1 μm (A & C) and 0.5 μm (B, D, E & F). 
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3.6.  
Figure 3.17. A & B) Representative TEM images of crystallin fibrils before (A) and 
after (B), sonication (Raynes, 2012). C & D) Representative TEM images of crystallin 
fibrils taken after 3 days of growth (C), and after 5 months (D) (Healy et al., 2012). 
Scale bars  
 
These results indicated that it is unlikely to be possible to apply the same “length-
controlling” conditions to different fibril systems, as was touched on previously when 
discussing the discrepancies seen when comparing results from the control of insulin 
fibril length in this study, to literature studies involving other fibril systems. It also 
raises the issue of the methods used to investigate fibril length. The majority of studies 
on fibril length use microscopy, such as TEM and AFM, to construct length 
distributions. As well as difficulties encountered such as those in this study, where the 
density of the network did not allow full length characterisation, there are other 
disadvantages associated with the use of these techniques in this way. AFM and TEM 
are often time consuming, and as the fibrils are in the dry state on a solid support, are 
not necessarily representative of the dispersion of fibrils in a suspension.  
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Preliminary work has been carried out using the qNano particle analyser (Izon, NZ) to 
construct length distributions of crystallin fibrils using resistive pulse sensing 
(Appendix B). Further work using this tool will hopefully result not only in 
characterisation of fibril length, but also of the concentration of fibrils in solution. With 
the right fibril system, it may also be possible to monitor the formation of fibrils in real 
time. 
 
3.7. Summary 
Length distributions of amyloid fibrils formed from bovine insulin were examined 
under different growth temperatures, pH, protein concentrations, and storage 
conditions. A range of fibril lengths were achieved, from very small fibril fragments 
resulting from freeze thaw cycles, through to fibrils of several microns long formed by 
lowering the growth concentration. At all of the conditions examined a range of fibril 
lengths still exist, due to the nature of the fibrillation mechanism. However, it has been 
shown that a range of average lengths and length distributions are achievable, by 
simply altering growth and storage conditions, and this finding takes us a step further 
towards control over dimensions. When the same set of conditions were applied to 
amyloid fibrils formed from crude fish crystallins, the same trends in fibril length were 
not necessarily observed, indicating that although there is a common fibril formation 
pathway, the resulting structures have properties that differ between fibril systems. 
However, other methods have shown to be effective in producing a range of crystallin 
fibril sizes. The ability to provide some degree of homogeneity in these structures 
offers the opportunity to explore length dependent properties, as well as providing 
guidelines where fibrils of particular length distribution are wanted. 
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4. Chapter Four  
Electrical properties and manipulation of 
amyloid fibrils 
 
4.1. Introduction 
The electrical properties of unmodified amyloid fibrils formed from bovine insulin, fish 
eye crystallins, and fungal hydrophobins had not been previously investigated. Network 
measurements are commonly used for investigation into the conductive properties of 
fibres (Liu et al., 2009; Malvankar et al., 2011; del Mercato et al., 2007), and for this 
study, methods based upon those of del Mercato et al. were initially used. del Mercato 
et al. used interdigitated electrodes to study the electrical conduction of “amyloid-like” 
fibrils formed from the elastin-related polypeptide, poly(ValGlyGlyLeuGly), finding 
that they were weak conductors. This chapter presents electrical characterisation, via 
network measurements, for all three aforementioned fibril systems. 
As many biological nanowires are seen to have low conductivity in their unmodified 
state (Storm et al., 2001), biological structures have been used as a scaffold for the 
formation of more highly conductive nanowires, via modification with metals (Bai et 
al., 2009; Braun et al., 1998; Ford et al., 2001; Patolsky et al., 2002; Patolsky et al., 
2004), or, as is the case in this study, conducting polymers (Hamedi et al., 2008; 
Herland et al., 2008; Nickels et al., 2004; Niu et al., 2007a; Niu et al., 2007b).  This 
chapter also assesses the level to which modification of bovine insulin amyloid fibrils 
by the conducting polymers, polypyrrole and polyaniline, increases conductivity. 
Chapter 4 – Electrical properties and manipulation of amyloid fibrils                         117 
 
 
 
In addition to network measurements, it is also desirable to carry out electrical 
characterisation on single or small numbers of isolated fibrils (Castillo et al., 2008). 
The technique of dielectrophoresis was used to isolate small numbers of crystallin 
amyloid fibrils between electrode pairs. Once immobilised, electrical properties of the 
crystallin amyloid fibrils were able to be examined, and these measurements compared 
to network measurements, as well as theoretical calculations of conductivity. 
 
4.2. Conductive properties of amyloid fibril networks 
The conductive properties of amyloid fibril networks formed from a) bovine insulin, b) 
fish eye crystallins, and c) fungal hydrophobins, were examined by deposition of 
amyloid fibrils onto gold interdigitated electrodes that were fabricated by 
photolithography, and subsequent measurement of the current-voltage (I-V) 
characteristics of the networks. 
 
4.3. Fabrication of microelectrodes 
The microelectrodes used to examine the conductive properties of amyloid fibril 
networks were fabricated via the process of optical lithography. Lithography is defined 
as “the process of transferring patterns of geometric shapes on a mask to a thin layer of 
radiation-sensitive material (called resist) covering the surface of a semi-conductor 
wafer” (Sze, 2002). To then produce permanent features on a semi-conductor wafer, in 
this case, an array of gold microelectrodes, these resist patterns must be transferred 
again to the layers comprising the device, and this is accomplished by selectively 
removing unmasked portions of a layer. Optical lithography involves the use of 
ultraviolet (UV) light.  
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4.3.1. Mask design and fabrication 
The first step in mask making is to use a computer-aided design (CAD) system to 
completely describe the desired circuit pattern. The CAD system then drives the pattern 
generation, an optical or electron beam lithographic system that transfers patterns to the 
electron-sensitised mask (Sze, 2002). Photomasks can be either positive or negative 
masks, meaning that the pattern on the mask is either the pattern desired on the 
substrate or the inverse, respectively.   
A positive photomask was created for the fabrication of the microelectodes, with nine 
different electrode designs transferred to the mask (Section 7.11.1). The nine designs 
had variation in electrode width (EW), electrode gap size (EG), spacing between 
electrode pairs (ES), and number of electrode pairs (EP) (Table 4.1). Each 
interdigitated electrode layout also required a landing space (LS) of sufficient size to 
enable the needles of the probe station to make contact with the electrodes, this was 200 
μm2 in all designs. In all designs the electrodes were 400 μm in length. 
 
Table 4.1. Detail of the nine electrode designs (A-I) transferred to the photomask for 
the fabrication of interdigitated microelectrodes. The designs vary in electrode width 
(EW), gap size (EG), spacing between electrode pairs (ES), and number of pairs (EP). 
Design 
EW 
(μm) 
EG 
(μm) 
ES 
(μm) 
EP 
(μm) 
A 3 3 3 16 
B 3 2 2 19 
C 3 5 5 12 
D 6 3 3 16 
E 3 3 3 4 
F 6 3 N/A 1 
G 6 3 18 6 
H 3 3 21 6 
I 3 4 4 13 
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The process for the transfer of the mask design to the mask is shown schematically in 
Figure 4.1. The mask material used consisted of soda lime glass coated with low 
reflective chrome onto which a layer of positive photoresist was applied (Figure 4.1, 
A). The designs detailed in Table 4.1 were transferred to the layer of positive 
photoresist using a mask-writer, with the exposed portions of photoresist removed 
using developer. The unprotected chrome region is then removed via etching, and the 
remainder of the photoresist then removed with acetone (Figure 4.1, B). This process 
results in the creation of a positive photomask. 
  
 
Figure 4.1. Schematic showing the procedure for mask manufacture. The mask 
material (A), consists of soda lime glass (white) coated with low reflective chrome 
(dark grey), over which a layer of positive photoresist is applied (maroon). The desired 
pattern is transferred to the mask via the procedure shown in B. Firstly, a mask-writer 
transfers the desired pattern onto the photoresist using UV light, which is then removed 
using developer. The chrome is then removed using chrome etch, and lastly, the 
remainder of the photoresist is removed using acetone. 
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4.3.2. Pattern transfer 
In order to create an array of gold interdigitated electrodes, a layer of gold, with a 
nichrome adhesion layer, was deposited via evaporation onto a silicon oxide wafer 
(Section 7.11.2). To this wafer, a layer of positive photoresist is then applied, and the 
patterns from the mask fabricated in Section 4.3.1 were then transferred using a mask 
aligner (Section 7.11.3). The exposed photoresist was then removed with developer and 
the exposed gold and nichrome removed via etching. The final result was a microchip 
containing arrays of interdigitated gold electrodes on an insulating silicon oxide wafer 
as shown in Figure 4.2. The photolithography process described above is shown 
schematically in Figure 4.3. 
 
 
Figure 4.2. Optical microscopy images of interdigitated gold electrodes fabricated by 
optical lithography shown after the development of photoresist (A), after the removal of 
gold by etching (B), and finally, after the removal of the nichrome adhesion layer by 
etching (C). Scale bars are 100 μm.. 
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Figure 4.3. Schematic showing the photolithographic process used for the fabrication 
of gold microelectrodes. A) A silicon oxide wafer. B) Gold and nichrome are deposited 
onto the silicon oxide wafer via evaporation. C) A layer of positive photoresist is spun 
onto the wafer. D) The pattern from the mask is transferred to the photoresist using a 
mask aligner, with UV light exposing the portions photoresist not masked. E) The 
exposed photoresist is removed with developer. F) and G) The gold and nichrome are 
removed via etching. H) The remaining photoresist is removed. 
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4.4. Bovine insulin fibrils 
For conductivity measurements, bovine insulin amyloid fibrils were formed under the 
conditions at which the average length of fibrils reached a maximum, with the 
exception of the removal of salt (Section 7.12).  Bovine insulin amyloid fibrils formed 
under these conditions are shown in Figure 4.4. For these experiments it was desirable 
to have long fibrils, as even though the amyloid fibrils exist in a network environment 
as opposed to isolated fibrils, the existence of amyloid fibrils of maximum length 
increases the likelihood of good contacts between the interdigitated electrodes. The 
importance of good protein-electrode contacts has been previously noted (del Mercato 
et al., 2007). 
 
 
Figure 4.4. TEM images showing bovine insulin amyloid fibrils formed under the 
conditions that were found in Chapter 3 to give the maximum average fibril length (A), 
and fibrils formed under this same condition with the exception of the removal of salt 
(B). Scale bar is 0.2 μm. 
 
Chapter 4 – Electrical properties and manipulation of amyloid fibrils                         123 
 
 
 
Salt was removed in order to eliminate its potential impact on conductivity 
measurements, which meant fibrils were formed in pH adjusted nanopure water, which 
would have only had very low salt present from the protein and pH adjustment. This 
was seen to have minimal effect on fibril growth or morphology (Figure 4.4, A), as 
compared to those grown under the same conditions with salt present (Figure 4.4, B). 
A similar length distribution is also seen for those fibrils grown in the absence of salt as 
shown in Figure 4.5, with the average fibril length 1.19 μm, as compared to 1.33 μm 
for those growth with salt present (Table 4.2) In the experiments of del Mercato et al., 
fibrils were also formed in nanopure water (del Mercato et al., 2007).  
 
Figure 4.5. Length distribution of bovine insulin amyloid fibrils formed in the presence 
(A), and absence (B), of salt.  
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Table 4.2. Average fibril length and range for bovine insulin fibrils formed in the 
presence and absence of salt. 
Growth conditions Sample size (n) Average fibril length 
(μm) 
Range (μm) 
Salt present in growth 
buffer 
230 1.33 0.19-4.21 
No salt in growth buffer 292 1.19 0.08-5.47 
 
For unmodified amyloid fibrils formed from bovine insulin, current values in the range 
of 10-9 to 10-8 A were recorded for bias voltages in the range of 0 – 2 V (Figure 4.6) 
(Section 7.12), with the different curves reflecting the fact that the fibrils exist as a 
network, with different numbers of fibrils bridging the electrodes at different points. 
Control experiments carried out on empty devices and in the presence of fibril buffer 
revealed low current values in the range of 10-12 A (Figure 4.6, insets A and B).  
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Figure 4.6. Typical current-voltage (I-V) curves observed for networks formed from 
bovine insulin amyloid fibrils on three different samples. Inset: A) Blank device and B) 
Control with insulin fibril buffer only.1 
 
When fibrils are formed from bovine insulin, as with other proteins, non-fibrillar 
species are often present, either in the form of soluble precursors which have not been 
converted to fibrils or amorphous aggregate (Zurdo et al., 2001). These non-fibrillar 
species can be removed using pepsin (Section 7.13), a protease which has activity at 
low pH, which will digest non-fibrillar species, whilst leaving amyloid fibrils intact 
(Zurdo et al., 2001). I-V curves were also measured for networks of bovine insulin 
amyloid fibrils that were treated with pepsin, in order to ascertain that the observed 
electrical characteristics could be attributed to the fibril structure. As an additional 
control, I-V curves were also measured after deposition of native insulin in solution. 
                                                 
1 This work is published in (Domigan et al., 2011) 
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TEM images taken before and after treatment with pepsin (Section 7.5), show the 
fibrillar structure of bovine insulin amyloid fibrils to still be intact, with no change to 
fibril morphology (Figure  4.7). A clearer TEM image is produced after pepsin 
treatment, likely due to the removal of any non-fibrillar protein from the background, 
which may have affected the contrast achieved with negative staining. 
 
 
Figure 4.7. TEM images of bovine insulin amyloid fibrils before (A) and after (B) 
digestion with pepsin. Scale bar is 0.2 μm. 
 
I-V curves for the digested insulin fibril samples showed a slight decrease in 
conductivity, with current values in the range of 10-10 A recorded for bias voltages in 
the range of 0–2 Volts (Figure 4.8). Control measurements are the same as those 
shown in Figure 4.6, A and B. This decrease in observed current values could be due to 
the removal of amorphous aggregate or native insulin protein that was in some way 
contributing to the observed current, or could be due to a decrease in the concentration 
of insulin fibrils, resulting from the removal of the pepsin by centrifugation prior to 
deposition of the protease-treated network onto electrodes. To further investigate this, I-
V curves were also constructed for native insulin protein deposited onto interdigitated 
electrodes. 
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Figure 4.8. Typical current-voltage (I-V) curves recorded for networks of insulin fibrils 
after treatment with pepsin on three different samples. 
 
I-V curves for native bovine insulin protein deposited onto interdigitated electrodes 
(Figure 4.9) were similar to those obtained with blank electrodes, or the buffer control 
(Figure 4.6, A and B). This suggests that the observed current values in Figure 4.6 can 
indeed be attributed to the fibril structure, and that the discrepancies seen in 
conductivity before and after pepsin treatment are most likely due to a decrease in the 
concentration of fibrils, meaning a reduced density of the network, and therefore fewer 
fibrils bridging electrodes. These additional controls of protease treated fibrils and 
native protein were not carried out in the investigation of del Mercato et al., although 
images of the poly(ValGlyGlyLeuGly) show little unfibrilised protein (del Mercato et 
al., 2007). 
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Figure 4.9. Typical current-voltage (I-V) curve for native bovine insulin deposited onto 
interdigitated electrodes. 
 
The bovine insulin used throughout was obtained commercially (Sigma Chemicals (Lot 
054K1375)), and is stated to contain 0.5 % zinc.  As stated previously in Chapter 3, in 
solution, insulin exists as an equilibrium mixture of monomers, dimers, tetramers, 
hexamers, and possibly higher associated states (Nielsen et al., 2001). Hexameric 
porcine insulin has been shown to contain two zinc ions per hexamer, 17 Å apart on the 
threefold symmetry axis, which traverses the central cavity of the hexamer (Harding et 
al., 1966). Each zinc ion is co-ordinated to three imidazoyl nitrogen atoms from His-
B10 and three water molecules (Adams et al., 1969). Hexameric bovine insulin has 
been shown to be structurally identical to porcine insulin (Smith et al., 2005), with the 
zinc ions existing with the same stoichiometry and arrangement (Figure 4.10).  
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Figure 4.10. PyMOL image showing hexameric bovine insulin complexed with two zinc 
ions. Both zinc ions lie on the threefold symmetry axis and so the second zinc ion is not 
visible in this image. The monomers are shown in alternating blue and orange, with the 
histidine residues involved in zinc binding shown in stick representation in black. Water 
molecules also involved in zinc binding have been omitted from this image for clarity. 
Constructed using PyMOL (Delano, 2002), from PDB file 2ZP6 (Jaimohan et al., 
2008). 
 
As amyloid fibrils were formed directly from dissolved bovine insulin powder, it was 
assumed that the zinc ions may have been present in the fibril structure. In order to 
investigate the possibility of a role of the zinc ions in the conductivity of bovine insulin 
fibrils, EDTA was used to remove zinc from the bovine insulin powder prior to fibril 
formation (Section 7.14). No great morphological differences were observed by TEM 
in the “minus-zinc” bovine insulin fibrils, although the presence of zinc is thought to 
perhaps influence uranyl acetate staining (Figure 4.11). 
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Figure 4.11. TEM images of bovine insulin amyloid fibrils formed with (A), and 
without (B), zinc. Scale bar is 1 μm. 
 
I-V curves for bovine insulin amyloid fibrils formed in the absence of zinc were very 
similar to those recorded for insulin fibrils with zinc present, with current values in the 
range of 10-9 A recorded for bias voltages in the range of 0–2 Volts (Figure 4.12). 
Control measurements are the same as those shown in Figure 4.6, A and B. As there 
was no large difference observed in the conductivity of insulin fibrils with and without 
zinc present it appears that the zinc ions do not play a major role in charge transfer 
within the fibril structure. 
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Figure 4.12. Typical current-voltage (I-V) curve for bovine insulin fibrils formed in the 
absence of zinc deposited onto interdigitated electrodes on three different samples. 
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4.5. Fish eye crystallins fibrils 
Conductivity measurements were also carried out on networks of crystallin fibrils 
formed from crude fish eye protein. Crystallin fibrils were formed using the standard in 
house conditions (Section 7.4.2) (Figure 4.13), as the fibrils formed from crystallin 
proteins are much longer than those formed from insulin and so adequate bridging of 
electrodes was not of concern. Length distributions of crystallin amyloid fibrils are 
shown in Section 4.10.2. 
 
 
Figure 4.13. TEM images of crude crystallin fibril sample used for conductivity 
measurements of fibril networks. Scale bars are 10 μm (A) and 1 μm (B). 
 
For amyloid fibrils formed from crude fish eye crystallin proteins, current values in the 
range of 10-10 to 10-11 A were recorded for bias voltages in the range of 0–2 V (Figure 
4.14) (Section 7.12). Control experiments carried out on empty devices (Figure 4.6, A), 
and in the presence of fibril buffer revealed low current values in the range of 10-12 A 
(Figure 4.14, insert). I-V curves for crude crystallin proteins in the native state 
deposited onto interdigitated electrodes were similar to those for the buffer control 
(Figure 4.15); this is the same as was observed for native insulin. Crystallin fibrils 
were not subjected to protease treatment, as preliminary experiments showed this to 
degrade the fibrils, and the fibril formation process for crude crystallins has also been 
optimised to eliminate the presence of amorphous aggregate. 
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Figure 4.14. Typical current-voltage (I-V) curve for crude crystallin fibrils deposited 
onto interdigitated electrodes on three different samples. Inset shows crystallin fibril 
buffer control. 
 
 
Figure 4.15. Typical current-voltage (I-V) curve for native crude crystallins deposited 
onto interdigitated electrodes on three different samples. 
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4.6. Fungal hydrophobins rodlets 
Conductivity measurements were also carried out for networks of fibrils formed from 
fungal hydrophobins (Section 7.12). The amyloid fibrils formed from this protein 
source give rise to a distinct network structure compared to that observed for insulin 
and crystallin fibrils. Hydrophobin rodlets form an ordered, regular network as opposed 
to a random one, as shown in Figure 4.16. This regular structure has been observed on 
fungal spores, as well as with in vitro formation of rodlets on a surface (Sunde et al., 
2008). The rodlet network is a monolayer which is approximately 1.3–2.8 nm thick, 
depending on preparation conditions (Paananen et al., 2003; Szilvay et al., 2007). It has 
also been shown that the monolayer lacks interwoven structures (Beever et al., 1979; 
Beever and Dempsey, 1978; Dempsey and Beever, 1979), making it an interesting 
network to study in terms of charge transfer. 
 
 
 
Figure 4.16. Representative tapping-mode AFM image of fungal hydrophobin rodlets 
Rodlets were formed onto a silicon wafer. Scan size 2 μm2. 
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Hydrophobin networks were deposited onto interdigitated electrodes and current values 
in the range of 10-10 A were recorded for bias voltages in the range of 0–2 Volts 
(Figure 4.17). Control experiments carried out on both empty devices (Figure 4.6, 
inset A), and in the presence of hydrophobin rodlet buffer (Figure 4.17, inset) showed 
low current values in the range of 10-12 A. As hydrophobins form rodlets spontaneously 
in the presence of a solid/water interface, it was not possible to obtain current values for 
native hydrophobins. 
 
Figure 4.17. Typical current-voltage (I-V) curves recorded for networks of fungal 
hydrophobin rodlets on three different samples. 
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4.7. Summary of conductive properties of amyloid fibril networks 
It was observed that networks of amyloid fibrils formed from bovine insulin, fish eye 
crystallins, and fungal hydrophobins all had fairly similar conductive properties, with 
networks from all three fibril systems having low current values in the range of 10-8 to 
10-10 A recorded for bias voltages in the range of 0-2 V (Table 4.3). As these current 
values fall within a narrow range it is therefore likely that the generic fibril structure is 
playing a role in influencing conductivity, as the native protein gives much lower 
current values, but with differences seen due to amino acid composition. Further 
studies, such as mutagenesis of charged residues, would be necessary to confirm this 
hypothesis. 
 
Table 4.3. Summary of conductive properties of amyloid fibril networks deposited onto 
interdigitated electrodes.   
Network components Current values (A) recorded (for bias voltages 0-2 V) 
Bovine insulin amyloid fibrils 10-9 to 10-8 
Bovine insulin amyloid fibrils – after digest with 
pepsin 
10-10 
Bovine insulin amyloid fibrils – in the absence of 
zinc 
10-9 
Fish eye crude crystallin amyloid fibrils 10-10 
Fungal hydrophobin rodlets 10-10 
Poly(ValGlyGlyLeuGly) amyloid-like fibrils 
(del Mercato et al., 2007) 
10-9 
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The observed current values for the three fibril systems in this study are similar to those 
previously recorded by del Mercato et al. in their study on the conductivity of 
“amyloid-like” fibrils formed from an elastin-related polypeptide, which formed fibrils 
with diameters ranging from 20 to 250 nm – much larger structures than the amyloid 
fibrils employed here (del Mercato et al., 2007). They recorded current values typically 
in the range of several nanoAmps, and suggested the presence of charge-transfer 
pathways in the fibrillar structures, with particular emphasis on an important role of 
water molecules. It can be speculated that a similar mode of charge-transfer is in place 
for the range of fibrils used in this study.  It is interesting that although these four 
amyloid fibril systems are significantly different, for example they range from fibrils 
formed from an engineered peptide (del Mercato et al., 2007), through to those formed 
from a crude protein mixture, the observed electrical behaviour is very similar, with 
low current values consistently recorded (Table 4.3). 
These results are in agreement with the findings of Schiebel et al. that in the 
unmodified state, amyloid fibrils are insulators (Scheibel et al., 2003). This was not an 
altogether surprising result, considering that most biological nanofibres and nanotubes 
have been found to have low conductivity (Storm et al., 2001). For example, although 
DNA has had varying conductivities reported, depending on sequence and 
environmental conditions, the conductivities are in the range of 2 S/cm down to 10-16 
S/cm (Bockrath et al., 2002; Gomez-Navarro et al., 2002; Tran et al., 2000), with the 
majority of reports finding DNA to be insulating. 
In conclusion, amyloid fibrils formed from bovine insulin, fish eye crystallins, and 
fungal hydrophobins all have low conductivity, and if they are to be utilised in an 
application where good ability to sustain electrical charge is necessary, they should be 
used as a scaffold or template for the formation of more highly conductive nanowires. 
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4.8. Modification of amyloid fibrils with conducting polymers  
Amyloid fibrils from bovine insulin were modified using the conducting polymers 
polypyrrole (PPY, Figure 4.18, C) and polyaniline (PANI, Figure 4.18, D). This 
modification process was carried out by collaborators, Cosmin Laslau and Jadranka 
Travas-Sejdic from the Polymer Electronics Research Group at Auckland University. 
Since the discovery of the electrically conductive properties of doped polyacetylene in 
1977 (Chiang et al., 1977), conducting polymers have been the focus of much scientific 
attention due to their wide applicability, such as in electronic circuitry, organic LEDs 
and solar cells, and in sensing devices (Gerard et al., 2002; Inzelt et al., 2000).  Both 
PPY and PANI are polyheterocyclics, a class of aromatic conducting polymers 
recognised as having good stability, conductivity, and ease of synthesis (Guimard et al., 
2007). 
Both PPY and PANI can be easily synthesised by either chemical oxidation or 
electrochemical polymerization of pyrrole and aniline respectively, under relatively 
mild conditions (Chandrasekhar, 1999; Genies et al., 1990; MacDiarmid et al., 1987), 
with advantages and disadvantages recognised for each type of synthesis (Ateh et al., 
2006). For this study, the polymerisation reactions were carried out using chemical 
oxidation by ammonium persulfate in the presence of the insulin fibrils. 
PANI is environmentally stable, with electronic characteristics that are controllable 
through a simple acid-doping/base-redoping pathway (Jang, 2006). Due to these 
characteristics, PANI can be used in a range of applications, such as sensing (Huang et 
al., 2003), field emission displays (Wang et al., 2001), and electronic circuitry (Drury 
et al., 1998). Of all the conducting polymers, PPY has been the most extensively 
studied for biological and medical applications, such as biosensors and tissue 
engineering scaffolds (Guimard et al., 2007), due to its high biocompatibility. 
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Figure 4.18. Structures of the monomers A) Pyrrole, and B) Aniline, with amino groups 
shown in red, and the conducting polymers C) Polypyrrole (PPY), and D) Polyaniline 
(PANI). Adapted from Martin (1995). 
 
Nanostructured conducting polymers, such as PANI and PPY, are of high interest, as 
nanoforms of these polymers offer new properties and superior performance (Li et al., 
2008; Li et al., 2009; Tran et al., 2009). 1-D conducting polymer structures were first 
produced in the 1970s, with the formation of films of polyacetylene nanofibres 
(Shirakawa et al., 1977). Since then, conducting polymer nanowires have been formed 
by a variety of different techniques such as electrospinning (MacDiarmid et al., 2001; 
Pinto et al., 2003), mechanical stretching (He et al., 2001), post-synthetic self assembly 
via deposition onto solid supports (Carswell et al., 2003; Malik and Nandi, 2002), and 
solution-phase synthesis, which has the advantage of being able to produce bulk 
quantities of  nanowires (Tran et al., 2009). 
Chapter 4 – Electrical properties and manipulation of amyloid fibrils                         140 
 
 
 
Solution-phase synthesis of conducting polymer nanowires can be either template or 
non-template directed. When a template is used, this may either be a “soft”-template, 
for example, a surfactant that can guide the growth of the polymer in or around self-
assembled micelles, or a “hard”-template (Tran et al., 2009). A hard-template is one 
with pre-formed nanoscale features. The template is often removed, although this can 
be a difficult procedure, such as in the case where the conducting polymer is 
synthesised using the inside pores of a membrane as a template (Martin, 1995).  
A range of different templates have been used for the seeding or templating of 
conducting polymer nanowires, ranging from the inorganic to the biological (Lu et al., 
2010). Biological templates that have been used include TMV molecules (Niu et al., 
2006; Niu et al., 2007a; Niu et al., 2007b), DNA (Ma et al., 2004; Moon et al., 2010; 
Nickels et al., 2004), RNA (Fan et al., 2007), polysaccharides (Numata et al., 2004; Shi 
et al., 2006), and amyloid fibrils - which were modified with the conducting polymers 
PEDOT-S, PTAA, and PPF (Hamedi et al., 2008; Herland et al., 2007; Herland et al., 
2008; Tanaka et al., 2008),  
PANI and PPY nanofibres have previously been synthesised in solution (Huang et al., 
2003; Huang and Kaner, 2004). TMV molecules have also been used for the formation 
of both PANI (Niu et al., 2006; Niu et al., 2007a), and PPY nanofibres (Niu et al., 
2007b), with the polymerisation carried out by chemical oxidation in both cases. To 
date, amyloid fibrils have not been used as templates for the formation of PANI or PPY 
nanofibres.  
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Bovine insulin amyloid fibrils were used as a scaffold for the formation of amyloid-
PPY and amyloid-PANI conjugate nanowires. In both cases, the polymerisation 
reaction was carried out in the presence of amyloid fibrils, resulting in the amyloid 
fibrils being coated with the conducting polymer, as shown in Figure 4.19. It can be 
seen in Figure 4.19 that the insulin fibril structure is still intact, an important 
observation as DNA was previously shown to be degraded by ammonium persulfate, 
causing visible breaks in the wires (Nickels et al., 2004). It was also seen that the two 
different conducting polymers give different coating morphologies, with the amyloid-
PANI showing a “webbed” morphology (Figure 4.19, B), while the amyloid-PPY 
shows a “beaded” morphology (Figure 4.19, C). This change in morphology was also 
observed by Hamedi et al., who saw an increased diameter of fibrils and a webbed 
morphology upon coating insulin fibrils with the conducting polymer PEDOT-S 
(Hamedi et al., 2008). It should be noted that Niu et al. managed to shift from the 
propensity to form a webbed morphology towards the formation of individual 
unbranched fibres in their studies on TMV-PANI, by changing the polymerisation 
conditions, namely with the addition of poly(sulfonated styrene) (PSS).  
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Figure 4.19. TEM images of: A) Bovine insulin amyloid fibrils prior to modification. 
Scale bar 200 nm. B) Amyloid fibrils modified with PANI. Scale bar 100 nm. C) 
Amyloid fibrils modified with PPY. Scale bar 100 nm. 
 
As to the mechanism of the polymer coating onto the fibrils, a similar mechanism to 
that proposed for the coating of TMV molecules is suggested. That is that the 
negatively charged surface residues “bind” the amino group (shown in red, Figure 
4.18) of the monomers, pyrrole or aniline (Figure 4.18, A and B respectively), through 
electrostatic interactions or hydrogen bonding (Li et al., 2008). This causes 
accumulation of monomers on the surface of the fibrils, with in situ polymerisation of 
absorbed monomers causing a thin layer of polymer on the surface. 
Chapter 4 – Electrical properties and manipulation of amyloid fibrils                         143 
 
 
 
The diameter of PANI nanofibres has been shown to vary depending on the reaction 
conditions, specifically the acid used for polymerisation, with nanofibres formed of 
diameters ranging from 30 to 120 nm (Li et al., 2008). In the studies by Niu et al., using 
TMV as a template, they saw diameters increase from 18 nm in the native TMV 
structure, to 22 nm for TMV-PPY (Niu et al., 2007c), and 40 nm to 1-2 μm for TMV-
PANI, depending on the pH at which the polymerisation was carried out at (Niu et al., 
2007a).  In this study, the conducting polymer coating saw an increase in diameter from 
7-10 nm to approximately 20 nm for the amyloid-PANI fibres, and approximately 30 
nm for the amyloid-PPY fibres (Figure 4.19). Alteration of the polymerisation 
conditions, as mentioned above, could be utilised in future work to achieve a more 
uniform coating, and to control the thickness of the coating. 
 
4.9. Conductive properties of modified amyloid fibril networks 
The conductive properties of both the amyloid-PPY and amyloid-PANI networks were 
examined by the same method as was used for the unmodified fibrils (Section 7.12). It 
was seen that for amyloid-PPY networks, current values in the range of 10-5 to 10-4 A 
were recorded for bias voltages in the range of 0–2 V (Figure 4.20).  Investigation into 
the conductive properties of amyloid-PANI networks saw that current values in the 
range of 10-8 to 10-7 A were recorded for bias voltages in the range of 0 – 2 V (Figure 
4.21).  Control measurements on blank electrodes were the same as for previous 
experiments (Figure 4.6, A).  
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Figure 4.20. Typical current-voltage (I-V) curves for networks of bovine insulin 
amyloid fibrils modified with polypyrrole (PPY) on three different samples.  
 
Figure 4.21. Typical current-voltage (I-V) curves for networks of bovine insulin 
amyloid fibrils modified with polyaniline (PANI) on three different samples. 
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As shown in Table 4.4, modification of bovine insulin amyloid fibrils with the 
conducting polymers PPY and PANI causes an increase in conductivity of the amyloid 
fibril network by four and one orders of magnitude respectively.  Doping of amyloid-
PANI nanowires carried out with HCl was unsuccessful, with no improved 
conductance. This was also the case for DNA-PANI nanowires (Nickels et al., 2004). 
 
Table 4.4. Summary of current values recorded for unmodified and modified bovine 
insulin amyloid fibril networks. 
Network components 
Current values recorded (for bias voltages 0-
2V) 
Bovine insulin amyloid fibrils 10-9 to 10-8 A 
Bovine insulin amyloid fibrils + PPY 10-5 to 10-4 A 
Bovine insulin amyloid fibrils + PANI 10-8 to 10-7 A 
 
 
4.10. Manipulation and immobilisation of amyloid fibrils by DEP 
Dielectrophoresis (DEP) is a non-destructive, non-invasive electrokinetic mechanism, 
that is defined as the motion of a polarisable particle in a non-uniform electric field 
(Lapizco-Encinas and Rito-Palomares, 2007). DEP has been used extensively on 
biological particles, for analysis and separation of particles such as cells (Kang et al., 
2008), micro-organisms (Moncada-Hernandez et al., 2011), DNA (Kuzyk et al., 2008), 
RNA (Giraud et al., 2011), protein particles (Lapizco-Encinas et al., 2008), and more 
relevant to this project, for the manipulation and isolation of biological nanotubes 
(Castillo et al., 2008), in order to probe electrical properties. At the nanoscale, DEP is 
most commonly used for controlled positioning of individual objects on a chip (Kuzyk, 
2011). 
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4.10.1. Theory of DEP 
DEP was first discovered by Pohl in 1951, and refers to the movement of particles 
induced by polarisation effects in non-uniform electric fields (Lapizco-Encinas and 
Rito-Palomares, 2007; Pohl, 1951). If a dielectric particle, that is, a particle that is 
polarisable, is suspended in an electric field, the particle will polarise. The magnitude 
and direction of this induced dipole depends on a number of factors: the frequency and 
magnitude of the applied electric field, and also the dielectric properties of both the 
particle and the medium. These dielectric properties are conductivity, the ease with 
which charge can move through a material, and permittivity, which is how much 
resistance is encountered when forming an electric field (Dimaki, 2009).  
In a uniform electric field, the force on either side of the particle is the same, so there is 
no net force pulling the particle anywhere and the particle will not move, unless the 
particle carries a net charge and the field frequency is close or equal to zero. In a non-
uniform electric field, as is the case with DEP, the field lines are denser on one side of 
the particle than the other, meaning that the electric field is stronger on one side than 
the other and the particle will move (Dimaki, 2009). If the particle is more polarisable 
than the medium, then the particle will move towards the strongest field, which is 
called positive DEP. If the particle is less polarisable than the medium you will get 
negative DEP, where the particle moves towards the weakest field. This is shown 
schematically in Figure 4.22. 
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Figure 4.22. A) Schematic showing positive and negative DEP. Positive DEP occurs 
when the particle is more polarisable than the medium, and so moves towards the 
strongest point of the electric field. Negative DEP is where the reverse occurs, the 
particle is less polarisable than the medium and so movement is in the direction of the 
weakest field. B) For this study, the aim is to immobilise crystallin fibrils between an 
electrode pair using positive DEP. 
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There are two ways of generating non-uniform electric fields: electrode-based DEP, 
which involves applying a voltage across an electrode array, and insulator-based DEP, 
where insulating structures are placed between a pair of electrodes (Gonzalez and 
Remcho, 2005). This study used electrode-based DEP. 
 
4.10.2. Governing equations 
The force (F) exerted by an electric field, E, on a dipole with dipole moment, p, is 
given by the following equation (Dimaki and Bøggild, 2005; Kuzyk, 2011): 
 ( . )F p E   (4.1) 
Where ? is the mathematical “del” operator. Here the higher order terms of the force 
are omitted. Therefore, the expression is only accurate if the magnitude of the electric 
field does not vary significantly across the dipole (Dimaki and Bøggild, 2005). In an 
AC-field the time-averaged force on a particle will be given by: 
   20. . .Re .DEP m fF K E     (4.2) 
Where Γ is a factor depending on the particle geometry, εm is the relative permittivity of 
the suspending medium, ε0 is the permittivity of the vacuum, and E is the applied 
electric field (amplitude and not root mean square). The factor Kf depends on the 
complex permittivities of both the particle and the medium, plus the particle geometry. 
As alluded to above, particle geometry is an important factor in dielectrophoresis. The 
geometry of crystallin fibrils was assumed to be that of a prolate ellipsoid (Figure 
4.23), where α1 >> α2 = α3.  This geometry was used as it had been previously used for 
structures of a similar geometry to crystallin fibrils: FF nanotubes (Castillo et al., 
2008), and SWNT (Lin et al., 2007).  
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Figure 4.23. The geometry of crystallin fibrils (B), was assumed to be that of a prolate 
ellipsoid, where α1 >> α2 = α3. 
 
The length distribution of crystallin fibrils was measured from TEM images of the fibril 
sample used for the DEP experiments (Figure 4.24), with an average length of 4.92 μm 
calculated (n = 207) (Section 7.10.2). The average diameter of crystallin fibrils was 
measured from AFM images of the same fibril sample, and was 16.3 ± 5.6 nm (Section 
7.10.3). 
 
 
Figure 4.24. Histogram showing length distribution of crystallin fibril preparation that 
was used for DEP experiments. 
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In the case of the prolate ellipsoid, the factor Kf  is now different for each principal axis 
n (n = 1, 2 and 3), and is given by: 
 
.( )
p mn
f
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 
  
    (4.3) 
Where εp and εm are the relative permittivities of the particle and the medium 
respectively, and An is the depolarising factor for the axis n. In the case of a prolate 
ellipsoid where α1 >> α2 = α3, as is the case with crystallin fibrils (Figure 4.23), and 
assuming that the major axis of the particle, axis 1 in this case, is aligned with the field 
(Figure 4.22, B), the depolarising factor is given by: 
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Where e is the eccentricity of the particle, which is given by: 
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That the particle geometry has been assumed to be a prolate ellipsoid also influences 
the geometry factor Γ (from Equation 4.2). The geometry factor Γ for a prolate ellipsoid 
is given by: 
 3
4 p
V  ellipsoid  1 2 3. . .      (4.6) 
Equation 4.2 shows that the dielectrophoretic force is dependent on the real part of Kf. 
If the real part is positive, then the DEP force is in the direction of increasing electric 
field, which gives positive DEP as described previously, and vice versa. The frequency 
at which the behaviour of the particle in the electric field changes from positive to 
negative DEP is called the turnover frequency, fto, and for a prolate ellipsoid, this is 
given by: 
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4.10.3. Manipulation and immobilisation of crystallin amyloid 
fibrils 
A DEP microchip, that was custom designed and fabricated by collaborators at 
Denmark Technical University, with 5 electrode pairs with a 5 μm gap was used in 
experiments to attempt to immobilise crystallin amyloid fibrils between electodes, with 
the aim of further electrical characterisation once fibrils were isolated. The methods for 
design and fabrication of the DEP microchip are laid out in Section 7.15.1, along with 
images of the microchip design in Figure 4.25. 
 
 
Figure 4.25 Design of the DEP microchip. The DEP microchip consisted of 5 pairs of 
electrodes, with large landing spaces located at the end of the chip for contact with the 
chip holder (A). A closer view of these electrodes (B and C), shows that each electrode 
pair is spaced 5 μm apart. 
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As described in Section 7.15.1, a range of parameter combinations, varying voltage 
frequencies ranging from 1 kHz to 1 MHz , and  voltage amplitudes of 10 and 20 V 
peak-peak were investigated in order to get the optimal values to manipulate the 
amyloid fibrils using positive DEP. Positive DEP was required as previously performed 
simulations of the electric field  had shown the electric field was to be strongest around 
the tips of the electrodes (Castillo et al., 2008), the point where fibril immobilisation 
was desirable. 
Positive DEP was only seen at a voltage of 20 V peak-peak (Vpp), and at frequencies 
from 50 – 100 kHz. Results of the DEP experiments, showing the percentage of 
instances of positive DEP from ten samples per parameter combination are summarised 
in Table 4.5. From the result of these experiments the turnover frequency, defined in 
Section 4.10.2, can be estimated to be 100 kHz.  
 
Table 4.5. Summary of the percentage of instances of positive DEP from ten samples 
per parameter combination 
Voltage (Vpp) Frequency (kHz) Percentage of electrode pairs at which positive DEP occurred 
20 50 80 
20 75 25 
20 100 10 
20 125 0 
20 150 0 
 
Control electrodes, where crystallin fibrils were deposited but no DEP forces applied, 
showed no immobilisation of crystallin fibrils (Figure 4.26, B), as compared to 
electrodes where immobilisation of crystallin fibrils by DEP was successful. 
Representative SEM images of crystallin fibrils immobilised on electrode pairs are 
shown in Figure 4.26 (Section 7.15.2). 
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Figure 4.26. SEM images showing A) Crystallin amyloid fibrils deposited on Au 
substrate, B) Control electrode pair, where crystallin fibrils 
forces applied, and C) and D),
resulted in successful immobilisation of crystallin fibrils between electrode pairs.
 
As shown in Figure 4.2
electrodes, as well as crystallin fibrils being immobilised, there was an unusual 
deposition of material at the tips of electrodes. By comparison to previously observed 
samples (Figure 4.27),
(Appendix C) it was ascertained that the gold was still intact, but at this point it is 
unknown what phenomena is occurring. 
were deposited but no DEP 
 representative images of where DEP forces applied 
6, D, when voltages of 20 Vpp at 100 kHz 
 and also by energy-dispersive X-ray spectroscopy
 
          153 
 
 
 
were applied to 
 (EDX) 
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Figure 4.27. SEM images of DEP electrodes showing unusual deposition, A) at the 
electrode tip, scale bar 4 μm, and B) at other places on the electrode, scale bar 10 μm. 
C) and D) are comparison SEM images of instances where the deposited gold layer has 
been known to be removed. Scale bars are 10 μm and 4 μm respectively. 
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4.11. Conductive properties of immobilised crystallin fibrils 
As mentioned previously, DEP can be used as a means of immobilising particles, in 
order that different properties, such as conductivity in this case, may be investigated. 
The turnover frequency of a particle can also be used to reveal some information about 
conductive properties. In this section, the conductive properties of immobilised 
crystallin fibrils will be discussed, firstly, as approximated by turnover frequency, and 
also as determined experimentally. 
 
4.11.1. Conductivity estimated by turnover frequency 
From Equation 4.7, the estimated turnover frequency can be used to give some 
approximation of the conductivity of crystallin fibrils.  
The turnover frequency (fto) was determined experimentally to be approximately 100 
kHz (Table 4.6, A), as it was above this frequency that positive dielectrophoresis was 
no longer observed (Table 4.5).  
Another important variable is permittivity, also referred to as the dielectric constant. 
The permittivity of free space (ε0), is a fundamental constant and is given by ε0 = 8.85 x 
10-12 C/Vm (Table 4.6, B). The permittivity of a material reflects the sum total of the 
polarisation response of the matter plus the residual electric field (Kirby, 2010). The 
permittivity of the medium (εm) was calculated from literature values for the 
permittivities of the components of the buffer mixture in which the crystallin fibrils are 
suspended, 25% n-propanol (Table 4.6, C) (Kirby, 2010). The permittivity of the 
particle, in this case, the crystallin fibrils, was assumed to be equivalent to the 
permittivity of protein, which is accepted to be between 10 and 35 (Table 4.6, D) 
(Simonson and Brooks III, 1996). 
The conductivity of the medium was measured using a digital conductivity meter. The 
medium is the buffer (25% n-propanol), and this had a conductivity of 2 μS/cm (Table 
4.6, E). 
From the variables described above, it is possible to very approximately calculate the 
theoretical conductivity of the particle (a crystallin fibril), as being in the range of 10-4 
S/m (Calculated by Maria Dimaki using MATLAB, personal communication).  
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Table 4.6. Summary of the variables required to calculate the conductivity of a particle 
from turnover frequency. 
Variable Value  
A) Turnover frequency (fto) 100 kHz 
Estimated from DEP 
experiments (see Table 4.5) 
B) Permittivity of vacuum 
(ε0) 0  8.85 x 10-12 C/Vm Fundamental constant 
C) Permittivity of medium 
(εm) 
1 3.20 .80 65
4 4m
     
Calculated from buffer mixture 
(25% n-propanol) 
1 3. .
4 4m n propanol water
     
 
 
D) Permittivity of particle 
(εp) 10-35 Assumed to be that of protein 
E) Conductivity of medium 
(σm) 2 μS/cm Measured 
F) Conductivity of particle 
(σp) 
~  9 x 10-4 S/m 
 
Unknown – calculated from 
Equation 7 
 
 
4.11.2. Conductivity measured experimentally by I-V curves 
As was shown in Section 4.10.3, crystallin fibrils were successfully immobilised 
between electrode pairs using DEP. This allowed for investigation into the electrical 
properties of the immobilised fibrils, and in this case, an investigation into the I-V 
characteristics of a smaller, and more specific number of fibrils than were observed for 
the network measurements (Section 4.5). I-V curves were constructed for the pairs of 
DEP electrodes using a probe station and parameter analyser (Section 7.15.3), as was 
used for the network measurements.  
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I-V curves were able to be obtained for three pairs of electrodes, with current values in 
the range of 10-10 A recorded for bias voltages in the range of 0–2 V (Figure 4.28).  
Other electrode pairs failed to give I-V curves above that observed for a blank electrode 
pair (Figure 4.28, insert), suggesting that in these cases although fibrils were 
immobilised between electrodes, there was not good contact between the gold 
electrodes and the fibrils. 
 
 
Figure 4.28. Typical current-voltage (I-V) curves recorded for crystallin amyloid 
fibrils immobilised between electrode pairs by DEP for three different samples.  Insert 
shows blank electrode pair. 
 
After I-V measurements were performed, the electrodes were covered with a thin layer 
of gold and it was verified by SEM that crystallin fibrils were immobilised between 
these electrodes. Clear SEM images were obtained for one pair of electrodes (Figure 
4.29), and it can be seen that there are a number of fibrils present between the electrode 
pair. 
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Figure 4.29. A), B), and C) SEM images of electrode pair which gave the highest 
current values. D) SEM image of electrode pair used for blank measurements. Scale 
bar is 1 μm in all images. 
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From the I-V curves obtained and the SEM images it is possible to obtain an 
approximate value in S/cm for the conductivity of the crystallin fibrils. For the DEP 
chip for which the SEM images in Figure 4.29 were obtained, the current value at 2 V 
was 5 x 10-10 A, which gives a resistance value of 4 x 108 Ω. From the SEM images 
(Figure 4.29), it can be approximated that there are 20 fibrils of average length 6 μm 
between the two electrodes. From these values, the conductivity of the crystallin 
amyloid fibrils can be approximated to be in the range of 10-6 S/m. Given that a number 
of approximations have been made in the calculation of this conductivity value as well 
as the theoretical one based on turnover frequency, no detailed comparison can be made 
between these two values. However, it is worth noting that the conductivity of small 
bundles of crystallin fibrils does correlate well to what was seen in the network 
measurements in Section 4.5. 
 
4.12. Summary 
Investigation into the conductive properties of amyloid fibril networks revealed 
amyloid fibrils formed from bovine insulin, fungal hydrophobins, and crude fish 
crystallins to all have low conductivity in the unmodified state, with typical current 
values in the nA to pA range achieved. These unmodified fibrils can then be treated as a 
nanowire scaffold, where their conductivity is increased through modification, or used 
unmodified in other applications. The modification of bovine insulin amyloid fibrils 
with the conductive polymers polyaniline and polypyrrole resulted in increased 
conductivity: by approximately two and four orders of magnitude respectively. 
Amyloid fibrils formed from crude fish crystallin proteins were able to be manipulated 
on a microchip using DEP. DEP was used to immobilise small bundles of fibrils 
between pairs of gold electrodes, which allowed the conductive properties of small 
numbers of crystallin fibrils to be examined, and these were seen to correlate well with 
the level of conductivity observed in network measurements. 
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5. Chapter Five  
A model application: glucose sensing 
5.1. Introduction 
The model nanowire application chosen was the creation of a glucose sensor, via 
immobilisation of glucose oxidase (GOx) to the amyloid fibril scaffold, and 
modification of electrodes with this now active scaffold. GOx was used in this study as 
it is used in a range of industrial processes, including in glucose sensing (Wong et al., 
2008). Also, the relatively low cost and good stability of GOx make the glucose/GOx 
system a convenient model for method development, particularly in the area of 
biosensing (Raba and Mottola, 1995).  
Conventional methods for enzyme immobilisation on the electrode surfaces include 
adsorption, cross-linking, electrochemical co-polymerisation, covalent attachment, and 
entrapment in polymeric gels or carbon paste (Yemini et al., 2006). Some of the 
limitations of these methods are low quantities of attached enzymes, partial loss of 
enzyme activity, low stability, non-biocompatible immobilisation compounds, and time 
consuming immobilisation processes (Wang, 1991). Using biomaterials such as lipids, 
proteins, and peptides can overcome some of these shortcomings (Deng et al., 2004). 
There are a few previously reported cases of PNT/PNFs being used in this way, 
beginning with FF peptides (Yemini et al., 2005a). Electrodes modified with FF 
peptides were shown to have H2O2 and NADH sensing capabilities (Yemini et al., 
2005b), and those modified with GOx functionalised FF peptides showed an 
amperometric response to glucose (Yemini et al., 2005b). A collagen-like peptide and 
the ionic complementary peptide EFK16-11 have also been used in this way (Qian et 
al., 2009; Yemini et al., 2006). 
This chapter describes the formation of GOx functionalised amyloid fibrils, and the 
glucose sensing capabilities of gold electrodes modified with these fibrils. 
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5.2. Glucose oxidase (GOx) 
Since it was first discovered by Muller in Aspergillus niger extracts (Müller, 1928), 
glucose oxidase (β-D-glucose:oxygen 1-oxidoreductase, GOx) has been found to be 
produced naturally in a range of fungi and insects (Wong et al., 2008). The function of 
GOx in vivo is as an antibacterial and antifungal agent, via the production of hydrogen 
peroxide (Wong et al., 2008). GOx is used in many industrial applications, such as food 
preservation, baking, dry egg production, wine production, gluconic acid production, 
glucose sensing, and potentially in fuel cell applications (Wong et al., 2008). GOx has 
been purified from a range of fungal sources (Bankar et al., 2009), with A. niger most 
commonly used for GOx production (Pluschkell et al., 1996), and this was used in this 
study. 
GOx is a flavoprotein which catalyzes the oxidation of β-D-glucose by molecular 
oxygen to glucono-δ-lactone, which spontaneously hydrolyzes to form gluconic acid, 
with hydrogen peroxide also produced (Leskovac et al., 2005). Subsequently the flavin 
adenine dinucleotide (FAD) cofactor of GOx is reduced to FADH2.  The overall 
reaction scheme is shown in Figure 5.1.  
GOx from A. niger has a molecular weight of approximately 160 kDa, and is a dimeric 
glycoprotein, with two identical polypeptide chain subunits covalently linked via 
disulfide bonds (Hecht et al., 1993). Each subunit contains one molecules of non-
covalently linked FAD as a cofactor, which functions by acting as an electron carrier 
during catalysis (Wilson and Turner, 1992; Wong et al., 2008). The structure of GOx is 
shown in Figure 5.2. 
GOx is widely used in glucose sensing, due to its high specificity for glucose, and 
broad temperature (20-50 °C) and pH (4-7) range (Bankar et al., 2009). 
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Figure 5.1. Schematic of the overall reaction catalyzed by GOx. The reaction involves 
oxidation of glucose to gluconolactone, which spontaneously hydrolyzes to form 
gluconic acid.  Consequently, the FAD cofactor of GOx is reduced to FADH2, and 
molecular oxygen to reduced to H2O2, the production of which leads to the reoxidation 
of the cofactor. Adapted from Leskovac et al. (2005). 
 
 
Figure 5.2. PyMOL image of the GOx dimer (Delano, 2002), with the two subunits 
shown in yellow and green. The FAD cofactors are shown in magenta. Image was 
constructed using PDB file 1GAL (Hecht et al., 1993) 
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5.3. Amplex® red assay to determine GOx activity 
GOx activity was determined using the Amplex® red assay (Section 7.17.1). A 
simplified mechanism for this assay is shown in  
Figure 5.3. When GOx converts glucose to gluconolactone, H2O2 is produced (Figure 
5.1). In the presence of horseradish peroxidase (HRP), Amplex® red (10-acetyl-3,7-
dihydroxyphenoxazine) reacts with H2O2 in 1:1 reaction stoichiometry to produce the 
red-fluorescent oxidation product resorufin. The fluorescence of resorufin is detected at 
excitation/emission of approximately 570/585 nm. 
 
 
 
Figure 5.3. A simplified mechanism of the Amplex® red assay for glucose oxidase 
activity. The Amplex® red assay works by coupling the GOx and HRP mediated 
reactions. The H2O2 produced by the GOx catalysed reaction reacts with Amplex® red 
in the HRP catalysed reaction to produce the fluorescent compound resorufin. 
 
A standard curve for the Amplex® red assay was constructed using GOx concentrations 
ranging from 1-7 mU/mL (Figure 5.4), with one unit defined as the amount that will 
oxidase one micromole of β-D-glucose to D-gluconolactone and H2O2 per minute at pH 
5.1 and 30 °C (Section 7.17.2).  
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Figure 5.4. GOx standard curve constructed using the Amplex® red assay for GOx 
concentrations from 1-7 mU/mL. One unit is defined as the amount that will oxidase 1.0 
µmol of β-D-glucose to D-gluconolactone and H2O2 per minute at pH 5.1 and 30°C 
(Invitrogen, 2006). 
 
5.4. Immobilisation of GOx to insulin amyloid fibrils 
GOx was immobilised to the insulin amyloid fibril scaffold using glutaraldehyde and 
SDS-PAGE was used to assess the degree of cross-linking. After immobilisation, the 
activity of the cross-linked samples was examined using the Amplex® red assay, to 
confirm that GOx was still active once immobilised. 
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5.4.1. Glutaraldehyde cross-linking of GOx to insulin fibrils  
Using the methods previously established in our lab (Pilkington et al., 2010), GOx was 
immobilised onto insulin fibrils using the cross-linking molecule glutaraldehyde (GA) 
(Figure 5.5). GA forms imine bonds between the free amine groups of surface lysine 
residues on proteins and the aldehyde groups of GA.  
 
 
Figure 5.5. Structure of the cross-linking molecule glutaraldehyde (GA) (Hermanson, 
1996). 
 
Dimeric glycosylated GOx has 30 lysine residues in its sequence, of which 24 of these 
are located on the surface of the protein, as shown in Figure 5.6. Of these surface 
lysines, five are available for cross-linking, as was shown by covalently reacting the 
residues with N-hydroxysuccinimde (Baszkin et al., 1997; Frederick et al., 1990; 
Kriechbaum et al., 1989).  
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Figure 5.6. Surface representation of the GOx dimer showing surface lysines residues 
in orange. Image was created using PyMOL from PDB file 1GAL (Delano, 2002; Hecht 
et al., 1993) 
 
The number of available lysine residues on the surface of insulin fibrils is unknown, 
due to insufficient structural information about the arrangement of native insulin within 
a fibril. However, it is thought that insulin fibrils form from association between 
monomers (Brange et al., 1997), and there is one lysine residue per monomer as shown 
in Figure 5.7. There are also two N-terminal amino groups available per insulin 
monomer. 
 
 
Figure 5.7. Primary sequence of bovine insulin showing lysine residue in red. 
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The cross-linking protocol followed the previously established methods (Pilkington et 
al., 2010), with the exception of the reaction order. In order to try to minimize fibril-
fibril cross-linking, and thus maintain the maximum possible surface area for 
immobilisation of GOx, GOx and GA were incubated first, and then fibrils added 
(Section 7.16).  
SDS-PAGE, which denatures proteins using the detergent SDS and separates proteins 
based on molecular weight, was used to confirm cross-linking had occurred (Section 
7.1). Amyloid fibrils are too large to enter the gel, and so remain in the well at the top 
of the gel. If GOx has been successfully immobilised to the amyloid fibrils then that too 
will remain in the well. If GOx has not been immobilised to the amyloid fibrils then it 
is free to move into the gel. The SDS-PAGE gel in Figure 5.8 confirms that 
immobilisation of GOx to insulin fibrils was successful. Native GOx resulted in a 
single band at approximately 80 kDa (Lane 1), which corresponds to the molecular 
weight of monomeric GOx, due to the dimer being denatured by SDS.  Insulin fibrils 
show no band, as they remain in the well (Lane 2). When GOx is incubated with insulin 
fibrils with no cross-linking molecule there appears to be some association with the 
fibrils, as shown by the decrease in intensity of the monomeric GOx band at 80 kDa 
(Lane 3). Cross-linking GOx alone using GA produces a very weak band at 80 kDa, 
and a band at 160 kDa, which corresponds to the stabilisation of the dimer by cross-
linking (Lane 4). Lane 5 shows insulin fibrils cross-linked to themselves, with again no 
band due to the fibrils remaining in the well. When GOx is immobilised to insulin 
fibrils using GA there is no GOx band on the gel, due to the GOx remaining in the well 
with the insulin fibrils (Lane 6). 
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Figure 5.8. SDS-PAGE gel of GA cross-linking of GOx to insulin fibrils. L = ladder 
(molecular weights in kDa on left hand side), 1 = GOx, 2 = insulin fibrils, 3 = GOx + 
insulin fibrils, 4 = GOx + GA, 5 = insulin fibrils + GA, and 6 = insulin fibrils + GA + 
GOx. 
 
The structures and morphologies of GOx-functionalised insulin fibrils (GOx:IF) were 
observed by TEM (Section 7.5), and representative images are shown in Figure 5.9.  
Under TEM, GOx gives a cloudy pattern (Figure 5.9, A and B), as grid assembly and 
staining is likely to cause the GOx dimer to be in a denatured anhydrous state. When 
GA is added to GOx, there is an increase in the density of the observed GOx (Figure 
5.9, C and D), which is consistent with the presence of intermolecular cross-links. 
When GOx is added to insulin fibrils, without any cross-linker, there is still some 
association, and this is seen under TEM (Figure 5.9, E and F). The sample with GOx 
covalently cross-linked to insulin fibrils shows an increase in this association, as 
expected (Figure 5.9, G and H). It is also worth noting that not all GOx is immobilised 
to the fibrils, as cloudy structures similar to those observed in the GOx only sample are 
visible, and also that there is some inter-fibril cross-linking occurring, as evidenced by 
the increased density of the insulin fibril network. Further optimisation of the cross-
linking method used in order to minimize these undesirable effects would be beneficial. 
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Figure 5.9. Representative TEM images of GOx (A & B), GOx + GA (C & D), GOx + 
IF (E & F), and GOx + GA + IF (G & H). Scale bars are 0.5 μm (A, C, E, G) and 0.2 
μm (B, D, F, H). 
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5.4.2. Activity of cross-linked samples 
The activity of cross-linked samples was assayed using the Amplex® red assay (Section 
5.2.1). Firstly, the activity of all samples was tested in solution, and then in order to test 
the effectiveness of the cross-linker, the insulin fibrils were collected using 
centrifugation, and the activity of the supernatant tested. The amount of GOx activity 
remaining in the supernatant was indicative of the degree of immobilisation of GOx to 
the insulin fibrils that was achieved (Section 7.17.3).  
Upon incubation of GOx with insulin fibrils, there was a slight decrease in activity 
compared to the GOx only control, with activity decreasing to 87 % as shown in Figure 
5.10, suggesting that the presence of fibrils interferes with the reaction in some way, 
possibly due to some association of GOx with the insulin fibrils. No activity is lost 
when GOx alone is crosslinked. When GOx is crosslinked to the insulin fibrils there is 
also a slight drop in activity to 91 % of the GOx only control, this is expected as 
immobilisation of enzymes often results in some loss of activity. Upon comparison of 
the activity of the supernatant of the samples containing GOx and insulin fibrils, with 
and without the presence of glutaraldehyde, the sample with glutaraldehyde present has 
significantly less activity in the supernatant, 6 % as compared to 62 %, which 
demonstrates the effectiveness of the immobilisation. 
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Figure 5.10. Graph showing % GOx activity, standardised against the GOx only 
control, of samples containing insulin fibrils (IF), GOx + IF, GOx + glutaraldehyde 
(GA), and GOx + GA + IF (white bars). The samples GOx + IF and GOx + GA + IF  
were then centrifuged to collect the insulin fibrils and the activity of the supernatant 
tested to ascertain the effectiveness of the cross-linker (cross-hatched bars). Each value 
represents the average of three replicates, with error bars representing the standard 
deviation. 
 
5.5. Immobilisation of GOx to crystallin amyloid fibrils 
The use of crystallin amyloid fibrils as a scaffold for enzyme immobilisation was also 
investigated, via the immobilisation of GOx to crystallin fibrils. Methods involving the 
use of GA, as well as an alternative cross-linking molecule, methylglyoxal (MG), were 
examined, with no successful immobilisation of GOx to the crystallin fibril scaffold. In 
order to resolve this issue the lysine availability of crystallin fibrils was analysed and 
the possibility of post-translational modification of fish crystallin proteins was 
investigated. 
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5.5.1. Cross-linking of GOx to crystallin fibrils  
It was first attempted to immobilise GOx to crystallin fibrils using the methods 
established for the immobilisation of GOx to insulin fibrils via GA cross-linking 
(Pilkington et al., 2010). The degree of cross-linking was assessed by SDS-PAGE 
(Figure 5.11) (Section 7.1). Native GOx resulted in a band at approximately 80 kDa 
(Lane 1), which corresponds to the molecular weight of monomeric GOx, due to the 
dimer being denatured by SDS.  There is also a slight band at approximately 160 kDa, 
indicating that the dimer was not completely denatured. Crude crystallin fibrils show no 
band, as they remain in the well (Lane 2). When GOx is incubated with crystallin fibrils 
with no cross-linking molecule the same bands appear as for GOx only (Lane 3). Cross-
linking GOx alone using GA produces a very weak band at 80 kDa, and a band at 160 
kDa, which corresponds to the stabilisation of the dimer by cross-linking, there is also a 
faint high molecular band, which corresponds to the presence of a higher order GOx 
species (Lane 4). When GOx is immobilised to crystallin fibrils using GA there is no 
decrease in the intensity of the GOx band on the gel, which indicates that no GOx was 
immobilised to the crystallin fibrils (Lane 5). 
 
Figure 5.11. SDS-PAGE gel of GA cross-linking of GOx to crude crystallin fibrils. L = 
ladder (molecular weights in kDa on left hand side), 1 = GOx, 2 = crude crystallin 
fibrils, 3 = GOx + crude crystallin fibrils, 4 = GOx + GA, 5 = crude crystallin fibrils + 
GA. 
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As the established method did not result in successful immobilisation of GOx to 
crystallin fibrils, a number of alternate methods were tried, which involved altering 
various variables, including the total cross-linking reaction time, time of pre-incubation 
of the cross-linking molecule with the fibrils, the reaction temperature, the reaction 
order, and the concentrations of the cross-linker, GOx, and the fibrils (Section 7.20). 
The different conditions tried are summarised in Table 5.1.  
 
Table 5.1. Details of different conditions attempted for immobilisation of GOx to crude 
crystallin fibrils (GOx=glucose oxidase, CF=crystallin fibrils, and X=cross-linker). 
Variable Different conditions tried 
Reaction order GOx+CF→X, GOx+X→CF, CF+X→GOx, 
GOx→CF→X, GOx→X→CF, GOx→CF→X, 
Total reaction time (min) 30-120 
Pre-incubation time (min) 
(GOx+CF/GOx+X/CF+X) 
5-20 
Reaction temperature (°C) 25, 37 
Cross-linker GA, MG, GA+MG 
Cross-linker concentration GA (10-150 mM), MG (1-4 %) 
Crystallin fibril concentration (mg/mL)* 1.0–10.0 
GOx concentration (mg/mL) 0.5–2.0 
*This value is approximate. Fibrils were formed using the standard in-house conditions and then 
concentration by centrifugation. 
 
An alternative cross-linking molecule was also used, methylglyoxal (MG) (Figure 
5.12). MG is an α-dicarbonyl compound, and forms protein-protein cross-links by 
reacting with lysine and arginine residues, preferentially reacting with arginine residues 
(Miller et al., 2003). None of the cross-linking conditions detailed in Table 5.1 were 
successful, with all resulting with levels of immobilisation similar to that seen in 
Figure 5.11. 
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Figure 5.12. The structure of methylglyoxal (MG) (Miller et al., 2003). 
 
5.6. Assessment of amino group availability of crystallin fibrils 
In order to investigate the lack of cross-linking via glutaraldehyde for crystallin fibrils, 
the amino group availability of crystallin fibrils was assessed. Two alternate assays 
were used to determine amino group availability: the o-phthaldialdehyde (OPA) assay, 
and the ninhydrin assay.  
 
5.6.1. OPA assay to determine amino group availability 
The OPA assay functions via the reaction of OPA  with primary amines, in the presence 
a reducing agent, for example 2-mercaptoethanol, to form a fluorescent product, a 1-
alkylthio-2-substituted isoindole, the absorbance of which can be detected at 340 nm 
(Figure 5.13) (Roth, 1971). This assay will therefore detect lysine residues, as well as 
N-terminal amines, in protein samples. The OPA assay was carried out according to in-
house methods (Roth, 1971) (Section 7.18), with a standard curve created using lysine 
concentrations ranging from 0.2–2.0 mM (Figure 5.14) (Section 7.18.1).  
 
 
Figure 5.13. OPA reacts with primary amines, in the presence of a reducing agent, to 
produce a fluorescent product that can be detected at 340 nm (Roth, 1971). 
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Figure 5.14. OPA standard curve showing absorbance at 340 nm for lysine 
concentrations ranging from 0.2-2.0 mM. Error bars represent the standard deviation 
of three replicates. 
 
5.6.2. Ninhydrin assay to determine amino group availability 
The ninhydrin assay functions by reaction of ninhydrin solution (triketohydrindene 
hydrate), with ε-amino groups and N-terminal amines, to produce a purple coloured 
compound diketohydrindylidenediketohydrindamine (Ruhemann’s purple) which can 
be detected at 570 nm (Friedman, 2004) (Figure 5.15). The ninhydrin assay was carried 
out according to in-house methods (Friedman et al., 1984) (Section 7.19), with a 
standard curve constructed using lysine concentrations from 0.2 to 2.0 mM (Figure 
5.16) (Section 7.19.1). 
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Figure 5.15. Ninhydrin reacts with primary amines to produce a fluorescent product, 
Ruhemann’s purple, that can be detected at 570 nm (Friedman, 2004). 
 
 
Figure 5.16. Ninhydrin standard curve showing absorbance at 570 nm for lysine 
concentrations ranging from 0.2-2.0 mM. Error bars represent the standard deviation 
of three replicates. 
 
Chapter 5 – A model application: glucose sensing 182 
 
5.6.3. Amino group availability of insulin fibrils 
Determining the amino group availability of amyloid fibrils is more complicated than 
for native proteins. Neither the number of native monomers per fibril, nor solvent 
accessibility of particular residues is known, therefore, it is impossible to calculate a 
theoretical amino group concentration in order to validate the use of a fluorescent 
amino group assay. There are also additional complicating factors associated with 
crystallin amyloid fibrils: 
1) The crystallin amyloid fibrils used in this study are formed from mixtures of 
crude crystallin proteins. 
2) The fibril formation process involves a step where amorphous aggregate is 
removed by centrifugation, meaning that even if the initial concentration of 
native protein is known, there is uncertainty in the concentration of native 
protein that becomes incorporated in the fibril structure. 
Because of this, the two assays described above were first used to determine the amino 
group availability of both native bovine insulin (1.0 mg/mL) and insulin amyloid fibrils 
(formed from 1.0 mg/mL native bovine insulin), in order to validate the use of these 
assays. The results of these assays are summarised in Table 5.2. 
By comparison with the theoretical amino group concentration of bovine insulin, the 
amino group availability as ascertained by each of the two assays indicates that 
approximately two out of three of the amino groups are accessible (Table 5.2). There 
was very good correlation between the two assays, indicating that both are suitable for 
determining the available amino groups in amyloid fibrils. Interestingly, there was not a 
great reduction in the available lysine in bovine insulin amyloid fibrils as compared to 
that in native bovine insulin. Further studies, assaying the availability of a range of 
different amino acids in the native and fibrilised form, could provide further insight into 
the arrangement of the native polypeptide chain within the fibril structure. 
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Table 5.2. Summary of both calculated (using the OPA and ninhydrin assays), and 
theoretical amino group availabilities of native bovine insulin and bovine insulin 
amyloid fibrils. 
Sample Amino group concentration (μM) calculated 
from standard curve* 
Theoretical amino group 
concentration (μM)** 
 OPA assay Ninhydrin assay 
Native bovine 
insulin 
(1.0 mg/mL) 
368 ± 20 366 ± 14 517 
Bovine insulin 
fibrils 
(formed from 
1.0 mg/mL 
native bovine 
insulin) 
314 ± 13 324 ± 1 N/A 
* The standard curve was constructed using lysine, therefore values were multiplied by two to obtain 
amino group concentration 
** Determined from bovine insulin sequence (Figure 5.7) 
 
5.6.4. Amino group availability of crude crystallin fibrils 
The OPA and ninhydrin assays were then used to assess the amino group availability of 
amyloid fibrils formed from crude crystallin proteins. The samples used were crystallin 
fibrils that were formed from 10 mg/mL native crystallin proteins, however, the 
concentration of protein in the fibrils is unknown due the removal of some as 
amorphous aggregate.  The results of these assays are summarised in Table 5.3. The 
theoretical amino group concentration is unknown, but based upon the relative 
abundances of α, β, and γ crystallins found in Section 2.6.1, and sequence information 
for these proteins from D.rerio, the amino group concentration of crystallin fibrils 
should be greater than that of insulin amyloid fibrils. However, based on the results of 
the OPA and ninhydrin assays, there are some available amino groups, and therefore 
cross-linking via amino groups should have been successful, indicating the presence of 
some other interference. 
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Table 5.3. Summary of calculated (using the OPA and ninhydrin assays) amino group 
availability of crude crystallin amyloid fibrils. 
Sample Lysine concentration (μM) calculated from standard curve 
OPA assay Ninhydrin assay 
Crude crystallin fibrils 
(formed from 10 mg/mL 
native crystallin proteins) 
214 ± 7 258 ± 10 
 
5.7. Post-translational modification of crystallin proteins 
As crystallin proteins are long-lived, they are often used to understand the chemical 
processes associated with aging, such as post-translational modifications (Harding et 
al., 1976). Crystallin proteins, from a range of species, have been observed to undergo a 
number of different post-translational modifications, such as; phosphorylation, 
truncation, deamidation, glycosylation, glycation, racemisation, isomerisation, 
deoxidation, acetylation, and carbamylation (Hanson et al., 1998; Kiss et al., 2010; 
Lapko et al., 2001; Miesbauer et al., 1994; Smith et al., 1992). The post-translational 
modification of crystallins is thought to have implications for cataract formation 
(Harding, 1991; Smith et al., 1992); however, of more interest to this study is the 
possibility of these types of modifications having an effect on the ability to target 
specific amino acid residues for immobilisation of GOx. Lysine is the site of a number 
of post-translational modifications, such as acetylation, carbamylation, and glycation 
(Cloos and Christgau, 2004). Due to time constraints, a full examination of lysine 
modification could not be performed; however, preliminary experiments have been 
carried out to investigate whether the crude crystallin proteins contain carbohydrates. 
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Carbohydrates can be incorporated into proteins both enzymatically (glycosylation), 
and non-enzymatically (glycation) (Hermanson, 1996). Glycosylation of proteins 
involves either N-linked, via asparagine, or O-linked, via threonine, serine, and 
hydroxylysine, sugar modification (Thotakura and Bahl, 1987). Although the amine 
groups of lysine residues are not directly targeted here, the attachment of carbohydrates 
could hinder access to lysine if it was located near an attachment site. Lysine residues 
are directly targeted in glycation, which adds a carbohydrate to a protein via reaction 
between reducing sugars and amine groups of proteins (Sojar and Bahl, 1987). The 
aldehyde group of a reducing sugar first forms a Schiff base linkage with the amine 
group, and then this bond can undergo an Amadori rearrangement to form a stable 
ketoamine derivative (Figure 5.17). This results in a blocked amine containing a sugar 
derivative (Hermanson, 1996). 
 
 
Figure 5.17. A reducing sugar may modify protein amine groups, such as those on 
lysine residues, through Schiff base formation followed by an Amadori rearrangement 
to give a stable ketoamine product. Schematic adapted from Hermanson, (1996). 
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The presence of carbohydrates in crystallin proteins was investigated by staining SDS-
PAGE gels with Pro-Q Emerald 300 staining solution (Molecular Probes, Invitrogen) 
(Section 7.21), which reacts with periodate-oxidised carbohydrate groups, creating a 
fluorescent signal on glycoproteins (Molecular Probes, 2007). Crude crystallin proteins, 
along with the fractions separated in Chapter 2, Section 2.12.1, were run on an SDS-
PAGE gel. GOx was also run as a positive glycoprotein control, as the GOx used is 
known to possess a carbohydrate shell (Leskovac et al., 2005) (Section 5.2). A 
representative SDS-PAGE gel is shown in Figure 5.18, with the image on the left the 
gel stained with the protein stain Coomassie Blue, and on the right, the same gel stained 
with Pro-Q Emerald 300. Positive staining for glycoproteins was seen for the GOx 
control (Lane 9), and also for bands containing both mixtures of crude crystallin 
proteins, and the fractions corresponding to semi-purified α, β, and γ crystallins (Lanes 
10-16). Although it is difficult to assign this to individual crystallin subunits due to the 
similarities in size, it can be confirmed that fish crystallin proteins do contain 
carbohydrates, which would at least contribute to the difficulty encountered with GOx 
immobilisation techniques. 
 
Figure 5.18. SDS-PAGE gel of crystallin proteins stained for proteins (left-hand 
image), and glycoproteins (right-hand image). L & L2 = ladder (molecular weights in 
kDa are indicated to the left of the ladder), 1 & 9 = GOx (glycoprotein positive 
control), 2 & 10 = crude crystallin proteins, 3 & 11 = αT1, 4 & 12 = αT2, 5 & 13 = 
βT1, 6 & 14 = βT2, 7 & 15 = γT1, and 8 & 16 = γT2. 
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Going forward, there are a number of different methods that could be utilised in order 
to achieve immobilisation of GOx, and other enzymes, to crude crystallin proteins: 
1) Coupling through polysaccharide chains. This involves mild sodium periodate 
oxidate, which cleaves adjacent hydroxyl groups in sugar residues to create 
highly reactive aldehyde groups. Immobilisation via this method could help 
preserve enzymatic activity as reactions are not taking place near the active site 
or other critical residues in the polypeptide chain (Hermanson, 1996). 
2) Removal of the carbohydrates, either chemically or enzymatically (Sojar and 
Bahl, 1987; Thotakura and Bahl, 1987). 
3) Immobilisation via other amino acid residues. Amine (lysine, arginine, 
histidine), carboxylic (aspartic acid, glutamic acid), sulfhydryl (cysteine), and 
hydroxyl (tyrosine) moieties can all be targeted for cross-linking (Hermanson, 
1996). 
For this work, remaining experiments were carried out with insulin amyloid fibrils. 
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5.8. Development of a glucose sensing device 
In the development of a glucose sensing device the activity of the functionalised fibrils 
needed to be taken into account; both the long-term activity, and the activity when the 
fibrils are on a surface as opposed to in solution. The electrochemical behaviour of 
insulin amyloid fibrils was also investigated. 
 
5.8.1. Time-course of activity of GOx functionalised fibrils 
The long-term activity of GOx:IF was investigated using the Amplex® red assay, with 
the activity of samples assayed over a 40 day period, during which samples were stored 
at 4 °C (Section 7.22.1). The results of this assay for samples containing GOx only, 
GOx and GA, GOx and insulin fibrils, and GOx:IF, are shown in Figure 5.19. It was 
seen that all of the four samples showed an initial drop in activity over the first two 
days, with activity loss ranging from approximately 20–30 % (Figure 5.19). The 
activity then reaches a plateau, with overall activity losses of approximately 25 % (GOx 
only), 35 % (GOx and GA), 45 % (GOx and insulin fibrils), and 20 % (GOx:IF). 
Immobilisation of GOx onto insulin fibrils resulted in increased stability, something 
which is commonly observed with enzyme immobilisation (Polizzi et al., 2007). These 
results also indicate that GOx:IF may be used in applications for at least 40 days 
without any loss in activity or inconsistency in results.  
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Figure 5.19. Timecourse of %  activity of samples stored at 4 °C. Black square = GOx, 
red circle = GOx + GA, blue triangle = GOx + IF, green triangle = GOx + GA + IF. 
Data points represent the mean of three replicates, with error bars showing the 
standard deviation. 
 
5.8.2. Surface activity of GOx functionalised fibrils 
It was also important to ensure that the functionalised fibrils retained activity when 
deposited on a surface, as this is the state that they would be in on an electrode. The 
activity of functionalised fibrils on a surface was investigated qualitatively, by 
depositing the functionalised fibrils on to a silicon oxide wafer, and removal of excess 
solvent by evaporation. A droplet of the Amplex® red assay reaction mix was then 
deposited on top of the fibrils, and the colour change observed (Section 7.22.2). Control 
samples containing insulin fibrils only and GOx only were also assayed in this way. An 
image of the results of this qualitative assay is shown in Figure 5.20. 
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Figure 5.20. Qualitative assay using Amplex® red of GOx activity of samples deposited 
onto silicon substrates. A = GOx control, B = insulin fibril control, and C = GOx + GA 
+ insulin fibrils. 
 
GOx only control displayed a vibrant pink colour (Figure 5.20, A), consistent with the 
formation of large amount of resorufin, which is indicative of the presence of GOx 
activity (Figure 5.3, A). The insulin fibril only control showed no colour change, as 
would be expected (Figure 5.20, B). The sample containing the functionalised fibrils 
(GOx, GA, and insulin fibrils) showed pink coloration (Figure 5.20, C), although not 
as vibrantly as the GOx only control. This is consistent with in solution activity assays, 
where the GOx activity of functionalised fibrils was approximately 90 % of that of the 
GOx only control (Figure 5.10). This indicates that the functionalised fibrils retain 
activity when deposited on a surface.  
 
5.8.3. Electrochemical behaviour of insulin amyloid fibrils 
The electrochemical behaviour of insulin amyloid fibrils was examined by deposition 
of fibrils onto gold electrodes, with excess solvent removed by evaporation. For these 
initial experiments, screen-printed electrodes were used (Dropsens), with a gold 
working electrode (4 mm diameter), a gold counter electrode, and a silver reference 
electrode (Section 7.22.3).  
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The electrochemical behaviour of insulin amyloid fibrils was examined using cyclic 
voltammetry in the presence of the mediator FcOH (1.5 mM in phosphate buffer, pH 
7.4). At higher concentrations of fibrils there was a marked decrease in the current 
response. This is because at high concentrations there are a large number of insulin 
fibrils, which then block the conductive electrode surface. In order to allow sufficient 
electron transfer, the concentration of insulin fibrils was kept at 0.21 mg/mL (diluted 
from fibrils formed at 1.9 mg/mL) for subsequent experiments. This blocking behaviour 
has also been observed for FF peptide nanotubes (Sasso et al., 2012). 
Figure 5.21 shows comparative cyclic voltammetry of a screen-printed gold electrodes 
response to 1.5 mM FcOH without (top), and with (bottom) modification with insulin 
amyloids at a range of scan rates. The responses observed are not dramatically 
different, likely due to the low concentration of fibrils deposited. However, when the 
electrode is modified with fibrils there is a larger background current, due to 
capacitance resulting from the protein charges on the surface. There is also an observed 
shift in peak potential, Epa = 98 mV for a fibril modified electrode versus Epa = 137 mV 
for a bare electrode. This is likely due to the negative charge of the protein stabilising 
the ferrocene oxidation product. 
No significant changes in the peak current were found after the potential was swept 
from -0.1 to +0.4 V and back at a scan rate of 50 mV/s for 50 cycles. This indicates that 
the insulin fibrils are well adhered to the gold electrode surface. 
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Figure 5.21. Comparative cyclic voltammetry of a screen-printed electrode response to 
1.5 mM FeOH with (bottom) and without (top) modification with insulin amyloid fibrils 
at different scan rates (from inner to outer): 5, 10, 25, 50, 75, 100 mV/s. The arrow 
indicates the initial scan direction. 
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5.9. Glucose sensing 
Under normal circumstances, direct electron transfer between the active site of reduced 
GOx and a metal electrode takes place slowly or not at all because the gap between the 
active site and the electrode surfaces is too large for electron transfer (Leskovac et al., 
2005). The use of electron transfer mediators can overcome this problem, and can be 
used in a number of ways, such as in solution where the mediator can diffuse freely 
between the enzyme and electrode (Leskovac et al., 2005).  
One electron acceptor mediators are usually used, and derivatives of ferrocene are the 
largest class of one electron oxidants (Leskovac et al., 2005). Ferrocene derivatives are 
also good because ferrocene is small enough to penetrate the active site of GOx 
(Alvarez-Icaza et al., 1995). 
Gold electrodes were modified with GOx:IF and their response to glucose examined by 
cyclic voltammetry in the presence of the mediator ferrocene methanol (FeOH). 
 
5.9.1. Modification of gold electrodes with GOx functionalised 
fibrils 
Gold electrodes were prepared by evaporating an 8 mm diameter circle of gold onto a 
10 mm2 silicon oxide wafer, using a custom made sample holder (Figure 5.22, A) 
(Section 7.23.1). GOx:IF were then deposited onto the gold electrode, and the excess 
solvent evaporated by incubating the electrodes for one hour at 37 °C (Section 7.23.2). 
Modified electrodes were prepared fresh before each experiment for consistency. 
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Figure 5.22. Schematic representations of: A) Gold electrodes on a silicon oxide wafer 
which were fabricated for glucose sensing experiments. B) Modification of gold 
electrodes with GOx:IF C) Schematic of the mechanism of electron transfer to the Au 
electrode. Glucose is oxidized to gluconolactone, and electron transfer from reduced 
GOx then occurs via the mediator molecule. 
 
Other studies have needed to incorporate thiol groups into peptides in order to maintain 
contact with the gold surface (Yemini et al., 2005a); however, one of the advantages of 
using amyloid fibrils formed from a full protein, as opposed to a peptide, is that there is 
a greater range of functional groups present. Figure 5.22, B, showed a very simplified 
schematic of the modified gold electrodes. The amyloid fibrils interact with the gold 
surface via thiol groups, and GOx is in turn covalently bound to the amyloid fibril, via 
the GA cross-linker. Figure 5.23 shows representative AFM images of unmodified (A), 
and GOx:IF modified (B) gold electrodes. 
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Figure 5.23. Representative AFM images of gold electrode before (A), and after (B), 
modification with GOx:IF. Scan size is 5 μm2. 
 
5.9.2. Response of modified electrode to glucose 
The catalytic activity of the GOx:IF modified electrodes was quantified in the presence 
of excess glucose, using FcOH as a mediator in solution (Section 7.23.3). Figure 5.22, 
C, shows a schematic of the mechanism of response of the modified electrode to 
glucose. As glucose oxidase is present, when glucose is present in the solution being 
examined, this is oxidised to gluconolactone. Electron transfer from the reduced 
enzyme to the gold electrode then occurs via the mediator molecule present, in this case 
FcOH. As glucose/gluconolactone and FADH2/FAD couples are two electron and two 
proton systems, and ferrocenes are one electron oxidizing systems, two equivalents of 
ferrocene and ferrocenium are involved in the reaction (Leskovac et al., 2005). 
 
 
Figure 5.24. Global representation of the oxidative half reaction of GOx. The oxidation 
of FADH2 to FAD involves the reduction of two equivalents of ferrocene (Q) to 
ferrocenium (P) (Leskovac et al., 2005). 
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As shown in Figure 5.25, A, in the absence of glucose (solid trace), a chemically 
reversible, diffusion-controlled response is obtained for the FcOH+/0 redox couple at the 
GOx:IF modified electrode. In the presence of glucose (dotted trace), the anodic current 
in amplified due the catalytic oxidation of glucose by GOx, mediatied by FcOH. This 
shows that this very simple device based upon GOx:IF is able to electrochemically 
detect glucose. Washing and repeated use of the modified electrode resulted in little 
reduction in the observed response, indicating that the fibrils are well adhered to the 
gold electrode and the device is reusable.  
The catalytic activity of the GOx:IF modified electrode can be expressed as the current 
amplification (CA), defined by:  
( ) /FcOH Glu FcOH FcOHCA i i i                                              
where iFcOH is the anodic peak current recorded at the electrode in the absence of 
glucose, and iFcOH + Glu is the anodic peak current recorded in the presence of glucose 
(Figure 5.25, A) (Lehr et al., 2010).  
The influence of the presence of the GOx:IF on current amplification was examined by 
comparing the average current amplification in the presence of excess (400 mM) 
glucose for gold only electrodes, GOx only modified gold electrodes, and the GOx:IF 
modified gold electrodes. The GOx only control was created by the same methods as 
detailed in Section 5.9.1, with the exception that GOx only was deposited. The GOx 
sample used was diluted in phosphate buffer to have the same activity in solution, as 
ascertained by the Amplex® red assay, as the GOx:IF sample used. The average CA in 
the presence of 400 mM glucose for for each of these three samples are shown in 
Figure 5.25, B. The Au only electrode showed no CA, as would be expected. The GOx 
only electrode and the GOx:IF electrode had CA values within error of each other, 
although it should be noted that there was quite high error for the GOx:IF electrode due 
to the heterogeneity of the fibrils in solution due to fibril-fibril cross-linking.  
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Figure 5.25. A) Representative cyclic voltammagram (scan rate = 5 mV) recorded in 
1.5 mM FcOH PB solution, pH 7.4, for a functionalised fibril modified Au electrode in 
the absence (solid trace), and presence (dotted trace), of 400 mM glucose (SCE = 
saturated calomel electrode). B) Average current amplification (CA) for Au only 
electrodes, GOx modified Au electrodes, and Au electrodes modified with 
functionalised fibrils. Each value represents the average of five replicates, with error 
bars representing the standard deviation of the mean. 
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This result suggests that the presence of fibrils is not increasing the CA of the electrode. 
This is very likely to be due to the fact that the GOx:IF have to be significantly diluted 
before deposition onto the electrode, due to the blocking behaviour of high 
concentrations of insulin fibrils (Section 5.8.3). This means that the benefit of the 
increased surface area available for enzyme attachment due to the presence of the fibrils 
is not being fully realised. 
 
5.10. Towards single-molecule sensors 
Preliminary experiments were carried out on the use of GOx:IF as single-molecule 
sensors, similar to those described in Section 1.8. As manipulation and isolation of 
individual insulin fibrils is not yet achievable, these experiments used the same 
experimental set-up as used in Section 4.2. Networks of GOx:IF were deposited onto 
interdigitated gold electrodes, which were fabricated as per Section 7.11 (Figure 5.26).  
 
 
Figure 5.26. A) Schematic representation of interdigitated gold electrodes fabricated 
on a silicon oxide wafer. B) Networks of GOx:IF were deposited onto these 
interdigitated electrodes. 
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I-V curves were constructed using a probe station and parameter analyser for networks 
of GOx:IF (Figure 5.27), showing current values in the range of 10-11 A recorded for 
bias voltages of 0-2 V.  This is a decrease in conductivity compared to insulin fibrils 
only (Section 4.4). This was also seen when GOx was immobilised to the surface of 
CNTs, with the reasoning being that GOx immobilisation decreased the capacitance of 
the tube (Besteman et al., 2003).  
 
 
Figure 5.27. Typical I-V curves obtained for networks of GOx:IF taken from three 
different samples. 
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I-V measurements were also taken in the presence of 0.2 mM glucose. An increase in 
current was observed, indicating that the GOx:IF showed glucose sensitivity. Figure 
5.28 shows a comparison of the current at 2 V for networks of insulin fibrils, GOx:IF, 
and both of these networks upon addition of glucose. Some increase in current is seen 
upon addition of glucose to insulin fibril networks, this is likely due to the conductivity 
of fibrils increasing upon hydration, as was observed by del Mercato et al. (2007).  
 
 
Figure 5.28. Preliminary results showing the current recorded at 2 V for networks of 
insulin fibrils (IF), networks of GOx modified insulin fibrils (GOx:IF), and these two 
networks upon addition of 0.2 mM glucose. 
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The large increase in current seen when glucose is added to GOx:IF indicates that it is 
GOx activity that is responsible for the increase in current. Besteman et al. (2003) 
observed similar results with a single-molecule sensor consisting of a GOx modified 
CNT. In their study they identified the need for further experiments to unambiguously 
identify which of the processes associated with the GOx catalysed reaction 
(conformational change, changed charge state of amino acids, conversion of oxygen to 
hydrogen peroxide) is responsible for the measured conductance change, and the same 
applies to this study. Nonetheless, these are promising initial results towards the 
formation of an amyloid fibril based single-molecule glucose sensor, with the much 
lower background current of the insulin fibrils, as compared to CNTs,  potentially 
offering higher sensitivity. 
 
5.11. Summary 
This chapter has investigated the use of amyloid fibrils in a model nanowire 
application: the creation of a glucose sensor. GOx was covalently immobilised to 
insulin fibrils using the cross-linker GA, with the functionalised fibrils showing GOx 
activity, and stability over a long time period. Attempts were also made to immobilise 
GOx to crystallin fibrils; however, these were unsuccessful. This is likely to be due to 
post-translational modification to fish crystallin proteins, such carbohydrate 
modification, which may be blocking access to key surface functional groups. 
Deglycosylation and alternative immobilisation techniques could be explored to 
overcome this problem.  
The modification of gold electrodes with GOx:IF resulted in a simple device that 
showed a response to glucose, as investigated by cyclic voltammetry. However, due to 
the blocking behaviour of insulin fibrils, the electrode was only able to be modified 
with low concentrations of GOx:IF, meaning that the full benefits of the increased 
surface area provided by the fibril scaffold were not realised. Preliminary investigations 
in the use of GOx:IF as single-molecule sensors showed the conductivity of GOx:IF 
networks to be glucose sensitive. This was a promising initial result towards the 
creation of a conductance-based glucose sensing device. 
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6.  Chapter Six 
Conclusions and suggestions for future work 
 
Amyloid fibrils have been recognised in the literature as being among a number of 
biomolecules and biomolecular assemblies that show potential to be used as 
nanomaterials (Gras, 2007; Waterhouse and Gerrard, 2004). This thesis aimed to 
investigate the use of amyloid fibrils as nanowires, a role suited to their size and 
morphology. A number of other protein nanotubes/nanofibres have also been identified 
for this role, although they are typically formed from purified proteins and engineered 
peptides (Gazit, 2007). Amyloid fibrils have the novelty of being forming from a large 
number of protein and peptide solutions (Dobson, 2003) and if they are to be used 
successfully in bionanotechnology, there is a need for a cheap and readily available 
protein source (Waterhouse and Gerrard, 2004). Crude crystallin proteins have been 
identified as meeting these requirements (Garvey et al., 2009), and so fibrils from this 
protein source were the major focus of this thesis, with an emphasis on their suitability 
as nanomaterials. Bovine insulin and fungal hydrophobins were also used. The use of 
amyloid fibrils as nanowires was investigated by examining the ability to control their 
dimensions and arrangement, as well as an evaluation of stability and conductivity. 
Functionalisation of fibrils enabled an investigation into their use in glucose sensing, 
chosen as a model nanowire application. 
Initially, fibrils were formed from each of the three protein sources, and the resulting 
fibrils were characterised by the ThT assay and TEM. Amyloid fibrils were readily 
formed from bovine insulin, validating its selection as the model amyloid forming 
protein for this thesis. Hydrophobin rodlets were also formed as per the literature 
(Kwan et al., 2006) with further investigation showing that the provision of additional 
air/water and solid/water interfaces increased the rate of fibrillation. Mixtures of crude 
fish crystallin proteins formed fibrillar structures, which were characterised both 
structurally, and in terms of their applicability to bionanotechnological applications. 
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X-ray fibre diffraction was used to examine the intermolecular structure of amyloid 
fibrils from crude fish crystallins for the first time. The resulting diffraction pattern 
showed isotropic reflections at 4.6 Å and 10.3 Å, which confirm the presence of the 
characteristic cross-β amyloid structure (Pauling and Corey, 1951; Serpell et al., 1999). 
The ability of all three classes (α, β, and γ) of fish crystallin proteins to form fibrils was 
also examined, with SEC used to successfully semi-purify the crystallin proteins. All 
three classes of crystallin proteins were shown to form fibrils under the same conditions 
used to form fibrils from crude mixtures of crystallins, with no noticeable differences in 
morphology. This result confirmed that all classes of crystallins are able to form 
amyloid fibrils (Garvey et al., 2009), as well as validating the use of a crude protein 
mixture, as further purification did not appear to improve fibril morphology or yield. 
Crystallin amyloid fibrils were shown to be stable across a wide pH range, as well as in 
water, phosphate buffer, ethanol, isopropanol, and methanol. Previous work had 
investigated the stability in solution of FF nanotubes (Andersen et al., 2011), a widely 
used PNT, and these showed considerably less stability than crystallin amyloid fibrils. 
Of the solvents tested, only acetonitrile dissolved crystallin amyloid fibrils and, 
interestingly, reduced concentrations of acetonitrile resulted in a change in fibril 
morphology, with the formation of circular assemblies. This result supports the use of 
crystallin fibrils as nanomaterials, particularly in applications requiring prolonged 
solvent contact, such as biosensing. 
A systematic study investigating the effect of growth and storage conditions on the 
dimensions of bovine insulin fibrils achieved a range of length distributions, although 
increased homogeneity would still be desirable. Fibril length increased with decreasing 
native protein concentration, with fibrils formed at 0.5 mg/mL existing up to 6 μm in 
length. This is likely due to the impact of protein concentration on the kinetics of 
nucleation and elongation (Brange et al., 1997; Mauro et al., 2007; Waugh, 1946).  
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The affect of storage conditions was also examined, with the most noticeable effect on 
fibril length resulting from freeze/thaw cycles, which saw the fragmentation of fibrils 
into much shorter species. Throughout these processes, no change was seen to fibril 
diameter. The ability to form fibrils of varied lengths is important for potential 
applications, where control over dimensions is desirable. For this thesis, the ability to 
grow long fibrils was also needed in order to carry out conductivity measurements, as 
fibrils were needed to be long enough to bridge electrodes. 
The conditions that gave the shortest and longest fibrils, namely, freeze-thaw cycles 
and low concentration respectively, were then applied to the crystallin fibril system, to 
investigate whether the same trend in fibril length was observed. Results indicated that 
it is unlikely to be possible to apply the same “length-controlling” conditions to 
different fibril systems, although previous work has shown that crystallin fibrils can be 
produced in a range of sizes (Healy et al., 2012; Raynes, 2012). A greater 
understanding of the mechanism of fibril formation from crude crystallin proteins along 
with optimisation of specific “length-controlling” conditions for this protein system 
would result in increased control over these structures. 
The conductivity of networks of amyloid fibrils formed from bovine insulin, fungal 
hydrophobins, and crude crystallin proteins was investigated via methods based upon 
those of del Mercato et al. (2007). A microchip with interdigitated gold electrodes was 
fabricated by optical lithography and etching, and networks of amyloid fibrils were 
deposited onto the microelectrodes. Amyloid fibrils from all three protein sources had 
low conductivity, with current values falling in the range of 10-8-10-10 A for applied 
bias voltages of 0-2 V. This narrow range of conductivity suggests a role of the generic 
fibril structure in determining conductivity, which is supported by the even lower 
current values observed for native protein (10-12 A). Further investigation involving 
mutation of charged residues could be used to fully elucidate the mode of conduction. 
This finding that amyloid fibrils are insulating is in agreement with previous work 
regarding the conductivity of biomolecules such as amyloid-like fibrils (Scheibel et al., 
2003); peptide nanotubes (Castillo et al., 2008); and DNA (Storm et al., 2001).  
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Although amyloid fibrils are insulating, they can be used as scaffolds or templates for 
the formation of conductive nanowires. Insulin amyloid fibrils were modified with the 
conducting polymers PPY and PANI. This modification saw an increase in the 
conductivity of insulin fibril networks by four and one orders of magnitude 
respectively. Although amyloid fibrils have been previously modified with the 
conducting polymers PEDOT-S, PTAA, and PPF (Hamedi et al., 2008; Herland et al., 
2007; Herland et al., 2008; Tanaka et al., 2008), this was the first use of PPY and 
PANI. Future work optimising the modification process would be useful in order to 
achieve more uniform coatings, as well as an investigation into whether crude crystallin 
fibrils can also be used as a successful nanowire scaffold. 
DEP was used to manipulate crystallin amyloid fibrils on a microchip, in order to probe 
the electrical properties of small numbers of fibrils. This has previously been done with 
FF peptides and CNTs (Castillo et al., 2008; Dimaki and Bøggild, 2005). DEP was 
shown to be a successful tool for manipulating and immobilising bundles of crystallin 
fibrils between electrode pairs in a controlled manner. Once immobilised, fibrils were 
imaged by SEM. Investigation into the conductivity of immobilised bundles showed 
low current values, similar to those seen in network studies. Continuing research 
focusing on the use of DEP as a tool to integrate these structures into biosensing and 
bioelectronics devices would be useful. Microfluidics could also be incorporated into 
the DEP chip to improve the orientation of immobilised fibrils, as flow has previously 
been shown to be effective in alignment of fibrils (Adachi et al., 2007). 
Amyloid fibrils can also be used as a scaffold for enzyme immobilisation, with amyloid 
fibrils acting as a high surface area support. GOx was successfully immobilised to 
insulin fibrils with GA as per the methods of Pilkington et al. (2010), although further 
work would be beneficial to optimise this process to minimise fibril-fibril cross-linking, 
and maintain maximal surface area for GOx immobilisation. GOx activity was shown 
to be maintained and localised on the amyloid fibrils, with immobilisation also 
increasing stability. 
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Attempts were made to immobilise GOx to crystallin fibrils using both GA and MG, 
although these were unfortunately unsuccessful, despite the use of a range of cross-
linking conditions. Post-translational modifications are thought to be the reason for this, 
and preliminary experiments involving carbohydrate-specific staining of SDS-PAGE 
gels showed crude crystallin proteins to be highly glycosylated. In order to use 
crystallin amyloid fibrils for enzyme immobilisation future work is needed exploring 
alternate immobilisation methods, relying on different surface chemistry and/or 
removal of carbohydrates. 
A very basic glucose sensing device was then made by modifying gold electrodes with 
the GOx functionalised insulin fibrils. Prior to glucose sensing experiments, the 
electrochemical behaviour of insulin fibrils was investigated and as high concentrations 
of fibrils were seen to block the conductive electrode surface, low concentrations of 
GOx functionalised fibrils were used in future experiments. The catalytic activity of the 
modified electrodes was quantified in the presence of excess glucose, using FcOH as a 
mediator in solution. The anodic current was seen to be amplified in the presence of 
glucose, which showed that this very simple device was able to be used to 
electrochemically detect glucose. Washing and repeated use of the modified electrode 
resulted in little reduction in the observed response, indicating that the fibrils are well 
adhered to the gold electrode and the device is reusable. Other PNT/PNFs such as FF 
PNTs have also been used in this way (Yemini et al., 2005), although it has 
subsequently been shown that they have poor stability in phosphate buffer (Andersen et 
al., 2011), in which they were immersed for glucose sensing experiments, raising 
doubts over their effectiveness and certainly the reusability of a sensing device based 
around them. 
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Comparison of current amplification achieved with GOx:IF modified electrodes was 
compared to a GOx only modified electrode, where the GOx sample used was diluted 
in phosphate buffer to have the same activity in solution as the GOx:IF sample used. 
The GOx:IF and GOx only modified electrodes show very similar current 
amplifications, which suggests that the presence of fibrils is not increasing the current 
amplification of the electrode. The role of the fibrils was to increase the available 
surface area to which GOx could be immobilised, and as fibrils had to be used at low 
concentrations due to their blocking behaviour, this benefit was not fully realised. It 
would be interesting to co-functionalise insulin fibrils with both conducting polymer 
and GOx, as increased fibril conductivity would overcome this blocking behaviour, 
meaning that fibrils could be fully utilised as a high surface area support for biosensing. 
Preliminary investigations towards the use of GOx:IF as single-molecule sensors 
showed the conductivity of GOx:IF networks to be glucose sensitive. This was a 
promising initial result towards the creation of a conductance-based glucose sensing 
device. Future work involving a full characterisation of this system’s capability would 
help realise this goal, particularly if insulin fibrils were able to be manipulated and 
immobilised by DEP in the same way that crystallin fibrils were. 
This study has confirmed a role for amyloid fibrils in bionanotechnology. The use of 
amyloid fibrils formed from crude crystallin proteins in this area would add value to a 
low cost waste product. Work on these fibrils and those formed from the other protein 
sources used in this thesis show amyloid fibrils to have potential as novel 
nanoscaffolds, with a number of desirable properties. Modification of these 
nanoscaffolds either to increase conductivity or add functionality would allow their use 
in a variety of nanowire applications, such as biosensing and bioelectronics. 
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7. Chapter Seven 
Experimental 
7.1. General  materials and methods 
Unless otherwise stated, all chemicals, reagents, and solvents were obtained from 
Sigma Chemical Co., BDH Laboratory Supplies or Invitrogen, and were of analytical 
grade. 
Fish heads were supplied by the local fish market, with eye lenses extracted in the lab. 
pH measurements were carried out using an UltraBasic UB10 pH meter, purchased 
from Denver Instrument Co. and fitted with a high-performance glass body pH/Tris 
electrode. The electrode was calibrated against standard buffers at pH 4.0, 7.0, and 9.0, 
purchased from BDH Laboratory Supplies. 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was run using 
a NuPAGE system gel electrophoresis box, with precast 10 well NuPAGE Novex® 4-
12 % Bis-Tris gradient gels 1.0 mm (Invitrogen). Samples were prepared by mixing 
with lithium dodecyl sulfate (LDS) 4 x sample buffer, and reducing agent, and then 
heating at 90 °C for 5 minutes to aid the reduction of disulfide bonds. An Invitrogen 
Novex® Sharp Pre-stained Wide-Range Protein Standard ladder was also run for each 
gel. Electrophoresis was carried out at a constant voltage of 200 V in 3-(N-
morpholino)ethanesulfonic acid (MOPS)-SDS running buffer (Table 7.1) at room 
temperature for 50 minutes. Gels were stained with Coomassie R-250 (Table 7.1) for 
30 minutes, and then destained with destaining solution (Table 7.1) for at least three 
hours. Gel images were captured using a BioImaging System (Syngene). 
Protein concentrations of unknown solutions were measured on a Thermo Scientific 
NanoDrop ND-1000 Spectrophotometer (A280) (Thermo Fischer Scientific), unless 
stated otherwise. Measurements of three replicates were averaged and corrected for a 
blank of the sample buffer. 
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Table 7.1. SDS-PAGE gel solutions 
Solution Contents 
(MOPS)-SDS running buffer 50 mM MOPS 
50 mM tris base 
0.1 % SDS 
1 mM ethylenediaminetetraacetic acid (EDTA) 
pH 7.4 
Coomassie R-250 2.5 ng/L Coomassie R-250 
10 % (v/v) glacial acetic acid 
45 % (v/v) methanol 
45 % (v/v) dH2O 
Destaining solution 30 % (v/v) methanol 
10 % (v/v) acetic acid 
60 % (v/v) dH2O 
 
Freeze drying of samples was carried out in a Thermo Savant Supermodulyo 230 freeze 
drier. 
Images of protein structures were constructed using PyMOL (The PyMOL Molecular 
Graphics System, Version 1.3, Schrodinger, LLC), from the appropriate PDB file. 
Alignments of protein sequences were performed using ClustalW (Larkin et al., 2007), 
on the server at the EMBL-EBI (Goujon et al., 2010), using the default alignment 
settings. Phylogenetic trees were constructed using FigTree (Version 1.3.1, BEAST 
Software).  
Optical microscopy images were taken using a Olympus BX60 Transmitted-Reflected 
Light Microscope fitted with a Leica DFC320 Digital Camera. 
 
7.2. Procedures for bovine insulin amyloid fibril formation and 
ThT assay 
Insulin amyloid fibrils were prepared by in-house methods adapted from the literature 
(Nielsen et al., 2001), using bovine insulin obtained commercially (Sigma Chemicals 
(Lot 054K1375)). Fibrils were analysed by the ThT fluorescence assay (LeVine III, 
1993). 
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7.2.1. Formation of fibrils from bovine insulin  
Unless stated otherwise, solutions of insulin were prepared in duplicate to 5.8 mg/mL, 
in insulin fibril buffer (Table 7.2). Samples were aliquoted (1 mL) into sealed 
Eppendorf tubes and placed in a heating block set at 60 °C for 24 hours. Insulin control 
samples were prepared and immediately placed in the freezer. The presence of fibrils 
was confirmed using the ThT assay and TEM imaging. 
 
Table 7.2. Components of insulin fibril formation buffer. 
Solution Contents 
Insulin fibril buffer 100 mM NaCl 
25 mM HCl, pH 1.6 with HCl 
 
 
7.2.2. ThT assay on insulin fibrils 
The ThT assay was carried out according to in-house methods. ThT solution was 
prepared fresh before each use by dissolving 2.5 mM ThT in ThT buffer (Table 7.3), 
and then filtering the solution with a syringe filter. ThT assay solutions (Table 7.3) 
were aliquoted into 96 well, clear bottomed NuncTM fluorescence well plates. The 
following controls were also prepared: 1) Insulin fibrils without ThT, 2) No insulin 
fibril solution. The well plates were sealed with NuncTM 236707 sealing tape, to 
minimise evaporation. ThT fluorescence emission intensity was measured using 
excitation/emission filters of 450 and 485 nm respectively. Measurements were 
recorded by a BMG Labtech FLUOstar OPTIMA Platereader (Alphatech Systems Ltd). 
Fluorescence was measured for at least three replicates. 
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Table 7.3. Details of ThT assay components 
Solution Contents 
ThT buffer 50 mM tris 
100 mM NaCl 
 pH 7.5 
ThT assay solution – regular  
(contents per well) 
100 μL ThT buffer 
66 μL nanopure water 
30 μL unknown sample 
4 μL ThT solution 
ThT assay solution – real time 
(contents per well) 
12.5 μM ThT 
Unknown sample (final volume 200 μL) 
 
Where fibril formation was monitored using the ThT assay in real-time, the protocol 
differed from that described above and is detailed in Table 7.3. Fluorescence was 
measured every five minutes for 240 minutes, with the platereader incubating the 
sample at the desired temperature for the duration of the assay. 
 
7.3. Procedures for hydrophobin rodlet formation and ThT assay 
Unless stated otherwise, hydrophobins were prepared by in-house methods from the 
Sunde lab (Kwan et al., 2008). Hydrophobin rodlets were formed using the 
hydrophobin protein EAS, kindly provided by Margie Sunde from the University of 
Sydney. Rodlets were analysed by the ThT fluorescence assay (LeVine III, 1993). 
 
7.3.1. Formation of hydrophobin rodlets 
Hydrophobins were dissolved in nanopure H2O at a concentration of 1 mg/mL, and 
rodlets then formed by vortexing the sample for two minutes (Kwan et al., 2008).  
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7.3.2. ThT assay on hydrophobin rodlets 
The ThT assay was carried out as per Section 7.2.2, with the exception that only 10 μL 
of protein sample was used per 200 μL assay volume. Where fibril formation was 
monitored using the ThT assay in real-time, the method described in Section 7.2.2 was 
followed, with the exception that fluorescence was measured every two minutes for 
three hours. 
 
7.4. Procedures for crystallin amyloid fibril formation and ThT 
assay 
Crystallin proteins were extracted from fish eye lenses and amyloid fibrils formed from 
this crude mixture by in-house methods adapted from Garvey et al. (2009). Fibril 
formation was confirmed by the ThT fluorescence assay (LeVine III, 1993), and TEM 
imaging. 
 
7.4.1. Extraction of crystallin proteins 
The crystallin protein extraction method was adapted from Garvey et al. (2009). Fish 
eye lenses were homogenised in extraction buffer, with 2 mL buffer used per lens. 
Homogenisation was carried out for 20 minutes using a IKA® Ultra Turrax® Tube 
Disperser fitted with tube ST-20. The homogenate was centrifuged at 10,000 rpm for 30 
minutes at 20 °C in an Eppendorf® MiniSpin® Plus bench-top centrifuge. The 
supernatant was removed and analysed for protein concentration using the Nanodrop 
(A280) (Section 0). The crude crystallin stock solution was then either used fresh for 
fibril formation or kept at 4 °C until use. 
Table 7.4. Details for solutions needed for extraction of crystallin proteins 
Solution Contents 
Extraction buffer 50 mM Tris 
5 mM EDTA 
1 mM DTT 
pH 7.0 
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7.4.2. Formation of fibrils from crude crystallins 
Amyloid fibrils were formed directly from crude mixtures of fish eye lens proteins 
using methods adapted from the literature (Garvey et al., 2009). The crude crystallin 
stock solution was diluted to 10 mg/mL into 25 % n-propanol, pH 3.8 that was 
preheated to 80 °C, to give a total volume of 1 mL. The sample was incubated for 1 
hour at 80 °C in a heating block and then centrifuged at 10,000 rpm for 1 min. The 
supernatant was then removed and returned to the heating block, where it was 
incubated at 80 °C for 24 hours. The sample was then incubated at room temperature 
for at least 3 days. The presence of fibrils was confirmed using the ThT assay and TEM 
imaging. 
 
7.4.3. ThT assay on crystallin fibrils 
The ThT assay on crystallin fibrils was carried out as described in Section 7.2.2. 
Control measurements were also carried out on a sample that was taken from the 
supernatant that fibrils were formed from (Section 7.3.2), prior to incubation. 
 
7.5. TEM imaging of amyloid fibrils 
Insulin, crystallin, and hydrophobin fibril formation and morphology were assessed by 
TEM using negative staining, as described in the literature (Nilsson, 2004). TEM 
samples were prepared using Formvar-coated copper TEM grids (200 mesh). Grids 
were first washed with 3 μL nanopure water. 3 μL of protein fibril sample was placed 
on the grid and left for 1.5 min, with excess removed with filter paper. The grid was 
then stained with 2 μL uranyl acetate (2% w/v) and left for 45 sec, with excess removed 
with filter paper. Grids were then rinsed with another aliquot of nanopure water, and 
left to air dry. For TEM imaging of hydrophobin rodlets the grid was floated on a 3 μL 
droplet of hydrophobin solution for 5 minutes, which allowed rodlets to form on the 
TEM grid. Samples were then stained as described. The micrographs were taken using 
a Morgagni 268D TEM (FEI Company, Oregan, USA) operating at 80 kV and fitted 
with a 40 μm objective aperture. 
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7.6. AFM imaging of amyloid fibrils 
Amyloid fibril samples were diluted to 0.01 mg/mL in pH 1.6 nanopure water, and 10 
μL of solution deposited onto silicon oxide wafers and dried by evaporation. For AFM 
imaging of hydrophobin rodlets the wafer was floated on a 400 μL droplet of 
hydrophobin solution for 5 minutes, which allowed rodlets to form on the wafer.  
Tapping-mode AFM images were obtained with a Digital Instruments Dimension 3100 
AFM, imaging in air. General purpose silicon probes with aluminium reflex coating 
(Tap300Al-G; Budget Sensors, Innovative Solutions Bulgaria Ltd) were used, with a 
force constant of 40 N/m and a resonance frequency of 300 kHz. Images were collected 
(512 samples/line) at scan speeds of 0.5-1.0 Hz. The images were flattened and 
analysed using NanoScope (R) III (Version 5.31 R1, Digital Instruments). 
 
7.7. X-ray fibre diffraction of crude crystallin fibrils 
X-ray fibre diffraction was carried at the University of Sydney by in-house methods, 
based on those of Serpell et al., (1999). Crude crystallin fibrils were concentrated using 
centrifugation (30 min at 13,500 rpm) and the pellet resuspended in minimal milliQ 
water. Aliquots of crude crystallin fibrils (10-20 μL) were suspended between two 
waxed-filled capillary ends, and the sample air-dried. The small stalk of protein 
obtained was placed in an X-ray beam and diffraction data were obtained using a CuKα 
Rigaku rotating anode source (wavelength 1.5418 Å) equipped with a MARresearch 
image plate detector. The sample to detector distance was 175 mm and the exposure 
time was 20 min. Images were examined and relections were measured using marView. 
 
7.8. Procedures for the formation of amyloid fibrils from semi-
purified crystallins. 
Mixtures of crude crystallin proteins were semi-purified into the three classes, α, β, and 
γ, using size exclusion chromatography (SEC), with amyloid fibrils then formed from 
the semi-purifed fractions (Garvey et al., 2009). 
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7.8.1. Separation of crystallin proteins using size exclusion 
chromatography. 
Crude crystallin proteins were prepared as described in Section 7.4.1 and purified by 
SEC on a HiLoad 16/60 Superdex 200 prep grade column (Garvey et al., 2009). The 
elution speed was 0.5 mL/min, with 20 mM Tris (pH 8.0) at 4 °C. The absorbance at 
280 nm was monitored, and 0.5 mL fractions were collected. This separation process 
was carried out multiple times, and achieved a typical elution profile with high 
reproducibility. Samples were run on an SDS-PAGE gel (Section 0) to assess purity. 
 
7.8.2. Formation of fibrils from purified crystallin proteins 
After separation (Section 7.8.1), fractions containing each of the various classes of 
crystallin proteins were pooled, and the protein concentrated by freeze drying (Section 
0). The freeze dried protein was then resuspended in minimal nanopure H2O, and the 
concentration determined by NanoDrop (Section 0). Amyloid fibril formation was then 
carried out as described in Section 7.4.2. 
 
7.9. Procedures to test crystallin fibril stability in various solvents 
The procedures to test crystallin fibril stability in the presence of various solvents were 
based on those of (Andersen et al., 2011). Fibrils formed from crude crystallins 
(Section 7.4.2) were collected by centrifugation at 10,000 rpm for 2 min, and 
resuspended in various solvents (Table 7.5). Presence of fibrils was assessed by the 
ThT assay (Section 7.4.3) immediately and also after 3 hours of incubation at room 
temperature. Samples were analysed by TEM after 3 hours of incubation. 
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Table 7.5. Details of the different solvents used to test crystallin stability 
Solutions Contents 
Crystallin fibril buffer 25 % n-propanol, pH 3.8 
Crystallin fibril buffer – pH 7.0 Crystallin fibril buffer 
adjusted to pH 7.0 
Water Nanopure H2O 
Phosphate buffer 100 mM sodium phosphate buffer, pH 7.4 
Ethanol 100 % ethanol 
Isopropanol 100 % isopropanol 
Methanol 100 % methanol 
Acetonitrile 100 % acetonitrile 
 
 
7.10. Procedures to assess the effect of growth and storage 
conditions on insulin amyloid fibril dimensions 
The effect of various growth and storage conditions on the dimensions of insulin 
amyloid fibrils were determined by the formation of fibrils at various combinations of 
conditions, followed by analysis of dimension using TEM and AFM imaging. 
 
7.10.1. Insulin fibril formation 
Fibrils were formed from adapted in-house methods. Bovine insulin was dissolved at 
varying concentrations (0.5, 1.0, 2.0, 3.0, 4.0, 5.0, and 5.8 mg/mL) in 100 mM NaCl 
adjusted to a various pH values (pH 1.0, 1.5, 2.0 and 2.5) with HCl. This preparation 
was then subjected to elevated temperature (30, 40, 50 and 60 °C) for periods of time 
ranging from 24 hours up to 7 days. The effect of storage condition was also 
investigated, with fibrils being stored at room temperature, under refrigeration, and 
frozen. A full description of the different combinations of conditions is detailed in 
Table 7.6. The presence of amyloid fibrils was confirmed using the ThT assay (Section 
7.2.2.). As we were interested in the resulting dimensions of fibrils we accounted for 
any discrepancies in the time taken for nuclei to form by making length and diameter 
measurements once all samples had reached similar ThT values. 
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Table 7.6. Detail of the different growth and storage conditions used for the insulin 
amyloid fibril samples. 
Sample 
number 
Growth 
concentration 
(mg/mL) 
Growth 
temperature 
(°C) 
Buffer 
Growth 
time 
Storage 
conditions pH Salt 
1 5.8 Room temp. 1.5 100 mM NaCl 24 hrs Room temp. 
2  30     
3  40     
4  50     
5  60     
6 5.8 60 1.0 100 mM NaCl 24 hrs Room temp. 
7   2.0    
8   2.5    
9 0.5 60 1.5 100 mM NaCl 24 hrs Room temp. 
10 1.0      
11 2.0      
12 3.0      
13 4.0      
14 5.0      
15 5.8 60 1.5 100 mM NaCl 24 hrs Refrigeration 
16      Freeze/thaw x1 
17      Freeze/thaw x2 
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7.10.2. TEM imaging of fibril length and data acquisition 
TEM imaging (Section 7.5) was used to assess the effect of growth and storage 
condition on insulin fibril length. Images of fibrils were captured randomly on the grids 
and their lengths were measured to construct a length distribution. To obtain reliable 
statistics, at least 200 fibrils were analysed for each sample. Only fibrils that could be 
clearly distinguished with both ends visible within the image were analysed (Humblet-
Hua et al., 2008). 
 
7.10.3. AFM imaging of fibril diameter and data acquisition 
AFM imaging (Section 7.6) was used to assess the effect of growth and storage 
condition on insulin fibril diameter. Diameter data were collected from a representative 
AFM image for 20 fibrils per sample, as the average of three measurements along the 
length of the fibril. 
 
7.11. Procedures for fabrication of microelectrodes by optical 
lithography 
In order to test the conductivity of amyloid fibril networks, interdigitated gold 
microelectrodes were fabricated using standard photolithographic techniques, based 
upon those of del Mercato et al., (2007). 
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7.11.1. Mask design and fabrication 
Mask designs were created using the CAD system L-Edit Layout Editor v. 12.6 (Tanner 
EDA). The mask material used consisted of 10 cm2 soda lime glass coated with low 
reflective chrome, onto which a layer of positive photoresist was applied using a 
Headway Research Inc. Spinner (Model PWM32). The designs were transferred to the 
mask material using a Heidelberg μPG 101 micropattern generator (Heidelberg 
Instruments, Germany). Following pattern transfer, the photoresist was removed using 
MIF 300 (metal ion free) developer, the active ingredient of which is TMAH 
(tetramethyl ammonium hydroxide). The chrome was then removed using chrome etch 
(consisting of ceric ammonium hydroxide), and lastly the remainder of the photoresist 
was removed using acetone. 
 
7.11.2. Wafer preparation 
Using a Balzers evaporator, fitted with a Sigma Instruments SQM-160 rate/thickness 
monitor, a 100 nm Au layer and a 10 nm NiCr adhesion layer were deposited onto a 
SiO2 wafer, which was washed successively with acetone, methanol, and isopropanol, 
and then baked at 100 °C to remove solvent traces prior to this. The thickness of the 
layers was confirmed using a Veeco Dektak 150 Surface Profilometer. Following the 
evaporation process, the wafer was cut into 1 cm2 chips using a diamond scriber. Prior 
to pattern transfer by optical lithography, the chips were cleaned via successive 
washing with acetone, methanol, and isopropanol, with the chips dried with a stream of 
nitrogen between washes. Following cleaning, the chips were baked at 100 °C for 15 
minutes to ensure all solvent traces had been removed. 
 
7.11.3. Pattern transfer by optical lithography 
A layer of HDMS was applied to the chip using a Headway Research Inc. Spinner 
(Model PWM32), with 1 drop deposited and spun on for one minute at 4000 rpm. Two 
drops of AZ1518 (general use positive photoresist) were then applied and spun for one 
minute at 4000 rpm. The chip was then baked for 90 seconds at 100 °C.  
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The mask pattern was then transferred to the substrate using a Karl Suss MA6 mask 
aligner, operating in vacuum contact mode, with an alignment gap of 100 μm, and an 
exposure time of 25 seconds. 
Following exposure, the photoresist was developed by being placed in AZ MIF 300 
positive resist developer for 17 seconds and then into de-ionized water to stop the 
reaction. The chip was blown dry with nitrogen and baked for 60 seconds at 100 °C. 
The chip was placed in gold etch for 5-10 second intervals, until the gold layer was 
confirmed to be removed by optical microscopy. The nichrome layer was removed in 
the same way using chrome etch. Finally, the remaining photoresist was removed using 
acetone and the chip blown dry with nitrogen. 
 
7.12. Conductivity measurements of amyloid fibril networks 
Conductivity measurements on amyloid fibril networks were carried out as per the 
methods of del Mercato et al., (2007). For insulin, both unmodified and modified, and 
crystallins, amyloid fibril samples of 10 μL were deposited onto gold interdigitated 
electrodes, and solvent removed via evaporation. For hydrophobin amyloid fibril 
samples, the chip was floated on a 400 μL droplet containing hydrophobins for five 
minutes, with excess solvent then removed by evaporation. The sample current was 
measured by means of a probe station (Micromanipulator 1800) combined with a 
parameter analyser (Hewlett-Packard HP 4155A).  
In order to remove the presence of salt as a complicating factor, the insulin fibril 
samples used for conductivity measurements were grown in the absence of salt after 
ensuring that this had no effect on dimensions of fibrils formed. Dimensions were 
analysed from TEM images as per Section 7.10.2 
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7.13. Protease treatment of insulin fibrils 
Insulin amyloid fibrils were treated with the protease pepsin, to remove any non-
fibrillar species present (Zurdo et al., 2001).  Pepsin was added to insulin amyloid 
fibrils at a ratio of 1:200 w/w pepsin:fibrils and the sample incubated at 37 °C for at 
least 1 hour. The sample was centrifuged at 14,500 rpm for 3 minutes using an 
Eppendorf® Minispin® Plus benchtop centrifuge. The supernatant was removed and the 
fibrils resuspended in insulin fibril buffer (Table 7.2).  
 
7.14. Formation of “minus-zinc” bovine insulin fibrils 
Prior to fibril formation, zinc was removed from bovine insulin powder. The desired 
concentration of bovine insulin was dissolved in nanopure water pH 1.6 with 5 mM 
EDTA and the sample incubated for 1 hour. The sample was run on a desalting column 
to remove EDTA. Following the removal of zinc, fibrils were formed as usual. 
 
7.15. Procedures for manipulation and immobilisation of amyloid 
fibrils by dielectrophoresis 
The following work was carried out during a visit to Denmark Technical University, 
Copenhagen. Crystallin amyloid fibrils were immobilised between electrodes on a 
microchip by DEP (Castillo et al., 2008). Immobilisation of fibrils was confirmed using 
SEM, and conductivity of the immobilised fibrils then investigated. 
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7.15.1. Manipulation of crystallin amyloid fibrils by DEP 
A DEP microchip, consisting of 5 gold electrode pairs with a 5 μm gap on a silicon 
oxide wafer, was custom designed and fabricated using standard photolithographic 
techniques by collaborators at Denmark Technical University (Dimaki and Bøggild, 
2005). An aliquot of 10 μL of crystallin amyloid fibrils, as prepared by the methods 
outlined in Section 7.4.2, was placed on top of the microelectrodes. The alternating 
current was then turned on and the different parameters were applied: frequency, 
potential magnitude, and time. Voltage amplitudes from 10 to 20 Vpp, frequencies from 
1 kHz to 1 MHz, and times up to 5 min were applied on the electrodes for the DEP 
experiment. After the chosen time was finished and the voltage turned off, excess 
solvent was removed from the chip using a stream of nitrogen (Castillo et al., 2008). 
Each parameter combination was carried out for ten samples. 
 
7.15.2. SEM imaging of DEP microchips 
SEM imaging of DEP microchips was carried out with a LEO 1550 Scanning Electron 
Microscope with EDX. 
 
7.15.3. Conductivity measurements 
The sample current of crystallin amyloid fibrils that had been immobilised between 
electrode pairs by DEP was measured by means of a probe station (Micromanipulator 
1800) combined with a parameter analyser (Hewlett-Packard HP 4155A) (Castillo et 
al., 2008). 
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7.16. Procedures for immobilisation of GOx to insulin amyloid 
fibrils using glutaraldehyde 
Methods used for the cross-linking of glucose oxidase to bovine insulin amyloid fibrils 
were based on the protocol established by (Pilkington et al., 2010). The cross-linking 
reaction involved 1.9 mg/mL insulin amyloid fibrils, 150 mM glutaraldehyde, and 0.6 
mg/mL glucose oxidase in 100 mM phosphate buffer at pH 7.4, at a ratio of 1:1:1. The 
insulin amyloid fibrils were first mixed by inversion with glutaraldehyde, and 
preincubated for 5 min, after which the glucose oxidase was added and the sample 
mixed by inversion again. The sample was incubated for 1 hour at 25 °C, after which 
the reaction was quenched by 100 mM Tris-HCl, pH 8.0, with the samples then 
immediately placed on ice. Samples were run on an SDS-PAGE gel to ensure that 
cross-linking had occurred (Section 0). “Active” amyloid fibrils were then collected by 
centrifuging the sample for two minutes at 14,000 rpm in a Eppendorf® Minispin® Plus 
benchtop centrifuge, with the fibrils then resuspended in 100 mM phosphate buffer, pH 
7.4, and stored at 4 °C. 
 
 
7.17. Procedures to determine glucose oxidase activity 
Glucose oxidase activity was measured using the Invitrogen Amplex® red/Glucose 
oxidase assay kit (Zhou et al., 1997). 
 
7.17.1. The Amplex® red assay 
Samples containing glucose oxidase were incubated with Amplex® red reaction mixture 
(Table 7.1), for 30 minutes at room temperature, taking care that the samples were 
protected from light. Fluorescence was measured with a Labtech FLUOstar OPTIMA 
plate reader using excitation at 530 nm and fluorescence detection at 590 nm. 
Background fluorescence, as determined for a control sample with no glucose oxidase 
present, was subtracted from each value.  
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Table 7.7. Components of Amplex® red reaction mixture 
Solution Contents 
Amplex® red reaction mixture 50 μm Amplex® red reagent 
0.1 U/mL horseradish peroxidise (HRP)  
50 mM glucose 
100 mM sodium phosphate buffer, pH 7.4 
 
7.17.2. GOx standard curve 
A standard curve for the Amplex® red assay was created using GOx concentrations 
from 0 – 10 mU, where one unit is defined as the amount that will oxidize 1.0 μmole of 
β-D-glucose to D-gluconolactone and H2O2 per minute at pH 5.1 and 30 °C. 
 
7.17.3. GOx activity of samples 
GOx activity of samples was determined using the Amplex® red assay as described in 
Section 7.18, with the exception that samples were first diluted 1/10,000 in 100 mM 
phosphate buffer, pH 7.4. A control sample containing the fibril formation buffer was 
also assayed.  All samples were assayed in triplicate. 
 
7.18. The OPA assay 
The OPA assay was carried out using in-house methods, based on those of Roth (1971). 
OPA solution was prepared as per Table 7.8. OPA solution (1 mL) was added to 50 μL 
of the sample of interest, and shaken by inversion for two minutes. The absorbance of 
the sample was then read at 340 nm using a BioRad SmartSpec Plus 
Spectrophotometer. 
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Table 7.8. Details of OPA solution components 
Solution Contents 
OPA solution 25 mL sodium borate (0.1 M) 
2.5 mL SDS (20 % (w/w)) 
40 mg OPA, dissolved in 1 mL methanol 
100 μL 2-mercaptoethanol 
Final volume adjusted to 50 mL with dH2O 
 
 
7.18.1. OPA standard curve 
A standard curve for the OPA assay was created using lysine, dissolved in nanopure 
H2O at concentrations from 0 – 200 μM, using the protocol described in Section 7.18. 
All samples were assayed in triplicate. 
 
7.18.2. OPA assay of samples 
The OPA assay was carried out on samples containing either native protein or amyloid 
fibrils using the protocol described in Section 7.18. A control sample containing the 
fibril formation buffer was also assayed.  All samples were assayed in triplicate. 
 
7.19. The ninhydrin assay 
The ninhydrin assay was carried out using in-house methods, based on those of 
(Friedman et al., 1984). Ninhydrin buffer was prepared by a 1:3 mixture of lithium 
acetate buffer and ninhydrin solution (Table 7.9), and stored, covered with foil, at 2-8 
°C. The ninhydrin buffer was added to diluted protein samples in a 1:1 ratio, along with 
a sample blank. The samples were heated in a water bath at 100 °C for ten minutes, 
vortexing after five minutes.  The samples were then cooled on ice. 300 μL of 95 % 
(v/v) ethanol was then added to 300 μL of each sample and vortexed. The absorbance 
of the sample was then read at 570 nm using a BioRad SmartSpec Plus 
Spectrophotometer. If the A570 exceeded 1.0, the samples were further diluted with 95 
% ethanol. 
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Table 7.9. Details of ninhydrin buffer components 
Solution Contents 
Lithium acetate buffer 4 M lithium acetate 
pH 5.2 with acetic acid 
Ninhydrin solution 0.01 M ninhydrin 
0.01 M hydridantin 
75 % (v/v) DMSO 
 
 
7.19.1. Ninhydrin standard curve 
A standard curve for the ninhydrin assay was created using lysine, dissolved in 
nanopure H2O at concentrations from 0 – 200 μM, using the protocol described in 
Section 7.19. All samples were assayed in triplicate. 
 
7.19.2. Ninhydrin assay of samples 
The ninhydrin assay was carried out on samples containing either native protein or 
amyloid fibrils using the protocol described in Section 7.19.  Samples were diluted with 
95 % ethanol when needed to obtain an A570 below 1.0. A control sample containing the 
fibril formation buffer was also assayed.  All samples were assayed in triplicate. 
 
7.20. Procedures for immobilisation of GOx to crystallin amyloid 
fibrils 
Attempts were made to immobilise GOx to crystallin amyloid fibrils using the methods 
in Section 7.16, and following this, attempts were made by varying the reaction 
conditions, including using the cross-linker methylglyoxal. Details of the different 
reaction conditions used are detailed in Table 7.10.  
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Crystallin fibrils were concentrated where desired by centrifugation and resuspension in 
minimal crystallin fibril buffer (Section 7.4.2). GOx, crystallin fibrils, and the cross-
linking molecule (GA or MG), were combined in a ratio of 1:1:1 in various orders, with 
pre-incubation of two components where desired. This reaction mixture was then 
incubated at either 25 or 37 °C for the specified reaction time, after which the reaction 
was quenched by the addition of 100 mM Tris-HCl, pH 8.0, with the samples 
immediately placed on ice. The degree of cross-linking was then assessed by SDS-
PAGE (Section 0). 
 
Table 7.10. Details of different conditions attempted for immobilisation of GOx to 
crude crystallin fibrils (GOx=glucose oxidase, CF=crystallin fibrils, and X=cross-
linker). 
Variable Different conditions tried 
Reaction order GOx+CF→X, GOx+X→CF, CF+X→GOx, 
GOx→CF→X, GOx→X→CF, GOx→CF→X, 
Total reaction time (min) 30 - 120 
Pre-incubation time (min) 
(GOx+CF/GOx+X/CF+X) 
5 - 20 
Reaction temperature (°C) 25, 37 
Cross-linker GA, MG, GA+MG 
Cross-linker concentration GA (10-150 mM), MG (1-4 %) 
Crystallin fibril concentration ( ̴mg/mL)* 1.0 – 10.0 
GOx concentration (mg/mL) 0.5 – 2.0 
* This value is approximate.  
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7.21. Glycoprotein gel protocol 
Glycoprotein gels were run using the Molecular Probes Pro-Q Emerald 300 
Glycoprotein Gel and Blot Stain Kit (Invitrogen). Proteins were first separated by 
standard SDS-PAGE (Section 0). The gel was then fixed by immersing the gel in 
approximately 100 mL of fix solution (Table 7.11), and incubating at room temperature 
with gentle agitation for 45 minutes. This step was repeated to ensure the SDS was 
fully washed out of the gel. The gel was incubated in approximately 100 mL of wash 
solution (Table 7.11), with gentle agitation for 10-20 minutes. This step was also 
repeated. The carbohydrates were oxidized by incubating the gel in 25 mL of oxidizing 
solution (Table 7.11), with gentle agitation for 30 minutes. The gel was washed in 
approximately 100 mL of wash solution with gentle agitation for 10-20 minutes, and 
this step was carried out three times.  The gel was stained by incubating in the dark in 
25 mL of Pro-Q Emerald 300 staining solution (Table 7.11), while gently agitating for 
90-120 minutes. The gel was washed by incubation for 15-20 minutes in 100 mL wash 
solution with gentle incubation. The stained gel was visualised using a 300 nm UV 
transilluminator, and gel images captured using a BioImaging System (Syngene). 
 
Table 7.11. Details of glycoprotein gel solutions 
Solution Components 
Pro-Q Emerald 300 Stock Solution Pro-Q Emerald 300 reagent dissolved in 6 
mL N,N-Dimethylformamide (DMF) 
Fix solution 50 % methanol 
5 % glacial acetic acid 
dH2O 
Wash solution 3 % glacial acetic acid 
Oxidising solution 2.5 g periodic acid 
250 mL 3 % glacial acetic acid 
Pro-Q Emerald 300 Staining Solution Pro-Q Emerald 300 Stock Solution diluted 
50-fold into Pro-Q Emerald 300 Staining 
Buffer 
(this was prepared fresh before each use) 
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7.22. Development of a glucose sensing device 
A glucose sensing device was developed using the GOx:IF that were formed as per 
Section 7.16.  
 
7.22.1. Time-course of GOx:insulin amyloid fibril activity 
The stability of the GOx:insulin amyloid fibrils, formed as per Section 7.16, was 
examined by testing the activity of samples stored at 4 °C, using the Amplex® red assay 
(Section 7.17.3). Activity was assayed in samples over a 40 day period. Controls of 
GOx only, GOx and GA, and GOx and insulin fibrils were also included. All samples 
were assayed in triplicate. 
 
7.22.2. Qualitative assay of GOx activity 
In order to ensure that GOx:IF were active when deposited on a surface, a qualitative 
assay of GOx activity was carried out. A 20 μL droplet of GOx:insulin fibrils, formed 
as per Section 7.16, was deposited onto 10 mm2 silicon substrates, and excess solvent 
removed by evaporation. A droplet of Amplex® red reaction mixture was then 
deposited onto the substrate, and the colour change observed.  Positive and negative 
controls of GOx only and insulin fibrils only respectively were also included. 
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7.22.3. Electrochemical characterisation of insulin fibrils 
Electrochemical characterisation of insulin fibrils was carried out using DropSens 
screen-printed electrodes (DRT-C220AT, DropSens, Spain), which have dimensions of 
3.4 x 1.0 x 0.05 cm (length x width x height), and consist of a 4 mm gold working 
electrode, a gold counter electrode, and a silver reference electrode. 20 μL of insulin 
fibril solution, at various concentrations diluted from fibrils formed at 1.9 mg/mL were 
deposited onto the electrode, and excess solvent removed by evaporation for one hour 
at 37 °C. Cyclic voltammetry was carried out in the presence of 1.5 mM FcOH in 
phosphate buffer, pH 7.4 (scan rate 5 mV/s) using a Uniscan Instruments PG581 
potentiostat-galvanostat with a Dropsens connector DRP-CAC to connect the screen-
printed electrode to the potentiostat. Once the optimum fibril concentration was 
established, cyclic voltammetry was carried out on both blank and fibril modified 
electrodes at scan rates from 5 to 100 mV. 
 
7.23. Glucose sensing 
The potential for GOx:IF to be used in a glucose sensing device was investigated by the 
modification of gold electrodes with GOx:IF followed by electrochemical detection of 
glucose in solution. 
 
7.23.1. Formation of gold electrodes 
A large silicon oxide wafer coated with a protective resist layer and then diced into 10 
mm2 wafers using a diamond scriber, and the resulting wafers washed successively with 
acetone, methanol, and isopropanol, and then baked at 100 °C to remove any solvent 
traces.  The wafers were then mounted in a custom made sample holder which only 
reveals a 8 mm diameter circle in the centre of the wafer, and a 100 nm Au layer with a 
10 nm NiCr adhesion layer deposited by evaporation using a Balzers evaporator fitted 
with a Sigma Instruments SQM – 160 rate/thickness monitor. Post evaporation, the 
wafers were again cleaned with acetone, methoanol, and  isopropanol, and baked at 100 
°C for 15 minutes. 
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7.23.2. Modification of gold electrodes 
Gold electrodes were modified with GOx functionalised insulin fibrils by methods 
based upon those of Qian et al., (2009). 10 μL of GOx:IF sample was deposited onto 
the gold electrode, and excess solvent removed by evaporation, with the electrode 
incubated at 37 °C for one hour. 
 
7.23.3. Electrochemical detection of glucose 
The electrochemical detection of glucose was carried out by methods based on those of 
Lehr et al., (2010). Electrochemical measurements were performed using a computer-
controlled EG & G PAR model 362 potentiostat. The GOx:IF modified electrodes 
(Section 7.23.2) were mounted on an insulated metal stage under a glass cell secured 
with four springs. A hole in the cell bottom was centred over the electrode and sealed 
with an O-ring. The area of the working electrode was 4 mm diameter. Electrical 
contact was maintained with a copper strip externally connected to the sample. The 
counter electrode was Pt wire and the reference electrode was silver/silver chloride. 
The catalytic activity of the GOx:IF modified electrode was quantified via cyclic 
voltammograms in the absence and presence of excess glucose (400 mM), using 1.5 
mM FcOH in 100 mM phosphate buffer, pH 7.4 as a mediator in solution. 
Voltammograms were obtained by cycling between -0.1 and +0.4 V at a scan rate of 5 
mV/s. Controls experiments were carried out on unmodified electrodes, and on 
electrodes with GOx, which had been diluted in 100 mM phosphate buffer, pH 7.4 to 
have the same activity in solution as the GOx:IF sample, as ascertained by the Amplex® 
red assay (Section 7.17.3). 
 
7.23.4. GOx:IF network sensors 
The glucose sensing capabilities of GOx:IF networks was investigated. I-V 
characterisation of GOx:IF was carried out as per Section 7.12, with additional I-V 
measurements taken after the deposition of a droplet of 0.2 mM glucose (in 100 mM 
phosphate buffer, pH 7.4) on top of the GOx:IF network. Control experiments were 
also carried out with deposition of glucose on to insulin fibril networks.  
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7.24. qNano characterisation of crystallin amyloid fibrils 
Methods for the characterisation of crystallin amyloid fibrils using the qNano were 
based upon those of Vogel et al. (2011), with all components obtained from IZON 
Science (New Zealand). Tunable nanopores were mounted on the q-Nano, and stretched 
open until the desired pore size was reached. Standard electrolyte buffer (SEB) was 
placed in both fluid cells which contain one electrode each, above and below the 
membrane. Current pulse signals were collected using IZON propriety software. 
Crystallin fibril samples run on the qNano were first diluted 100 x into SEB, and then 
placed in a sonicating water bath for 10 minutes. 
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A. Appendix A 
Sequence alignments of crystallin proteins 
 
In Chapter 2, PyMOL images are shown of some examples of crystallin protein 
structures. Where possible, the structure shown was that from Danio rerio (zebrafish), 
as this is the only fish for which full crystallin sequence information is available. If no 
structure from D. rerio was available, the structure shown was that of the PDB files 
available, that had the highest sequence similarity to D. rerio. Sequence alignments 
were carried out using ClustalW. Details of the structures chosen, with justification, are 
shown in Table A.1, with the various sequence alignments shown in Figure A.1 (αB-
crystallin), Figure A.2 (βA4-crystallin), Figure A.3 (βB2-crystallin), and Figure A.4 
(γB-crystallin). 
 
Table A.1. Details of crystallin sequence information and representative structures 
chosen. 
Protein sequence ID 
(D. rerio) 
Structures 
available 
Sequence ID Alignment 
score * 
(%) 
Structure 
used ** 
PDB 
ID 
αA-
crystallin 
AAK61363.1 D. rerio*** AAK61363.1 N/A D. rerio 3N3E 
αB-
crystallin 
AAD49096.1 H. sapiens ACP18852.1 58.0 H. sapiens 3L1G 
βA4-
crystallin 
NP_001018135.1 H. sapiens NP_001877.1 68.0 H. sapiens 3LWK 
βB2-
crystallin 
NP_001018138.1 B. taurus NP_777232.1 71.0 H. sapiens 1YTQ 
  M. musculus NP_031799.1 71.0   
  R. 
norvegicus 
NP_037069.1 71.0   
  H. sapiens NP_00487.1 72.0   
γB-
crystallin 
NP_001012390.1 H. sapiens NP_005201.2 59.0 B. taurus 1AMM 
  B. taurus NP_001013612.1 64.0   
*This is the pairwise alignment score (%) upon alignment with the D. rerio sequence. 
**The structure used was that with the highest sequence similarity (based on alignment score) with the 
D. rerio sequence. 
*** If the D. rerio structure was available then this was used. 
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Figure A.1. Sequence alignment of αB-crystallin proteins from D. rerio and H. sapiens.  
 
 
Figure A.2. Sequence alignment of βA4-crystallin proteins from D. rerio and H. 
sapiens. 
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Figure A.3. Sequence alignment of βB2-crystallin proteins from M. musculus, R. 
norvegicus, H. sapiens, B. Taurus, and D. rerio. 
 
Appendix A – Sequence alignments of crystallin proteins                                           243 
 
 
 
 
Figure A.4. Sequence alignment of γB-crystallin proteins from H. sapiens, B. taurus, 
and D. rerio. 
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B. Appendix B  
Characterisation of crystallin fibrils using the 
qNano 
 
The qNano particle analyzer (Izon, New Zealand) was investigated as an alternative 
method for the characterization of crystallin fibrils. The qNano consists of a resizable 
nanopore, which is embedded in a thermoplastic polyurethane (TPU) membrane, which 
is in turn, situated in a fluid cell. The fluid cell contains an electrolyte solution, and 
when a voltage is applied across this membrane, a stable current, which may be 
attributed to the electrolyte solution, is observed. The instrument operates by detecting 
the change in resistance or ionic current caused by the passage of particles through the 
sensing channel or pore (Willmott et al., 2011; Willmott and Moore, 2008). This is 
shown schematically in Figure B.1. 
Crystallin amyloid fibrils were lightly sonicated, using a sonicating water bath, prior to 
being introduced into the upper fluid cell. This was in done in order to reduce the 
number of large fibrillar aggregates, to increase the likelihood of visualising single-
molecule translocation events. The fibrils were confirmed to be still intact by TEM 
(Figure B.2) and not fragmented to the degree seen with heavy sonication (Chapter 3, 
Section 3.5).  
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Figure B.1. Schematic of the nanopore system utilised by the qNano. The nanopore 
system consists of a resizable nanopore which is embedded in a membrane. On either 
side of the membrane is an electrolyte solution which is contained in a fluid cell. A 
voltage is applied across this membrane, and so when a particle traverses the 
membrane via the nanopore, a fluctuation in current is observed, also known as a 
blockade event. 
 
 
Figure B.2 Representaitve TEM images of crystallin fibrils that were resuspended into 
SEB and then placed in a sonicating water bath for 10 minutes. Scale bars are 1 μm 
(A), and 0.2 μm (B). 
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As crystallin fibrils are insulating (Chapter 4), when they pass through the pore they 
reduce/block the ionic current in a manner that reflects both their size and 
conformation. Each single-molecule translocation can be characterised by two 
parameters; the average blockade height (nA), and the duration of the blockade, that is, 
the time taken for the molecule to completely traverse the pore. Figure B.3 shows a 
scatter plot of these two parameters for 64 events, along with examples of some of the 
current-time traces observed for translocation events. It is tempting to speculate that an 
event in which there is an increased blockade for a short time (Figure B.3, B, i) is due 
to the fibril being folded over on itself, in contrast to a long blockade duration where 
the fibril is stretched out (Figure B.3, B, ii). This was observed for DNA molecules 
passing through a graphene nanopore (Garaj et al., 2010); however, further 
investigation is required to establish if this is occurring with the fibrils in this study. 
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Figure B.3. A) Scatter plot of blockade baseline duration versus blockade height, and 
B), examples of individual blockade traces, which correspond to the red circled events 
in the scatter plot. 
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The qNano is able to be using for the gathering information on the size distribution of 
sample, by relating the blockade height to the size of the particle. Standard particles are 
used in order to generate data corresponding to the absolute size of particles. However, 
to date, the standard particles used are spherical, and so the absolute size distribution of 
crystallin fibrils was not able to be established from these. Figure B.4 shows the 
distribution of average blockade heights (nA) of single-molecule translocation events 
for crystallin amyloid fibrils. Although absolute sizes of fibrils cannot be obtained from 
this, the existence of a large population of small fibrils is seen, similar to what was 
observed in the length characterisation of insulin fibrils in this thesis, and also in other 
studies in the literature. The development of a rod-shaped standard particle would allow 
a more meaningful analysis of the size distribution of amyloid fibrils.  
 
 
Figure B.4. Distribution of average blockade heights (nA) of single-molecule 
translocation events for crystallin amyloid fibrils. 
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A major problem encountered during this work was the clogging of the nanopore by the 
crystallin fibrils. This resulted in difficulty in achieving large sample sizes, as data were 
only able to be collected for approximately five minutes before the pore clogged. It also 
complicates the analysis of the parameters detailed in Figure B.3, as a long 
translocation event could be due to membrane-fibril interactions. Previous work, using 
a synthetic nanopore, overcame this problem by coating the nanopore with a fluid 
bilayer (Yusko et al., 2011). This coating eliminated non-specific interactions, meaning 
that translocation events of molecules that aggregate and have a tendency to clog 
nanopores were able to be analysed. This coating allowed analysis of translocation 
events of αβ-amyloid fibrils for 40 minutes at a time; however, no size data was 
gathered. A coating of this type on the TPU membranes used in the qNano would allow 
full characterisation of these type of molecules. 
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C. Appendix C  
EDX analysis of DEP electrodes 
 
Figure C.1. EDX analysis of electrode pairs after immobilisation of crystallin fibrils by 
DEP. Top: SEM image of electrode pairs and sites of EDX analysis. Bottom: EDX 
spectra with assigned peaks for A) Gold electrode, B) Silicon oxide wafer, C) Electrode 
tip, and D) Middle of electrode pair.  
 
